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ABSTRACT 
 
In recent years, there is a greater health care, with people increasingly looking for a healthy 
lifestyle and therefore healthy foods, which could also provide innovative therapeutic options. 
To this end, public awareness of the need for a careful and healthy diet has increased. In this 
way, there is a greater demand for healthy food and food products that associated with its 
nutritional function, have health benefits, namely functional foods, as well as food 
supplements and/or nutraceutics. In this context, mushrooms arise as an excellent option for 
their nutritional value, bioactive compounds and health-promoting properties.  
Mushrooms have been pointed as valuable health foods, rich in protein, vitamins and 
minerals; a source of bioactive compounds, such as unsaturated fatty acids or 
mono/oligosaccharides; and as having bioactive properties, such as antioxidant, anti-
inflammatory, or antimicrobial activities, as well as having cardiovascular beneficial effects, 
amog others. 
Since Bragança (Portugal) is one of the regions of Europe with greater mycological 
biodiversity, it is important to undertake a careful identification and characterization of a large 
number of wild edible mushroom species. In addition, being also a region where mushroom 
picking is a tradition, the scientific community plays an important role in the formation of the 
general population, and this is also one of our research group concerns.  
Thus, the present work aims to increase edible mushroom (wild and cultivated) databases, 
pursuing to valorize mushrooms as promising natural resources by providing new information 
about their potential as a source of functional ingredients and/or nutraceuticals. To this 
purpose, this dissertation focuses on the chemical characterization of 17 different edible 
mushroom species and their extracts (mainly methanolic), with subsequent evaluation of their 
bioactive potential, namely antioxidant, antimicrobial and antitumour properties.  
The chemical characterization of the species included the evaluation of i) mushroom 
nutritional value (crude protein, crude fat, ash, total carbohydrates and energy) measured 
relying on AOAC procedures; ii) mushroom nutrient content (soluble sugars and fatty acids) 
assessed through chromatographic techniques, namely high performance liquid 
chromatography (HPLC) and gas chromatography (GC), and iii) mushroom bioactive 
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compounds (ascorbic acid and other organic compounds, phenolic and tocopherols) identified 
by HPLC or UFLC.  
Generally, the studied edible mushroom species revealed low fat contents and quite low 
energetic values, being carbohydrates the main macronutrients present. Mannitol and 
trehalose were the main soluble sugars found in the studied species. Regarding the fatty acids 
profile, palmitic, stearic, oleic and linoleic acids were the main fatty acids quantified in all the 
studied species, with polyunsaturated fatty acids prevailing over saturated fatty acids. 
Moreover, ascorbic acid and tocopherols were also present in some species, and regarding this 
latter, the β- and γ- isoforms, seems to be the main isoforms presented by these natural 
matrices. Regarding other bioactive compounds present in the studied edible mushrooms, 
oxalic acid, quinic acid, malic acid, citric acid, and fumaric acid were the main organic acids 
detected in the studied samples; and gallic acid, protocatechuic acid, p-hydroxybenzoic acid, 
and p-coumaric the phenolic acids identified as well as the related compounds cinnamic acid.  
The antioxidant potential of the mushroom extracts was evaluated by different in vitro 
methodologies, namely the Folin-Ciocalteu assay, ferricianide/Prussian blue assay, DPPH 
radical-scavenging assay, β-carotene/linoleate or β-carotene bleaching inhibition assay and 
the thiobarbituric acid reactive substances (TBARS) assay. Overall, all the studied 
mushrooms revealed antioxidant potential, which suggests that some of the previously 
compounds identified, and known for their antioxidant potential (e.g., ascorbic acid, 
tocopherols or phenolic acids), may be related with such property.  
The antimicrobial assays used different species of food contaminants, and the minimum 
inhibition concentration (MIC), minimum bactericidal and fungicidal concentration (MBC 
and MFC, respectively) were determined for the mushroom extracts. The bacteria strains 
included Gram-positive (Staphylococcus aureus, Bacillus cereus, Micrococcus flavus and 
Listeria monocytogenes) and Gram-negative (Pseudomonas aeruginosa, Salmonella 
typhimurium, Escherichia coli and Enterobacter cloacae) bacteria, and the antifungal 
potential was evaluated against Aspergillus (A. fumigatus, A. versicolor, A. ochraceus, and A. 
niger), Trichoderma (T. víride), and Penicillium (P. funiculosum, P. ochrochloron and P. 
verrucosum var. cyclopium) species. Among the studied species for their antimicrobial 
properties, some revealed very promising results (Suillus granulatus), since they revealed 
MIC’s, MBC’s and MFC’s lower than commercially available antibiotic and antifungal drugs.  
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The antitumor potential was evaluated testing the mushroom extracts against a panel of 
human tumour cell lines (MCF-7: breast adenocarcinoma, NCI-H460: non-small cell lung 
cancer, HCT-15: colorectal adenocarcinoma, HeLa: cervical adenocarcinoma, HepG2 
hepatocellular carcinoma, and AGS gastric adenocarcinoma), performing the sulforhodamine 
B (SRB) assay and calculating the percentage of cell growth inhibition (GI50). Carrying out 
the same colorometric assay (SRB), the extracts cytotoxicity was also evaluated in non-
tumour primary cell cultures obtained from porcine liver (PLP2), in order to have some 
preliminary results regarding their hepatotoxicity, in a cheap, fast and ethical test. In a more 
in-depth study (article 9), the human breast non-malignant cell line MCF-10A was used as 
non-tumour control. All the studied extracts revealed antiproliferative effects in the tested cell 
lines (with the exception of Cordyceps militaris in HepG2 cells) and no cytotoxicity was 
observed for the tested concentrations in the non-tumour cells.  
Given the previously results, some in-depth studies were carried out, in order to infer the 
possible mechanism of action of the studied mushroom extracts. For these assays Leccinum 
vulpinum and Ganoderma lucidum were selected. Different techniques were carried out for 
both studied. L. vulpinum proved to decreased cellular proliferation (BrdU assay) and induced 
apoptosis (Western blot and flow cytometry) in breats adenocarcinoma cells (MCF-7). 
Moreover, the results also suggest that the extract causes cellular DNA damage (Comet 
assay). On the other hand, G. lucidum proved to induce autophagy. A gastric adenocarcinoma 
cell line (AGS) was transfected with a mCherry-LC3 expression vector, and tretated with the 
methanolic extract of G. lucidum. This treatment increased the formation of autophagosomes 
(vacuoles typical from autophagy). Moreover, the cellular levels of LC3-II were also 
increased, and the cellular levels of p62 decreased (Western blot), confirming that the extract 
affects cellular autophagy. Treatment with the extract together with lysossomal protease 
inhibitors (E-64d/pepstatin) caused a further increase in the cellular LC3-II levels together 
with an increase in p62 levels (Western blot) proving that the methanolic extract of G. 
lucidum cause an induction of autophagy rather than a reduction in the autophagic flux.  
 
Overall, mushrooms from the Northeastern region of Portugal, proved that these natural 
matrix may be considered a functional food, since the compounds found therein have, besides 
the nutritional effect, beneficial properties such as antioxidant, antimicrobial and antitumour 
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potential. However, further in-depth studies such as the study of the compounds’ mechanism 
of action both in vitro and in vivo are needed. 
Since the obtained data highlight the potential of mushrooms as a source of bioactive 
compounds, the present study also contributes to the awareness for the conservation of the 
mycological resources not only for environmental issues, but also for their potential as a 
source of nutraceutical / pharmaceutical compounds. 
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RESUMEN  
 
En los últimos años, ha incrementado el interes por cuestiones de salud publica, estilo de vida 
saludables y por lo tanto se la incrementado la búsqueda de alimentos saludables que además 
ofrezcan alternativas terapéuticas innovadoras. De esta manera, existe una mayor demanda de 
alimentos y productos alimenticios saludables que además de presentar un buen perfil 
nutricional, tengan o aporten beneficios para la salud, a saber, alimentos funcionales, así como 
complementos alimenticios y / o nutracéuticos. En este contexto, las setas se presentan como 
una excelente opción por su valor nutricional, contenido en compuestos bioactivos y 
propiedades beneficionas para la salud. Las setas son alimentos saludables, ricos en proteínas, 
vitaminas y minerales; son fuente de compuestos bioactivos, tales como ácidos grasos 
insaturados o mono/oligosacáridos; y que tienen propiedades bioactivas, tales como 
actividades antioxidantes, antiinflamatorias o antimicrobianas, además de tener efectos 
beneficiosos cardiovasculares, entre otros. 
Bragança (Portugal) es una de las regiones de Europa con mayor biodiversidad micológica, y 
de gran tradición de recolección de setas silvestres, de modo que es importante realizar una 
cuidadosa identificación y caracterización de dicha biodiversidad, con el mayor numero de 
especies de setas silvestres comestibles posible.  
Así, el presente trabajo tiene como objetivo principal contribuir a la construcción de bases de 
datos sobre setas silvestres comestibles, con el fin de revalorizarlas como recursos naturales 
prometedores aportando nueva información sobre su potencial como fuente de compuestos 
bioactivos y/o nutracéuticos. Para ello, la presente tesis doctoral se centra en la 
caracterización química de 17 especies diferentes de setas comestibles y sus extractos 
(principalmente metanólicos), para posterior evaluación de su potencial actividad biológica, 
en concreto de sus propiedades antioxidantes, antimicrobianas y antitumorales. 
La caracterización química de la especie incluyó la evaluación de: i) el valor nutritivo de las 
setas (proteína bruta, grasa bruta, ceniza, carbohidratos totales y energía) mediante los 
procedimientos validados de la AOAC; ii) contenido de algunos nutrientes concretos en setas 
(azúcares solubles y ácidos grasos) evaluado mediante técnicas cromatográficas, como la 
cromatografía líquida de alta resolución (HPLC) y cromatografía de gases (GC) y iii) 
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contenido de algunos compuestos bioactivos (ácido ascórbico y otros ácidos orgánicos, ácidos 
fenólicos y tocoferoles) identificados por HPLC y UHPLC. 
En general, las especies de setas comestibles estudiadas presentaron bajos contenidos de grasa 
y valores energéticos bastante bajos, siendo los hidratos de carbono el macronutriente 
principal. El manitol y la trehalosa fueron los principales azúcares solubles encontrados en las 
especies estudiadas. En cuanto al perfil de los ácidos grasos, los ácidos grasos palmítico, 
esteárico, oleico y linoleico fueron los principales ácidos grasos cuantificados en todas las 
setas estudiadas, predominando los ácidos grasos poliinsaturados frente a los ácidos grasos 
saturados. Por otra parte, el ácido ascórbico y los tocoferoles también estaban presentes en 
algunas especies, y con respecto a los tocoferoles, las isoformas β- y γ-, fueron las principales 
isoformas pospresentes en estas matrices naturales. En cuanto a otros compuestos bioactivos, 
el ácido oxálico, ácido quínico, ácido málico, ácido cítrico y ácido fumárico fueron los 
principales ácidos orgánicos detectados en las muestras estudiadas; mientras que el ácido 
gálico, ácido protocatequídico, ácido p-hidroxibenzoico y p-cumárico, fueron los ácidos 
fenólicos identificados así como el compuestos relacionados ácido cinámico. 
El potencial antioxidante de los extractos de setas se evaluó mediante diferentes metodologías 
in vitro, como el ensayo Folin-Ciocalteu, el ensayo de ferricianide/Prussian blue, el ensayo de 
captación de radicales DPPH, el ensayo de β-caroteno/linoleato o inhibición de la 
decoloración del β-caroteno y el ensayo de TBARS. En general, todas las setas estudiados 
destacaron por su potencial antioxidante, lo que sugiere que algunos de los compuestos 
anteriormente identificados, y conocidos por su potencial antioxidante (por ejemplo, ácido 
ascórbico, tocoferoles o ácidos fenólicos), pueden estar relacionados con dicha propiedad. 
Para la evaluación de la actividad antimicrobiana, se emplearon diferentes especies de 
contaminantes alimentarios, y se determinó la concentración mínima de inhibición (CMI), la 
concentración bactericida y fungicida mínima (CMB y CMF, respectivamente) para los 
extractos de las setas estudiadas. Las cepas bacterianas incluyeron bacterias Gram positivas 
(Staphylococcus aureus, Bacillus cereus, Micrococcus flavus y Listeria monocytogenes) y 
Gram negativas (Pseudomonas aeruginosa, Salmonella typhimurium, Escherichia coli y 
Enterobacter cloacae) y el potencial antifúngico fue evaluado contra cepas de Aspergillus (A. 
fumigatus, A. versicolor, A. ochraceus y A. niger), Trichoderma (T. víride) y Penicillium (P. 
funiculosum, P. ochrochloron y P. verrucosum var. cyclopium). Entre las especies estudiadas 
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por sus propiedades antimicrobianas, algunas de ellas destacaron presentando resultados muy 
prometedores, como es el caso de Suillus granulatus, con valores de CMI, CMB y CMF 
inferiores a los antibióticos y anfifúngicos disponibles en el mercado. 
El potencial antitumoral se evaluó frente a un amplio panel de líneas celulares tumorales 
humanas (MCF-7: adenocarcinoma de mama, NCI-H460: carcinoma de pulmón, HCT-15: 
adenocarcinoma colorrectal, HeLa: adenocarcinoma cervical, HepG2: carcinoma 
hepatocelular, y AGS: adenocarcinoma gástrico), realizando el ensayo de sulforodamina B 
(SRB) y calculando el porcentaje de inhibición del crecimiento celular (GI50). Realizando el 
mismo ensayo colorimétrico (SRB), se evaluó también la citotoxicidad de los extractos en 
cultivos celulares primarios no tumorales obtenidos a partir de hígado porcino (PLP2), con el 
fin de obtener unos resultados preliminares respectante a su hepatotoxicidad. En un estudio 
más pormenorizado (artículo 9 de la presente tesis doctoral), se utilizó la línea celular humana 
no maligna de mama MCF-10A como control no tumoral. Todos los extractos estudiados 
revelaron efectos antiproliferativos en las líneas celulares ensayadas (con excepción de 
Cordyceps militaris frente a células HepG2) y no se observó citotoxicidad para las 
concentraciones ensayadas en las células no tumorales. 
A partir de los resultados obtenidos en los ensayos anteriormente citados, se realizaron 
algunos estudios con el fin de establecer un posible mecanismo de acción antitumoral de los 
extractos de las setas estudiadas. Para estos ensayos se seleccionaron las especies Leccinum 
vulpinum y Ganoderma lucidum. En el caso de L. vulpinum, esta especie demostró diminuir la 
proliferación celular (ensayo de BrdU) e inducir la apoptosis (Western blot y citometría de 
flujo) en células de adenocarcinoma de mama (MCF-7). Además, los resultados también 
sugieren que el extracto de esta seta puede causa daños en el ADN celular (ensayo de Comet). 
Mientras que G. lucidum demostró inducir autofagia. Para ello, se transfectó una línea celular 
de adenocarcinoma gástrico (AGS) con un vector de expresión mCherry-LC3, y se sometió a 
tratamiento con el extracto metanólico de G. lucidum. Este tratamiento aumentó la formación 
de autofagosomas (vacuolas típicas de la autofagia), además de que los niveles celulares de 
LC3-II también aumentaron, y los niveles celulares de p62 disminuyeron (Western blot), lo 
que confirma que el extracto de G. lucidum afecta a la autofagia celular. Concretamente, 
podemos afirmar que el extracto de G. lucidum puede causar una inducción de la autofagia en 
lugar de una reducción en el flujo autofágico, ya que el tratamiento con el extracto junto con 
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inhibidores lisossómicos de proteasa (E-64d / pepstatin) provocó un aumento adicional de los 
niveles de LC3-II celular junto con un aumento en los niveles de p62 (Western blot). 
Podemos concluir que en general, las setas de la región noreste de Portugal demostraron que 
son una matriz natural que se puede considerar como alimento y/o ingrediente funcional, ya 
que demostraron presentar diversios compuestos bioactivos que además de destacar por su 
funcion nutricional, presentan propiedades beneficiosas para la salud, destacando por su  
potencial antioxidante, antimicrobiano y antitumoral. Sin embargo, son necesarios estudios 
más profundos tales como la determinación del mecanismo de acción de estos compuestos 
tanto mediante técnicas in vitro como in vivo. 
Dado que los datos obtenidos ponen de relieve el potencial de las setas como fuente de 
compuestos bioactivos, el presente estudio también contribuye a la concienciación de la 
conservación de los recursos micológicos no sólo por cuestiones ambientales, sino también 
por su potencial como fuente de compuestos nutracéuticos / farmacéuticos.  
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1.1. Functional foods and nutraceuticals 
Nowadays there are an increasing number of cases of several illnesses (e.g., chronic diseases 
that can lead to cardiovascular problems), largely because the adopted lifestyle.  Moreover, 
the rising cost of health care and pharmaceuticals, increased life expectancy and the 
consequent increase in the number of elderly people, as well as the demand for an improved 
quality of life, has led to an increased concern about food intake and an emergence of new 
concepts of nutrition (Ghosh et al., 2014). In fact, this is one of the concerns of the several 
official statements, such as the European Food Safety Authority (EFSA) and World Health 
Organization (WHO), whose commitment is to ensure that the foods consumed in Europe and 
worldwide are safe, and release information which help people to acquire healthy lifestyle 
habits associated with a balanced diet (EFSA, 2010; WHO, 2004).  
The primary role of diet is to provide nutrients essential for metabolic needs but it also 
prevents malnutrition, promotes satiety and well-being and provides health benefits at 
physiological levels while ensuring optimal health and preventing disease (Alkerwi, 2014; 
Diplock et al., 1999). Thus, the quality of the diet is strongly related to the quality of life. 
Indeed, the diet plays a very important role in the diseases most prevalent in our society, 
including cardiovascular diseases (Estruch et al., 2013; McEvoy & Woodside, 2015), 
hypertension (Drenjančević-Perić et al., 2011; Sacks & Campos, 2010), or obesity (Ding et 
al., 2010; Hensrud, 2004) and cancer (Baena & Salinas, 2015; Gonzalez & Roboli, 2010).  
Nowadays, it is well established that diets should be rich in fruits, vegetables, legumes, grains 
and nuts while the intake of free sugars and salt should be limited. By adopting this advice 
and avoiding sedentary behaviour, it is possible to attain energy balance and a healthy weight 
as well as to reduce the risk of some diseases (Ghosh et al., 2014; Gonzalez & Roboli, 2010; 
Key, 2011; Lock et al., 2010; Reis et al., 2017; WCRF/AICR, 2007; WHO, 2004; 
WHO/FAO, 2003).   
Given the strong evidence linking diet quality to life quality and due to advances in food 
science and technology, new food concepts have been developed, including “functional 
foods” and “nutraceuticals”. There is no consistent and universally accepted definition for 
functional foods. The difficulty in finding a definition (especially according to Europe and 
USA legislations) seems to be due to the fact that functional foods are considered as a concept 
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rather than a well-defined group of food products (Roberfroid, 2000; Alzamora et al., 2005; 
Siró et al., 2008; Ghosh et al., 2014). Consequently, there are many definitions for this term. 
The European Commission’s Concerted Action on Functional Food Science in Europe 
(FUFOSE) defined functional food as “a food that beneficially affects one or more target 
functions in the body beyond adequate nutritional effects in a way that is relevant to either an 
improved state of health and well-being and/or reduction of risk of disease. It is consumed as 
part of a normal food pattern. It is not a pill, a capsule or any form of dietary supplement” 
(EU, 2010).  
Actually, in the broad sense, all foods can be functional, as they provide the nutrients and 
energy necessary for the body metabolism. Nonetheless, functional foods may regulate the 
energy balance and body weight, promote early development and growth, have cardiovascular 
and intestinal functions, defensive effects against oxidative stress, and/or enhance the physical 
and mental well-being, promoting long-term health (Diplock et al., 1999; Howlett, 2008). 
This way, a functional food can be (Diplock et al., 1999; Roberfroid, 2000; Howlett, 2008): 
 - A natural, unmodified food; 
- A food in which one of the components has been enhanced through special growing 
conditions, breeding or biotechnological means; 
 - A food to which a component has been added to provide benefits; 
- A food from which a component has been removed by technological or 
biotechnological means so that the food provides benefits not otherwise available; 
- A food in which a component has been replaced by an alternative component with 
favourable properties; 
- A food in which one or more components has been modified by enzymatic, chemical 
or technological means to provide a benefit; 
- A food in which the bioavailability of one or more components has been modified; 
- A combination of any of the above. 
 
The use of food or food ingredients to promote health is well established (Ghosh et al., 2014; 
Howlett, 2008). However, it should be kept in mind that the disease state occurs due to a 
whole range of biological processes and, therefore, the functional food intake alone does not 
eliminate the risk of disease in general. So we cannot forget all the healthy habits (e.g., avoid 
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a sedentary lifestyle, do not smoke, etc.), associating them with a healthy and balanced diet 
(Howlett, 2008).  
Furthermore, functional foods and medicines/drugs should not be confused. If on one hand 
functional foods are ingested so as to restore, strengthen or maintain the normal physiology of 
the body, drugs are consumed to treat and/or prevent specific diseases, intervening in a 
disturbed physiological process. Unlike functional foods that are consumed as part of the 
normal diet, drugs are usually administered in precise doses, under medical supervision, as 
part of a controlled treatment, and often in the form of pills, tablets, capsules or syrups 
(Howlett, 2008).  
Food supplements are also available, which are defined as foodstuffs the purpose of which is 
to supplement the normal diet and which are concentrated sources of nutrients or other 
substances with a nutritional or physiological effect, alone or in combination, marketed in 
dose form, namely forms such as capsules, pastilles, tablets, pills and other similar forms, 
sachets of powder, ampoules of liquids, drop dispensing bottles, and other similar forms of 
liquids and powders designed to be taken in measured small unit quantities (Commition 
Directive 2002/46/EC). Once food supplements have a pharmaceutical form, and they are not 
consumed as traditional foods in daily diet, they cannot be regarded as functional foods. 
However, given that from a legal point of view, they are not considered as treating or 
preventing diseases, they still are governed by food laws (Howlett, 2008; Directive 
2002/46/EC).  
Finally, for food labelling proposes (commercial communications, including, inter alia, 
generic advertising of food and promotional campaigns) it should have scientifically based 
claims, which have been previously authorized by EFSA. It is necessary to ensure that the 
substances for which a claim is made have been shown to have a beneficial nutritional or 
physiological effect (e.g., nutrient content claims, which refers to the levels of a nutrient 
contained in a food; it may be a source of certain minerals or high in fibre and unsaturated 
fatty acids) (Diplock et al., 1999; Roberfroid, 2000; Regulation (EC) No 1924/2006). 
 
Unlike functional foods that, in most cases, their role is related with reducing the risk of 
diseases rather than preventing it, nutraceuticals appear as exerting a pharmacological role. 
So, although both have benefits for health, it is considered that the concept of functional foods 
belongs to nutrition and the concept of nutraceutical belongs to pharmacology (Ghosh et al., 
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2014; Howlett, 2008; Kalra, 2003; Roberfroid, 2000). Nutraceuticals were first defined as “a 
food (or part of a food) that provides medical or health benefits, including the prevention and 
treatment of a disease” (DeFelice, 1993), and although there is no single definition for these 
products (as for functional foods), all of them are based on this statement. Once functional 
foods and nutraceuticals concepts are related, they are often confused and used incorrectly. 
Furthermore, according to some definitions, a functional food provides the essential and 
required nutrients to a healthy daily life. However, when a functional food aids in the 
prevention and treatment of certain diseases or sickness, shall be called nutraceutical (Kalra, 
2003; Ghosh et al., 2014). 
Consequently, nutraceuticals are usually consumed to promote well-being, through the 
prevention and/or treatment of diseases and/or disorders. They may be a food extract, a single 
natural compound or nutrient and not necessarily a complete food (e.g., resveratrol, curcumin, 
vitamin E), which may be included in pharmaceutical form (pills, tablets, etc) as dietary 
supplements and as part of a specific diet (Gupta et al., 2010; Hardy, 2000; Kalra, 2003; 
Pandey et al., 2010; Reis et al., 2017; Sikora et al., 2010; Silk & Smoliga, 2014). Noted that, 
while exerting a pharmacological function, nutraceuticals, also known as pharmaconutrients, 
should not be confused with medicines, which are administered in precise doses, under 
medical supervision, to treat or prevent a specific disease (Hardy, 2000; Howlett, 2008). 
Table 1 shows the main differences between functional foods, food supplements, 
nutraceuticals and medicines/drugs. 
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Table 1. General differences between functional foods, food supplements, nutraceuticals and 
medicines/drugs (Reis et al., 2017). 
 
 
Functional food 
Food 
supplement 
Nutraceutical Medicines 
Form Food  Pill, tablet, 
capsule, syrup 
Pill, tablet, capsule, 
syrup 
Pill, tablet, 
capsule, syrup, 
injectables, etc. 
Consumption Consumed as 
part of the 
normal diet 
Usually during a 
certain period of 
time 
Daily consumed 
(usually for a period 
of time), once they 
are food  
constituents / 
extracts  
Controlled doses 
according to 
medical 
prescription and 
for a 
predetermined 
period of time 
Purpose Exert a health or 
physiological 
effect; 
improvement of 
the state of 
health and well-
being and/or 
reduction of the 
risk of disease 
Typically 
consumed to 
ensure the intake 
of certain 
ingredient(s) 
(e.g., vitamins, 
mineral, amino 
acids);  
They may also 
help to reduce 
the risk of 
disease 
Promote well-being 
through the 
prevention and/or 
treatment of 
diseases and/or 
disorders 
Pharmacological 
purpose; 
To treat a 
specific disease 
 
Examples - Natural food: 
mushrooms, 
nuts, tomatoes, 
fatty fish; 
- Processed 
food: dairy 
products and 
beverages (e.g., 
yoghurts and 
energy-restoring 
drinks or teas) 
fortified with 
“functional 
ingredients” rich 
in vitamins, pro- 
and prebiotics, 
polyphenols, or 
plant sterol 
esters, such as 
margarines. 
- Vitamin and 
mineral 
supplements  
 
- Cod liver oil  
- Resveratrol 
- Reishi capsules 
- Amiloride 
(diuretic) 
- Omeprazole 
(antiulcer)  
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According to their potential, nutraceuticals may be classified in two groups: potential 
nutraceuticals and established nutraceuticals (Pandey et al., 2010). The first group includes 
the products identified as potentially beneficial to health; from the moment in which there is 
scientific and clinical data showing their bioactivity, these become established nutraceuticals 
(Pandey et al., 2010). Unfortunately, most nutraceuticals still belongs to the first group, hence 
the need to perform more studies in this area. Surprisingly, the preference of these products 
over pharmaceuticals is well accepted by pharmaceutical and biotechnology companies 
(Kalra, 2003) and the interest in this field is increasing. This is due to the fast advances in 
scientific knowledge that attest to the vital role of diet in health and prevention of diseases, 
health costs have been rising dramatically over time, increased life expectancy, the advances 
in the food industry and the regulatory environment changing (Pandey et al., 2010). 
However, this field still needs for more in-depth studies concerning the bioactivity and 
possible side effects of nutraceuticals. Furthermore, long-term clinical trials are also needed to 
scientifically validate nutraceuticals as biologically active. The interaction of nutraceuticals 
with food and drugs is also an area that should be further developed, as well as bio-
availability tests and efficacy of nutraceuticals (Pandey et al., 2010).  
Overall, an unbalanced diet can lead to the development of many diseases, as well as a proper 
diet can prevent many illness states. Based on this knowledge, emerge the concepts of 
functional foods and nutraceuticals, which aim, in addition to providing essential nutrients, is 
to promote healthy development and consumer welfare. Although often confused, the 
majority difference between these two concepts lies in that the functional food indeed play a 
nutritional role associated with preventive effects of diseases and sickness, while 
nutraceuticals can be used in an attempt to accomplish desired therapeutic outcomes with 
reduced side effects. It cannot be forgotten that a balanced diet alone is not enough for an 
optimal state of health. Healthy habits must be acquired and risky behaviours must be avoided 
(e.g., sedentary lifestyle, smoking). 
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1.2. Mushrooms as functional foods and as a source for nutraceutical’s 
development 
When we think of a balanced diet and the healthiest means by which to achieve it, plants and 
plant products immediately come to mind, as well as mushrooms. Although their use has been 
reported for thousands of years, it has only been in recent years that the consumption of 
mushrooms has increased, mainly due to the increasing awareness that a stable and balanced 
diet exerts a key role in normal body functioning and sustaining health (Reis et al., 2017). 
Consumed for their texture, aroma and flavour, mushrooms are an excellent choice for both 
their nutritional value and medicinal properties (Valverde et al., 2015). Indeed, some authors 
consider mushrooms as “inherent functional foods” (Smith & Charter, 2011). 
 
1.2.1. Bioactive compounds in mushrooms 
As previously mentioned, in addition to their nutritional value, in recent years there was an 
increasing study of mushrooms as a source of bioactive compounds. Mushrooms have in their 
chemical constitution fatty acids (Gao et al., 2012), phenolic compounds, tocopherols, 
carotenoids, ascorbic acid, among others (Ferreira et al., 2009 and 2010; Lindequist et al., 
2005; Roupas et al., 2012; Valverde et al., 2015) responsible for their bioactive properties.  
Since mushrooms get their nutrients by absorption, they are toughly influenced by the 
environment in which they develop. This influence is reflected in their chemical composition 
which varies according to the region where they came from, as well as from species to 
species. However, some chemical properties are maintained within the genus/species. Indeed, 
there are some specific molecules of certain species, such as cordycepin (from the genus 
Cordyceps), ganoderic acid (from the genus Ganoderma) or agaritin (from the genus 
Agaricus). Thus, while the mushrooms are quite influenced by the environment, it seems that 
there is a chemical profile that is maintained and is typical of each species. 
The following are some of the most bioactive compounds (hydrophilic and lipophilic) present 
and described in mushrooms. 
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Hydrophilic compounds 
 Vitamin C – Ascorbic acid and dehydroascorbic acid 
All vitamins are essential to our well-being (even in limited quantities), and as we are unable 
to synthesize them, we must obtain them through the diet.  
Vitamin C is a water-soluble vitamin with a similar structure to glucose (C6H8O6). In foods, 
vitamin C is mostly found as ascorbic acid, and then this is the nomenclature commonly used 
for this vitamin. However, we can also find vitamin C in its oxidized form, the 
dehydroascorbic acid (Figure 1) (Gropper & Smith, 2012; Hickey & Saul, 2008).   
 
 
 
Figure 1. Chemical structure of the two forms of vitamin C (oxidation reaction; adapted from 
Gropper & Smith, 2012). 
 
 
Ascorbic acid is absorbed throughout the small intestine assisted by the sodium-dependent 
vitamin C transporters SVCT 1 and SVCT 2. SVCT 1, the main responsible for vitamin C 
absorption, is down-regulated by ascorbic acid, which prevents the absorption of excessive 
and unnecessary amounts of this vitamin. Therefore, the absorption of vitamin C decreases 
with increased intake. Regarding the oxidized form of vitamin C, dehydroascorbic acid, it is 
absorbed by glucose transporters (mostly GLUT 1 and 3) in the gastrointestinal tract. When 
absorbed, it is reduced back to ascorbic acid (mediated through dehydroascorbic acid 
reductase) (Gropper & Smith, 2012).  
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Vitamin C performs important roles in human body, being well-known for its antioxidant 
properties, as an endogenous non-enzymatic antioxidant defence (Ferreira et al., 2009). In this 
context, it is effective in scavenging the superoxide anion (O2˙
-
), hydrogen peroxide (H2O2), 
hydroxyl radical (HO˙), singlet oxygen (O2) and reactive nitrogen oxide (˙NO). Vitamin C 
protects water soluble substances from oxidizing agents (DeBruyne et al., 2015). Moreover, it 
may regenerates already-oxidized substances to their original active form, such as vitamin E 
(Burke, 2007; Carocho & Ferreira, 2013; DeBruyne et al., 2015; Medeiros & Wildman, 
2013). In addition, vitamin C protects iron from oxidation in the intestines, improving its 
absorption, and in cells and body fluids, it protects other molecules and even fat-soluble 
compounds, such as vitamins A and E and PUFA from oxidative processes (DeBruyne et al., 
2015). 
 
Vitamin C is also a cofactor in some important enzymatic reactions, playing central roles in 
many physiological processes in the human body, one of the most recognized, the collagen 
synthesis. Vitamin C is required for the posttranslational modifications of collagen, which 
allow aggregation and cross-linking of the chains (Gropper & Smith, 2012; Hickey & Saul, 
2008; Medeiros & Wildman, 2013). Vitamin C is also required for carnitine synthesis, a 
molecule required for the transport of long-chain fatty acids into the mitochondria to produce 
energy (Gropper & Smith, 2012; Hickey & Saul, 2008), and is involved in the synthesis of 
amino acids such as tyrosine, and neurotransmitters such as serotonin (Gropper & Smith, 
2012; Medeiros & Wildman, 2013). 
 
Several illnesses increase vitamin C needs. For years that consumption of foods rich in 
vitamin C is recommended for colds/flu. Because of this, there are some suggestions for 
antihistamine activity by this vitamin. Moreover, the needs of this vitamin in stressful 
situations are also increased (DeBruyne et al., 2015).  
 
Severe deficiency of vitamin C (total body vitamin pool falls below about 300 mg and plasma 
vitamin concentration drop to < 0.2 mg/dL) results in scurvy development. This disease has 
many symptoms; initially fatigue and malaise, which may be associated with impaired 
carnitine synthesis. Other symptoms are associated with the improper formation of collagen, 
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wound healing, inflamed and bleeding gums or capillary fragility (Fantuzzi, 2014; Gropper & 
Smith, 2012). 
 
Besides its known antioxidant potential, there is also some evidence of the antiatherogenic 
and antitumour activities of vitamin C (Carr et al., 2000; Verrax & Calderon, 2009). Note 
that, although the intake of high concentrations of vitamin C (2000 mg / day or more) have 
been associated with antitumour effects, some studies have inferred a possible pro-oxidant 
and even an anti-carcinogenic effect at high concentrations (Li & Schellhorn, 2007; Naidu, 
2003). 
 
 Organic acids 
Organic acids are weak acids, soluble in water and in organic solvents, comprising a group of 
substances having acidic properties. These acids are characterized by the carboxyl group (-
COOH), which dissociates into a proton and the conjugated base, conferring them the acid 
properties. Since their main chemical feature is the presence of one or more carboxyl groups, 
they are also named carboxylic acids.  Usually, they contribute to the organoleptic properties, 
stability and microbiological control in foods (Nollet, 2004; Nollet & Toldrá, 2015; Yildiz, 
2009). They are classified depending on their chemical structure, namely the type of carbon 
chain, extent of saturation and substitution, and the number of carboxyl groups (Figure 2; 
Nollet, 2004; Yildiz, 2009).  
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Figure 2. Chemical structure of some organic acids present in foods. Oxalic acid (2C), malic acid 
(4C), and fumaric acid (4C), dicarboxylic acids; quinic acid (7C), a monocarboxylic acid; and citric 
acid (6C), a tricarboxylic acid (based on Yildiz, 2009). 
 
 
Organic acids may occur naturally in foods or may be incorporated to add or enhance some 
properties to food products. They are added as stabilisers, acidulants or preservatives, 
contributing for the sensorial properties of food products (Carocho et al., 2014; Nollet, 2004). 
For example, an additive widely used in the food industry, is citric acid (E-330), added to 
foods as a flavouring and preservative component (Lee, 2014). 
 
Noted that some of the organic acids found naturally in mushrooms are intermediates in the 
Krebs cycle, also named citric acid cycle, one of the main metabolic pathways of primary 
metabolism in living beings (Hanson, 2008; Yildiz, 2009).  
 
In Table S1 (Annex 1) it is possible to consult data referring to the studies that report the 
ascorbic acid contents and main organic acids found in Portuguese edible mushroom species. 
Ascorbic acid has not been reported in all the studied species. Regarding other organic acids, 
these are found in several species at varying concentrations. However, oxalic, malic and 
fumaric acids seem to be the most common acids present (the latter generally in lower 
amounts). 
                                                                                                Introduction 
 
12 
 
 
 Phenolic acids and related compounds 
Phenolic compounds are part of the secondary metabolites produced by mushrooms. These 
compounds are characterized by one or more hydroxyl groups in their chemical constitution, 
attached directly to an aromatic ring (Vermerris & Nicholson, 2007), and are widely known 
for their bioactive potential.  
Phenolic compounds range from relatively simple molecules, such as phenolic acids or 
flavonoids to large and complex ones, such as lignins and tannins. Indeed, there are several 
molecular groups of the phenolic compounds family, namely hydroxybenzoic acids, 
hydroxycinnamic acids, flavonoids or coumarins (Carocho & Ferreira, 2013; Vermerris & 
Nicholson, 2007). However, the present work will be focus in the first two classes, which are 
the most commonly found in mushrooms.  
 
Hydroxybenzoic acids are produced through the shikimate pathway and are constituted by 
seven carbon molecules, with a C6-C1 skeleton, and characterized by the presence of a 
carboxyl group substituted on the phenol (Figure 3). This group includes gallic acid, p-
hydroxybenzoic acid, and protocatechuic acid, among others (Vermerris & Nicholson, 2007). 
Whilst, hydroxycinnamic acids are derivatives of cinnamic acid, obtained through the 
phenilpropanoid pathway. These compounds are more common if foods comparing with 
hydroxybenzoic acids (Yildiz, 2009). Hydroxycinnamic acids present a C6-C3 skeleton with 
one or more hydroxyl groups, some of which may be methylated. Some of the most 
representative compounds of this group are p-coumaric, caffeic and ferulic acids (Vermerris 
& Nicholson, 2007).  
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Figure 3. Chemical structure of some phenolic acids and related compounds. 
 
 
Phenolic compounds are usually involved in the allelopathy mechanisms (Cheema et al., 
2012). However, in addition of acting as signalling molecules against pathogens, they can also 
allow the establishment of symbiosis relationships (i.e., mychorrizas) (Mandal et al., 2010; 
Reis et al., 2011a).  
Phenolic acids are widely known for their antioxidant potential. Moreover, they have also 
been referred as having anti-inflammatory and anticancer properties. In human body free 
phenolic acids are mainly absorbed throughout the stomach and small intestine, and then 
metabolised in the liver. In this stage, they undergo methylation, glucuronidation and sulfation 
reactions, as well as are degraded into other acids or compounds (Ho et al., 2013). These 
alterations in their chemical structure may affect/alter their redox potential and/or their 
antioxidant activity. In some cases, the obtained metabolites are even more bioactive than the 
parental compounds. For this reason, it becomes important to perform some studies regarding 
the bioactive potential of these metabolites resulting from the body metabolism. The 
unabsorbed fraction is deesterified and dehydroxylated in the colon and further metabolized in 
the liver. The resulting metabolites are excreted through bile and urine (Ho et al., 2013).  
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Table S2 (Annex 1) shows the most common phenolic acids and related compounds found in 
Portuguese edible mushrooms. Generally, p-hydroxybenzoic acid is the main phenolic acid 
reported in the majority of the studied species, as well as the related compound cinnamic acid.  
 
Overall, mushrooms have a great nutritional value, being a reasonably source of vitamins, 
such as vitamin C and E. Moreover, they have a great variety of bioactive compounds, such as 
phenolic acids. Therefore, mushrooms are an excellent source of many different nutraceuticals 
and might be definitely included in the human diet as a functional food product, as well as to 
promote health based on the synergistic effects of all their components. 
 
Lipophilic compounds 
 Fatty acids 
Fatty acids consist in a hydrocarbon chain of variable length, with a carboxyl group (COOH) 
at one end (the delta (Δ) end) and a methyl group (CH3) at the other end (the omega (ω) or n-
end) (Figure 4). Besides varying in chain length, fatty acids can vary the degree of 
unsaturation, being classified as saturated (no double bonds), monounsaturated (single double 
bond) and polyunsaturated (several double bonds). Their nomenclature is also made according 
the position of the first double bond (i.e., omega-3 and omega-6) and the configuration thereof 
(cis and trans) (Chow, 2007; Driskell, 2007; McGuire & Beerman, 2012; Sanders & Emery, 
2003). Although the fatty acids mainly found in foods are composed of 14 to 22 carbon 
atoms, their backbone chain length can range 2 to 80 carbon atoms (Sanders & Emery, 2003). 
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Figure 4. Chemical structure of oleic acid. It is possible to identify the delta (Δ) and omega (ω) ends; 
one double bond located at the n-9 position (the ninth carbon from the methyl end); and verify that 
the hydrogen atoms next to the double bond is on the same side of the carbon chain. Accordingly, 
oleic acid is a monounsaturated omega-9 fatty acid with a 18-carbon chain and one cis-double bond 
(Lipid number – C18:1n9).  
 
 
Fatty acids, the most abundant lipids in the human body, result from the digestion of fats 
ingested through the diet. Fats are essentially digested in the small intestine, where they are 
reduced to fatty acids and glycerol, and subsequently absorbed. Fats metabolism occurs in 
cells and in the liver. In cells, the obtained energy is released through the breakdown of fatty 
acids. This metabolism leads to the formation of water and carbon dioxide that can be used by 
the cell or released by circulatory, respiratory and excretory systems. The fat that is not 
necessary to the cell at that time is stored as adipose tissue. In the liver triglycerides are 
hydrolysed to form new ones, depending on the metabolic needs (Roth, 2013).  
 
Fatty acids, particularly the unsaturated fatty acids (mono and polyunsaturated), play many 
roles in the human body. Although their main functions are associated with the storage and 
energy supply, they also perform structural and metabolic functions especially at cellular 
membrane level. Fatty acids are stored in the form of triglycerides (three fatty acids chains 
attached to a molecule of glycerol) in adipose tissue, functioning as energy suppliers in case 
of need (e.g., starvation conditions). In turn, the adipose tissue serves to support and protect 
the organs and bones, as well as protecting our body against low temperatures (Roth, 2013; 
The British Nutrition Foundation, 2013). Furthermore, fatty acids are an integral part the cells 
membranes, namely in the form of phospholipids, exerting structural functions and 
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contributing to the membrane flexibility, fluidity and permeability. Phospholipids can also 
circulate throughout the body, forming the lipoproteins complexes which help in digestion, 
absorption and transport of lipophilic compounds such as vitamin E, triglycerides or 
cholesterol (Kidd, 2007; Li et al., 2015; Roth, 2013). Fatty acids are also involved in 
metabolic processes underlying the response of cells to hormones, neurotransmitters and cell 
growth factors (The British Nutrition Foundation, 2013). 
There are also some studies reporting fatty acids as having influence in reducing the risk of 
certain illnesses such as cardiovascular disease (Estruch et al., 2013; Gillingham et al., 2011), 
to have anti-inflammatory properties (Calder, 2015; Wall et al., 2010), even being associated 
to have beneficial effects in diseases such as cancer (Jing et al., 2013; Laviano et al., 2013).  
 
There are two essential fatty acids, linoleic and α-linolenic acids. Linoleic acid is a 
polyunsaturated omega-6 fatty acid, while the latter is a polyunsaturated omega-3 fatty acid 
(Figure 5). In addition to being cellular membrane components, from these two essential 
nutrients, our organism synthesises new fatty acids, particularly all the other omega-6 and 
omega-3 fatty acids and other compounds, such as eicosanoids, with important functions in 
the body (i.e., blood pressure, clot formation, blood lipid concentration, immune response, 
inflammatory response, among others). The longer-chain fatty acids derived from linoleic and 
α-linolenic acids (e.g., arachidonic and docosahexaenoic acids) have also maintain the normal 
cellular function and regulation of gene expression, and some of their derivatives have also 
hormone-like effects, as is the case of eicosanoids that regulate the immune and 
cardiovascular systems and act as chemical messengers modulating several physiological 
functions (DeBruyne et al., 2015; McGuire & Beerman, 2012; Roth, 2013). Generally, 
omega-3 fatty acids have been particularly associated with a lower risk of heart disease, while 
omega-6 fatty acids have cholesterol-lowering effect (McGuire & Beerman, 2012; Roth & 
Townsend, 2003).   
Since the essential fatty acids are stored in adipose tissue, their deficiency is rare. However, 
this deficiency may arise in persons with fragile health and, in this case there may be 
infections and slow wound healing processes (McGuire & Beerman, 2012).  
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Figure 5. Chemical structure of the essential fatty acids. A- Linoleic acid (LA), a polyunsaturated 
omega-6 fatty acid with a 18-carbon chain and two cis-double bonds (Lipid number – C18:2n6); B- 
α-Linolenic acid (ALA), a polyunsaturated omega-3 fatty acid with a 18-carbon chain and three cis-
double bonds (Lipid number – C18:3n3).  
 
 
Although the fat content in mushrooms is low, it is possible to find a wide range of fatty acids 
in mushrooms. Though, some are dominant, particularly the saturated palmitic acid (C16:0), 
the unsaturated oleic acid (C18:1), and predominantly the polyunsaturated linoleic acid (LA, 
C18:2n6) (Cheung, 2008; Guillamón et al., 2010; Kalač, 2009 and 2013). Although the values 
can undergo some fluctuations according to the species under study, generally unsaturated 
fatty acids predominated over saturated fatty acids, which make mushrooms interesting food 
choices. Some data state that at least 72% of total fatty acids have been found to be 
unsaturated (Miles & Chang, 2004). More recent studies report that 50 – 78% of the total 
percentage of fatty acids comprises linoleic acid; 6 – 20% oleic acid and 11 – 26% palmitic 
acid (OECD, 2015). According to the WHO, there is convincing evidence that palmitic acid 
contributes to an increases risk of developing cardiovascular disease (WHO/FAO, 2003). On 
the contrary, French et al. demonstrated in 2002 that palmitic acid has no hypercholesteraemic 
effect if the intake of LA is greater than 4.5% of total energy. However, although this is one 
of the majority fatty acids found in mushrooms, its amount is far below compared to oleic 
acid (an omega-9 fatty acid) or linoleic acid (an omega-6 fatty acid). These fatty acids, as 
unsaturated fatty acids in general, are often reported as being potentially beneficial to health, 
being associated with a low risk of inflammatory processes, cardiovascular disease or cancer 
development (Baum et al., 2012; Cardoso et al., 2011; Carrillo et al., 2012; Czernichow et al., 
2010; Sales-Campos et al., 2013). It is recommended to consume a minimum of 1% energy as 
n-6 PUFA and 0.2% energy as n-3 polyunsaturated fatty acids. Adequate intakes for male 
adults must be around 14-17 g per day of LA and 1.6 g per day of ALA, whereas for females 
the adequate intakes are lower, around 11-12 g per day of LA and 1.1 g per day of ALA 
                                                                                                Introduction 
 
18 
 
 
(Trumbo et al., 2002). Hence, mushrooms have a variety of fatty acids, mainly MUFA and 
PUFA, being a source of essential fatty acids (Table 2). 
 
 
Table 2. Some of the fatty acids commonly found in mushrooms (Reis et al., 2014a) 
 
Fatty acid Lipid number (C:D form) 
Caproic acid C6:0 
Caprylic acid C8:0 
Capric acid C10:0 
Lauric acid C12:0 
Tridecylic acid C13:0 
Myristic acid C14:0 
Myristoleic acid C14:1 
Pentadecanoic C15:0 
Palmitic acid C16:0 
Palmitoleic acid C16:1 
Heptadecanoic acid C17:0 
Stearic acid C18:0 
Oleic acid C18:1n9 
Linoleic acid  C18:2n6 
α-Linolenic acid C18:3n3 
Arachidic acid  C20:0 
Eicosenoic acid C20:1 
Eicosadienoic acid C20:2 
Eicosatrienoic acid C20:3n3 
Heneicosanoic acid C21:0 
Eicosapentaenoic acid C20:5n3 
Behenic acid C22:0 
Erucic acid C22:1n9 
Tricosanoic acid C23:0 
Lignoceric acid C24:0 
Nervonic acid C24:1 
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 Vitamin E – Tocopherols and tocotrienols 
Vitamin E is the term used for a family of chemically related compounds, tocopherols and 
tocotrienols, which share a common structure consisting of chromanol head/ring and a prenyl 
side chain. Vitamin E is therefore constituted by eight chemical compounds: four tocopherols 
(α-, β-, γ- and δ-isoforms) and four tocotrienols (also with α-, β-, γ- and δ-isoforms) (Kamal-
Eldin & Appelqvist, 1996; Munné-Bosch & Alegre, 2002). These lipid-soluble molecules 
differ between them only in the degree of saturation of their hydrophobic prenyl side chains 
(Figure 6). 
 
 
Figure 6. General chemical structure of vitamin E isoforms. A- Tocopherols (α-tocopherol: R1 and R2 
= Me; β-tocopherol: R1 = Me and R2 = H; γ-tocopherol: R1 = H and R2 = Me; δ-tocopherol: R1 and R2 
= H). B - Tocotrienols (α-tocotrienol: R1 and R2 = Me; β- tocotrienol: R1 = Me and R2 = H; γ- 
tocotrienol: R1 = H and R2 = Me; δ- tocotrienol: R1 and R2 = H) (Modified from Stipanuk & Caudill, 
2013).  
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Tocopherols have been recognized as one of the most important antioxidants. This is due to 
their ability to protect the cell membranes, inhibiting the production of lipid peroxyl radicals 
induced by reactive oxygen species (ROS), thereby protecting cells from peroxidation of 
polyunsaturated fatty acids (PUFA) in the phospholipid membrane from oxidative damage 
(Fang et al., 2002; Gropper & Smith, 2012; McGuire & Beerman, 2012). The mechanism of 
action of vitamin E as antioxidant is well known.  During the process of lipid peroxidation, 
PUFA (LH) reacts with free hydroxyl radicals (˙OH) or with molecular oxygen (O2), leading 
to the formation of alkyl radicals (L˙) and water or alkyl radicals and the hydroperoxyl radical 
(HO2˙), respectively (Equation 1). 
 
LH +  ˙OH →  L˙ + H2O;   
LH + O2 →  L˙ +  HO2˙  
Equation 1. Two pair reactions involved in lipid peroxidation, depending on the reaction of PUFA 
with hydroxyl radicals or with molecular oxygen. 
 
In turn, alkyl radicals may react with molecular oxygen in a propagation reaction to form a 
lipid peroxyl radical (LOO˙), which promotes lipid peroxidation (Equation 2).  
 
L˙ + O2 → LOO˙ 
Equation 2. Reaction of alkyl radicals with molecular oxygen.  
 
This radical reacts with other organic compounds, such as other PUFA located in the cell 
membrane, arresting a hydrogen atom from these and generating stable lipid peroxides 
(LOOH) (Gropper & Smith, 2012). However, tocopherols located in or near the membrane 
surface may react with these radicals. Thus, tocopherols (TOH) react with lipid peroxyl 
radicals (LOO˙) and generate more stable products (Equation 3). 
 
LOO˙ + TOH → LOOH + TO˙   
Equation 3. Reaction of lipid peroxyl radical with other compounds producing stable products.  
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Tocopherols may also react directly with alkyl radicals (L˙ + TOH → LH + TO˙) or with 
alkoxy radicals (LO˙), which are formed during the propagation process (LO˙ + TOH → LOH 
+ TO˙) (Gropper & Smith, 2012; Kamal-Eldin & Appelqvist, 1996; Niki, 2014). After these 
reactions, tocopherols become oxidized, and the resulting radical (tocopheroxyl radical; TO˙) 
reacts with other peroxyl radicals to form inactive compounds, such as tocopherylquinone 
(Gropper & Smith, 2012). The tocopheroxyl radical may also be reduced, which will allow 
the reuse of vitamin E. As abovementioned, this vitamin is regenerated by vitamin C, but also 
by other molecules such as GSH (reduced glutathione), or NADPH (Gropper & Smith, 2012). 
Since vitamin E is involved in oxidative stress, protecting cells from free radical-induced 
oxidative damage, some authors infer that it can function as prevention of many diseases, 
such as heart disease or even cancer (Gropper & Smith, 2012; Ju et al., 2010). α-Tocopherol 
has long been considered the most active form of vitamin E (Kamal-Eldin & Appelqvist, 
1996). However, other isoforms have been also recognized as bioactive. For example, γ-
tocopherol is more effective suppressing reactive nitrogen species (RNS), has higher anti-
inflammatory potential, and has been pointed as being more effective preventing cancer-
related processes (Brigelius-Flohé, 2006; Hensley et al., 2004; Yang et al., 2012a). Although 
there are fewer studies on the specific activities of tocotrienols, these vitamers have been 
mentioned as having positive effects particularly in neurodegeneration process (Brigelius-
Flohé, 2006), as well as anticancer and cholesterol-lowering properties (Colombo, 2010). 
Moreover, some studies reported that the corresponding tocopherols and tocotrienols isoforms 
exert the same antioxidant activity against lipid peroxidation in solution and liposomal 
membranes (Yoshida et al., 2003), and others suggests that, in fact, their antioxidant activity 
is higher than that of tocopherols (Packer et al., 2001). This could be due to the fact that 
tocotrienols are more readily transferred and incorporated into the cell membranes than 
tocopherols. However, though its bioavailability still remains poorly understood, it is known 
that tocotrienols plasma concentrations are much lower compared to tocopherols (Fu et al., 
2014; Yoshida et al., 2003).  
 
Vitamin E is hydrolysed and absorbed in the intestine, and as a fat-soluble vitamin, this 
process depends of the normal function of pancreas, since it requires biliary and pancreatic 
secretions in order to form micelles that will allow vitamin uptake by the intestine. After this 
course, vitamin E becomes solubilised, and the resulting micelles are then wrapped by 
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enterocytes through passive diffusion and incorporated together with other lipids, in 
chylomicrons which are secreted into the lymphatic system (Eggermont, 2006; Litwack, 2007; 
Rigotti, 2007; Stipanuk & Caudill, 2013; Traber, 2007). This seems to be the main via 
through which vitamin E is absorbed in the intestine. Lastly, vitamin E is secreted into the 
plasma (Litwack, 2007; Rigotti, 2007; Stipanuk & Caudill, 2013). Once incorporated in 
chylomicrons, vitamin E and other lipids will be transported to adipose tissue and muscles 
where takes place a partially digestion (lipolysis) of chylomicrons, that results in “remnant 
chylomicrons” free of triglycerides and enriched in cholesterol and with the four isoforms of 
tocopherols. The remnant chylomicrons are then taken up by hepatocytes (after binding to 
specialised low-density lipoprotein (LDL)-related receptors), where α-tocopherol is 
preferentially retained by the action of α-tocopherol transfer protein (α-TTP). This protein 
regulates the levels of vitamin E in the blood. Therefore, it is also responsible for the secretion 
of α-tocopherol from the liver to the plasma. α-TTP has higher affinity with α-tocopherol; 
therefore, this is the isoform preferentially transferred to the plasma, which explains the 
higher concentrations of this α-tocopherol in human body, comparing with the other isoforms 
(Eggermont, 2006; Rigotti, 2007; Traber, 2007). In the circulation, α-tocopherol is assembled 
into the very low-density lipoprotein (VLDL) and LDL particles and released for use by the 
peripheral tissues (Eggermont, 2006; Rigotti, 2007).   
Vitamin E is not accumulated. It is metabolized similarly to xenobiotics, being excreted in 
urine or bile. It is estimated that about half of the tocopherols consumed throughout the diet is 
absorbed, being the remainder excreted in the faeces (Eggermont, 2006; Stipanuk & Caudill, 
2013; Traber, 2007).     
The deficiency in this vitamin is rare in people. However, it might occur in premature babies 
or people with fat malabsorption problems. Vitamin E, namely α-tocopherol deficiency, may 
cause peripheral neuropathy or blood disease problems (i.e., increased erythrocyte hemolysis) 
(Roth, 2013; Traber, 2007).  
Overall, vitamin E is an important exogenous lipophilic radical-scavenging antioxidant, 
preventing the auto-oxidation of PUFAs in cell membranes. Therefore, the intake of vitamin E 
depends on the intake of diets rich in PUFA; higher amounts of vitamin E are required when 
PUFA intake is high (Alfin-Slater & Kritchevsky, 2012; Bijlani & Manjunatha, 2010). 
Vitamin E antioxidant potential is well known and, probably due to its effectiveness as 
antioxidant, holds other properties, namely anti-inflammatory potential (Tahan et al., 2011). 
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Vitamin E, as vitamin C, is sensitive to different abiotic factors being easily degraded by 
light, water and heat (Wang et al., 1993).  
 
1.2.2. Bioactivity of mushrooms 
 
1.2.2.1. Antioxidant activity 
In the human body (as in other aerobic organisms) free radicals and other reactive species are 
continually being produced during the normal cellular metabolism. This may occur by 
“accident” (e.g., the leakage of electrons from the mitochondrial electron transport chain) or 
with some required purposes, such as involvement in cell signalling and homestasis processes 
or defence against pathogens (Ferreira et al., 2009; Halliwell, 2011; Halliwell & Gutteridge, 
2015). These reactive species are very unstable, so the exposure of the body to these species 
leads to the development of endogenous defence mechanisms (enzymes and non-enzymatic 
molecules) in order to eliminate them (Ferreira et al., 2009; Goetz & Luch 2008; Valko et al., 
2007). Therefore, in normal physiological conditions, the production of reactive species is 
maintained in balance by these antioxidant defence mechanisms. However, this balance may 
be affect by several factors (e.g., decrease in antioxidants production or exposure to high 
levels of oxygen, UV and pollution exposure), and when this unbalanced situation tends to an 
increased production of free radicals (over the capability of the cell to orchestrate an effective 
antioxidant response), the body comes under oxidative stress (Ferreira et al., 2009; Halliwell 
& Gutteridge, 2015; Silva & Coutinho, 2010).  
A free radical is defined as any atom or molecule that has unpaired electrons in the outer orbit 
(Gutteridge & Halliwell, 2000; Halliwell & Gutteridge, 2015). Therefore, these radicals are 
very unstable, and tend to capture an electron from stable neighboring molecules, so that they 
become electrochemically stable. Free radicals may derive from three elements, namely 
oxygen, nitrogen and sulphur, producing ROS, RNS and RSS, respectively. ROS are the most 
important class of reactive species originated in biological systems. These include the 
superoxide anion (O2˙
-
), which is considered a “primary ROS”, the hydroxyl radical (OH˙) 
and hydrogen peroxide (H2O2), defined as “secondary ROS” (Carocho & Ferreira, 2013; 
Ferreira et al., 2009). 
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The oxidation mechanism is divided into three stages: initiation, propagation and 
transformation. In the first stage, free radicals are formed, which leads to an overall increase 
in the number of these species (Equation 4). 
 
X˙ + LH → L˙ + XH  
Equation 4. Initiation stage of the oxidation mechanism. 
In the propagation stage, the number of free radicals is maintained, once the free radicals 
formed in the first stage react with other molecules, and the result is one new free radical 
(Equation 5). 
 
L˙ + O2        LOO˙ 
LOO˙ + LH        L˙ + LOOH   
Equation 5.  Propagation stage of the oxidation mechanism.   
     
Finally, the termination reactions (Equation 6) are those resulting in a decreased number of 
free radicals, since two free radicals combine to form a more stable molecule (Divya & 
Pandey, 2014; Shils et al., 2006). 
 
LO˙ + LO˙ → non-radical polymers 
LOO˙ + LOO˙ → non-radical polymer 
L˙ + L˙ → non-radical polymers 
LOO˙ + L˙ → non-radical poltmers 
Equation 6. Transformation stage of the oxidation mechanism. 
 
As abovementioned, in normal physiological conditions there is a balance between free 
radicals production and antioxidant defences. These antioxidant defences can be endogenous 
or acquired through the diet. Regarding the endogenous defences, these may be enzymatic 
such as superoxide dismutase, catalase or glutathione peroxidase. Cells also have non-
enzymatic antioxidants, such as glutathione, minerals (such as zinc and selenium), or the 
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coenzyme Q10. It is also possible to obtain antioxidants through the diet, such as carotenoids, 
vitamins and phenolic acids (Carocho & Ferreira, 2013). 
Antioxidants play their role through different mechanisms: i) inhibiting free radical oxidation 
reactions, through inhibiting the formation of free lipid radicals; ii) interfering with the 
propagation of the autoxidation chain reaction; iii) singlet oxygen quenchers; iv) acting 
synergistically with other antioxidants; v) converting hydroperoxides or pro-oxidants into 
stable compounds; vi) inhibitors of pro-oxidant enzymes (Carocho & Ferreira, 2013).  
As shown in Figure 7, free radicals have different causes and different cellular targets, 
namely proteins, carbohydrates, lipids and nucleic acids. For this reason, many disease 
conditions have been associated with oxidative stress, such as atherosclerosis (Fearon & Faux, 
2009), diabetes (Jaganjac et al., 2013), and cancer (Vera-Ramirez et al., 2011). 
 
  
 
Figure 7. Main causes for the overproduction of free radicals, probable cellular targets and main 
consequences in human health associated to oxidative stress (Reis et al., 2017). 
 
For this reason, there has been an increasing concern with regard to obtaining antioxidant 
compounds. Natural compounds have emerged as key candidates due to recognition of the 
inverse relationship between dietary intake of natural antioxidants and the incidence of human 
diseases. This has lead to an increased worldwide interest in using natural antioxidants in 
food, cosmetic, and pharmaceutical industries (Lobo et al., 2010; Taofiq et al., 2016; Valverde 
et al., 2015).  
Mushrooms have been reported as a source of several antioxidants (Asatiani et al., 2010; 
Ferreira et al., 2009; Witkowska et al., 2011). Table S3 (Annex 1) lists the edible mushroom 
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species from the Portuguese mycoflora that have been identified as having antioxidant 
properties. 
 
1.2.2.2. Antimicrobial activity 
The term antimicrobial comprises a wide variety of pharmaceutical agents, which include 
antibacterial, antifungal, antiviral and anti-parasitic drugs (Leekha et al., 2011). The treatment 
of bacterial infections is extremely important. Despite the wide variety of existing antibiotics 
(e.g., aminoglycosides, β-lactams, oxazolidinones, lincosamides, quinolones), treating 
bacterial infections has become an increasingly complicated task due to the development of 
bacterial resistance in recent years due to the inappropriate use of antibiotic drugs (Gualerzi, 
et al., 2013). Antibiotic drugs typically act by interfering with the synthesis of the bacterial 
cell wall, inhibiting protein or nucleic acid synthesis, inhibiting metabolism or breaking the 
bacterial membrane (Gallo et al., 2013; Figure 8). 
Bacterial resistance can be intrinsic or innate, which means that the bacteria species are 
resistant to certain classes of antimicrobial agents. Moreover, the resistance may be acquired, 
which means that populations that were initially sensitive become resistant to an antibacterial 
agent and were able to proliferate in its presence. This resistance state may be developed by 
the acquisition of genes encoding enzymes that destroy the antibacterial agent before it can 
exert its effect; bacteria may acquire efflux pumps that extrude the antibacterial agent from 
the cell before it can reach its target; or bacteria can acquire different genes to perform an 
alternative metabolic pathway, which will result in the synthesis of modified bacterial cell 
walls that does not contain the binding site of the agent; besides, bacteria can also suffer 
mutations which restrict the access of the antimicrobial agents to the intracellular targets 
(Tenover, 2006). For all these reasons, the development of antibiotics has been one of the 
most important scientific challenges of the last years. 
Because of the resistance phenomena, bacterial diseases that were previously treated may 
constitute serious problems today. For example, some of the microorganisms that have 
developed resistance to antibiotics are Klebsiella spp. and Escherichia coli. These bacteria 
species are the most important causal agents of Gram-negative bacteremia (presence of 
bacteria in the blood) both in hospitals and the community (Peralta et al., 2012). These 
microorganisms produce extended spectrum beta-lactamases (ESBL) that cause resistance to 
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most of the beta-lactam antibiotics, such as penicillins, monobactams and most 
cephalosporins. To treat such, known or suspected to be caused by multidrug-resistant 
bacteria, the use of wide spectrum antibiotics, fundamentally carbapenems, is recommended 
(Alves et al., 2012; Peralta et al., 2012). Other well-known Gram-negative group of bacteria 
that developed multi-antibiotic resistance is Pseudomonas spp. Although this genus is a 
common inhabitant of aquatic environments including drinking water, Pseudomonas spp. 
includes species considered opportunistic pathogens that can colonize animals and humans. 
Pseudomonas aeruginosa is the most studied pathogen from this genus and it can cause 
severe infections either in healthy or in immunocompromised persons (Mena & Gerba, 2009). 
Other species such as Pseudomonas fluorescens, Pseudomonas stutzeri or Pseudomonas 
putida may also be associated with human infections (Ana et al., 2010; Vaz-Moreira et al., 
2012; Yoshino et al., 2011). This genus is resistant to aminoglycosides, carbapenemics and/or 
cephalosporins (Alves et al., 2012). Regarding Gram-positive bacteria, MRSA (Methicillin-
resistant Staphylococcus aureus) is widely known as a common cause of bloodstream and 
other infections in hospital patients along with vancomycin-resistant Enterococci (Alves et al., 
2012; Rice, 2006; Segal-Maurer et al., 1996). 
 
Pathogenic fungi also cause injury in humans, animals, crops, and other living organisms 
(Alves et al., 2013). Although fungal infections contribute substantively to human morbidity 
and mortality, and despite the need for efficient diagnostic tests and new medicines and 
vaccines, research on the pathophysiology of human fungal infectionsthat cause disease falls 
short of other caused by other pathogens (such as the aforementioned bacteria) (Brown et al., 
2012). The main pathogens responsible for fungal infections are dermatophytes, yeasts and 
moulds, being the most illnesses caused by pathogenic fungi, the superficial infections of the 
skin and nails. Actually, skin mycosis affects approximately 25% of the world's population 
(Havlickova et al., 2008). Dermatophytes belong essentially to three genera: Trichophyton, 
Microsporum and Epidermophyton. The genus Trichophyton is known to cause athlete’s foot 
(tinea pedis); Microsporum canis is one of the best known species from the Microsporum 
genus, which in addition to causing ringworm in pets, is also a widespread agent of tinea 
capitis in humans (ringworm of the hair/scalp); Epidermophyton species such as 
Epidermophyton floccosum are also known to cause tinea, namely tinea pedis and tinea cruris 
(ringworm of the groin) (Havlickova et al., 2008). 
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Among the yeast-like fungi Candida spp. is one of the most common infectious agents. 
Furthermore, the last data available (2011-2012), indicate this genus as the 5
th
 most common 
pathogen associated with bloodstream infections (BSIs), isolated in 7.4% of all documented 
cases (European Centre for Disease Prevention and Control, 2016). Although Candida species 
are part of the transient or commensal flora in specific regions of the body, they become 
pathogenic to humans under particular systemic and local conditions (e.g., when mucosal 
barriers are disrupted or the immune system is compromised). These species, including the 
well-known Candida albicans, can cause infection in skin, nails, mucous membranes and 
gastrointestinal tract (Havlickova et al., 2008), besides the BSIs in hospitalized patients. This 
infection (candidemia) has increased over the past few decades and is a challenge for the 
clinic. This is because it is caused by Candida species other than Candida albicans, namely 
Candida glabrata and Candida krusei, which tend to be more resistant to fluconazole, that is a 
reliable, cost-effective, and clinically safe antifungal agent against Candida infections 
(Kourkoumpetis et al., 2011; Martins et al., 2015; Pfaller et al., 2011; Puig-Asensio et al., 
2014).  
Fungal contamination is also closely associated with agricultural products. The products 
spoilage by fungi may result in the decrease of quality and yield of crops (e.g., reduced 
palatability and the loss of nutritive value), as well as huge economic losses. After fungal 
attack, the crops may be contaminated with toxic secondary metabolites produced by fungi, 
known as mycotoxins. This contamination of food and feed crops may occur in various stages 
of the food chain (Bryden, 2012; Zain, 2011). Contamination of standing crops and stored 
feeds with mycotoxins is dependent on the fungi present, the agronomic practices, the 
composition of the commodity and the conditions of harvesting, handling and storage 
(Bryden, 2012). Among the best known and widely studied moulds that mostly contaminate 
agricultural products and produce mycotoxins, are the Penicillium, Aspergillus and Fusarium 
genera (Commission Regulation (EC) No 401/2006). Besides their metabolic versatility with 
great biotechnological potential, having many uses for the production of several food and 
non-food by-products (e.g., production of the antibiotic penicillin by Penicillium species, 
large-scale obtaining of citric acid carried out by Aspergillus niger or Fusarium venenatum 
production to use as a meat substitute), these genera also include the foremost producers of 
mycotoxins (e.g., Aspergillus flavus and Aspergillus parasiticus producers of aflatoxins; or 
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Aspergillus ochraceus, Aspergillus carbonarius, and Penicillium verrucosum producers of 
ochratoxin A) (Reis et al., 2017).  
Exposure to mycotoxins is mostly by ingestion of contaminated foods, as well as by dermal 
contact or inhalation of toxic spores. The diseases caused by the exposure to mycotoxins are 
known as mycotoxicoses. As all toxicological syndromes, mycotoxicoses can be categorized 
as acute or chronic (Zain, 2011). Acute toxicity generally has a quick onset and an evident 
toxic response (e.g., hemorrhagic necrosis of the liver or kidney disorders), while chronic 
toxicity is characterized by low-dose exposure over a long period of time, resulting in 
commonly irreversible effects (e.g., hepatocellular carcinoma) (Zain, 2011). 
The economic impact of mycotoxins include loss of human and animal life, increased health 
care and veterinary care costs, reduced livestock production, discarding contaminated foods 
and feeds, and investment in research and applications to reduce severity of the mycotoxin 
problems (Zain, 2011). It should be noted that guidelines exist to monitor/control the levels of 
mycotoxins in foodstuffs (Commission Regulation (EC) No 401/2006), to ensure the safety of 
consumption. 
Figure 8 shows the main antibacterial and antifungal agents and their mechanism of action, 
namely their target on the microorganism’s cells. 
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Figure 8. Mechanism of action of the antibacterial and antifungal agents used in clinical use. 
Antibacterial agents exert their effect mainly by 5 ways. They inhibit the cell wall synthesis 
interfering with peptidoglycan (cell wall component) synthesis, which will affect the rigidity and 
integrity of the cell wall leading to cell lysis / death. Antimicrobials may also alter the function or 
integrity of the cell membrane, disorganizing its permeability so that nucleic acids and cations leak 
out and the cell dies. Regarding the interaction with nucleic acids, antimicrobials may inhibit 
nucleotide synthesis or their interconversion, prevent DNA from functioning as an appropriate 
template; and they may also interfere with the polymerases involved in the DNA replication and 
transcription. Antimicrobials also inhibit protein synthesis interacting directly with the ribosome, 
binding to one or both 50S and 30S subunits. The metabolism of the cell may also be affected by 
antimicrobials, such as sulfonamides that interfere with folate metabolism. This class of 
antimicrobials, competitively blocking the biosynthesis of tetrahydrofolate, which is necessary for the 
ultimate synthesis of DNA, RNA and bacterial cell wall proteins. Regarding the antifungal agents, 
they can form a complex with ergosterol compromising the cell membrane fluidity. Other antifungals, 
such as azoles, inhibit the synthesis of this sterol. They are 14α-demethylase inhibitors, an enzyme 
that catalyzes a critical reaction of the sterol biosynthetic pathway, leading to the depletion of 
ergosterol in the membrane. Finally, other antifungal classes inhibit glucan biosynthesis, acting as 
specific non-competitive inhibitors of β-(1,3)-glucan synthetase (Reis et al., 2017). 
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Some studies suggest mushrooms as inhibitors of mycotoxins production. Culture filtrates 
from Lentinula edodes (Berk.) Pegler and Trametes versicolor (L.) Lloyd have revealed 
promising aflatoxin-inhibiting effects (Reverberi et al., 2005; Zjalic et al., 2006).  
Some mushroom extracts, particularly obtained from L. edodes and Phellinus linteus 
(Berkeley & Curtis) Teng, have been reported as effective even against highly resistant 
bacteria, such as MRSA (Hearst et al., 2009; Hur et al., 2004). Besides, both primary and 
secondary metabolites from mushrooms have been associated with their antimicrobial 
properties, such as oxalic acids, peptides or proteins, and terpenes, steroids or benzoic acids 
derivatives (Alves et al., 2012).  
Table S4 (Annex 1) lists the Portuguese mushroom species already described for its 
antibacterial potential, while Table S5 (Annex 1) lists the Portuguese mushroom species 
already described for its antifungal potential. 
 
1.2.2.3. Antitumour activity 
Cancer is the leading cause of death in developed countries. The most frequently occurring 
forms of the disease in the European Union are breast, prostate, lung and colorectal cancers. 
Lung cancer is the most frequent cause of cancer death in men, while in women, is breast 
cancer. In both men and women, colorectal cancer is the second most common cause of 
cancer death (Commission Regulation (EC) No 401/2006). Over the recent years, the 
scientific community has been trying to find ever more effective treatments with fewer side 
effects. However, many studies are still being conducted at this level (Steichen et al., 2013; 
Voskens et al., 2013). 
In order to better understand the biology of cancer and how the tumour growth and metastatic 
dissemination are processed, Hanahan & Weinberg (2011) proposed six hallmarks of cancer. 
One of these hallmarks is the ability of tumour cells to resist cell death. Therefore, therapies 
based on the induction of cancer cell death, namely programmed cell death (PCD), may 
constitute one approach to help in the treatment of certain types of cancer. Indeed, some drugs 
that induce apoptosis are already available such as inhibitors of Bcl-2 (e.g., venetoclax; Cang 
et al., 2015).  
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Several studies have confirmed the antitumour potential of extracts and compounds obtained 
from different mushroom species (Ferreira et al., 2010; Giavasis, 2014; Lemieszek & Rzeski, 
2012; Lindequist et al., 2005; Poucheret et al., 2006; Zaidman et al., 2005). Thus, the 
identification and chemical characterization of mushroom extracts that induce PCD in tumour 
cells may allow the discovery of novel compounds to be used as drugs or nutraceuticals in 
cancer treatment. In fact, in some countries such as Japan, some mushroom 
extracts/fractions/compounds are approved to be used in cancer treatments. Some examples 
are PSP (polysaccharide-peptide) and PSK (polysaccharide-K) (Zaidman et al., 2005), 
lentinan (polysaccharide; Ina et al., 2013) and schizophyllan (polysaccharide; Sullivan et al., 
2006). Therefore, the identification of the compounds responsible for the bioactivity is crucial 
for the development of nutraceutical and/or pharmaceutical formulations. 
The balance between cell division and cell death is very important for the maintenance of 
multicellular organisms. Given its importance, these processes are highly regulated. It is well 
recognised that cells have a mechanism of PCD, mediated by an intracellular program, which 
is established to conduct death of a cell in any pathological state format (Ouyang et al., 2012). 
Taking into account the phenotypic and molecular factors involved in the process, it is 
accepted that cells have multiple routes through which they can execute PCD, including 
apoptosis (the most studied mechanism), autophagy and programmed necrosis (Bialik et al., 
2010). These three main mechanisms of PCD are characterized by distinct morphological 
features and are executed through different signalling pathways (Bialik et al., 2010; Ouyang et 
al., 2012; Tan et al., 2009).  
Apoptosis is characterized by several events such as cell shrinkage, chromatin condensation 
and fragmentation, membrane blebbing and disintegration of the cell into apoptotic bodies; 
autophagy unfolds through the appearance of double-membrane cytoplasmic vesicles, the 
autophagosomes, engulfing bulk cytoplasm and/or cytoplasmic organelles such as 
mitochondria and endoplasmic reticulum for recycling; and necrosis is defined as non-
lysosomal vesiculate degradation, which involves cell swelling, organelle dysfunction and cell 
lysis (Bialik et al., 2010; Krysko & Vandenabeele, 2009; McCall, 2010; Nishida et al., 2008; 
Ouyang et al., 2012). 
Since homeostasis and cell death are very important processes of morphogenesis, an 
imbalance in these mechanisms leads to various pathological processes including cancer 
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(Ouyang et al., 2012; Sun & Peng, 2009; Tan et al., 2009). The ability of chemotherapeutic 
agents and ionizing radiation to induce PCD in tumour cells constitutes the basis of cancer 
therapy (Tan et al., 2009). Therefore, it becomes very important to fully understand the 
pathways involved in the various types of PCD, in order to find potential therapeutic targets 
and to identify novel compounds that are inducers of PCD.  
Figure 9 shows, in a simplified way, the apoptosis pathway, while Figure 10 summarizes the 
autophagy process, both considered two main types of PCD. 
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Figure 9.  Apoptosis general pathways. In the intrinsic pathway BH3-only proteins (members of the 
Bcl-2 protein family) induce the oligomerization of Bax or Bak, which triggers mitochondrial release 
into the cytosol of apoptogenic factors, such as cytochrome c, SMAC/DIABLO and HtrA2/OMI. 
SMAC/DIABLO and HtrA2/OMI interfere mostly with the caspase-inhibitory function of the 
inhibitor of apoptosis proteins (IAPs). Once in the cytosol, cytochrome c is recruited into the 
apoptosome with APAF-1 and procaspase-9, and activates the caspase cascade (initiated with 
caspase-9 activation). Activated caspase-9 then cleaves and activates the executioner caspases-3, -6 
and -7 which will result in the cleavage of death substrates, such as PARP. The extrinsic pathway 
comprises oligomerization of death receptors (e.g., Fas) with their ligands (e.g., FasL), resulting in the 
recruitment and activation of the initiating caspase-8 and/or caspase-10. Caspase-8 can directly cleave 
and activate the executioner caspase-3 (which also belongs to the intrinsic pathway). In addition, 
activated caspase-8 cleaves Bid (a BH3-only protein member), generating truncated Bid (t-Bid). t-Bid 
translocation to mitochondria leads to the release of apoptogenic factors, causing further activation of 
the apoptotic cascade by formation of more apoptosomes (Reis et al., 2016a). 
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Figure 10. Autophagy general pathways. In the absence of energy/nutrients, AMPK (AMP-activated 
protein kinase) phosphorylates TSC1/2 activating the ULK kinase complex (ULK 1/2, Atg13 and 
FIP200) and inhibiting mTOR Ser/Thr kinase. Once mTORC1 kinase (one of mTOR complexes) is 
inhibited, autophagy is triggered. Beclin 1 binds to VPS 34 (a lipid kinase) following its interaction 
with other autophagy regulators such as Ambra 1. Autophagy related genes (Atg) such as Atg12, Atg5, 
Atg7, Atg10 and Atg16, as well as LC3 lipidation into LC3-II, are required for the formation and 
maturation of the autophagosomes. Concerning the LC3 system, the membrane associated LC3-II is 
produced after conjugation of LC3-I with phosphatidylethanolamine (PE) through an ubiquitination-
like enzymatic reaction. Fusion of the autophagosome with the lysosome results in the digestion and 
recycling of the autophagolysosomes cargo (Reis et al., 2016a). 
 
Several mushroom extracts have been reported to have influence in PCD, being modulators 
especially of apoptosis and autophagy in several human tumour cell lines (Reis et al., 2016a). 
Once again, most of the studies were conducted all over the world. Regarding the Portuguese 
mycoflora, only the species Clitocybe alexandri (Gillet) Gillet (Vaz et al., 2012a), Suillus 
collinitus (Fr.) Kuntze (Vaz et al., 2012b) and Leccinum vulpinum Watling (Reis et al., 2016b) 
were identified as inducers of apoptosis. The Ganoderma lucidum (Curtis) P. Karst. species 
was identified as a modulator of autophagy (Oliveira et al., 2014; Reis et al., 2015).  
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Scope and Objectives 
 
The Iberian Peninsula, and particularly Bragança (Portugal), is one of the regions of Europe 
with greater mycological biodiversity, where mushrooms’ picking is a tradition. Thus, with 
this study it is expected to undertake a careful identification and characterization of the largest 
number of wild mushroom species, contributing to the development of databases and prizing 
their traditional consumption as foods with high nutritional value.  
In addition to its gastronomic and culinary relevance, the potential of mushrooms as 
functional foods and as a source of bioactive compounds has been explored over time. As 
aforementioned, since ancient times people have been taking advantage of their medicinal and 
therapeutic properties, such as antioxidant, anti-cancer, prebiotic, immunomodulating, anti-
inflammatory, cardiovascular, antimicrobial, and anti-diabetic, and there is an attempt to 
promote this natural matrix as a new generation “biotherapeutic”.  
Given the bioactive/therapeutic importance of mushrooms, there was also a demand for 
identifying potentially bioactive extracts, testing the antioxidant, antimicrobial and antitumour 
potential of the studied species. Therefore, this work aims to take a step forward towards 
classifying mushrooms, namely the studied species, as functional foods.  
 
From this background, the main objective of this research work was:  
 
The study of edible mushrooms from the Northeast of Portugal performing their 
chemical characterization (including the evaluation of their nutritional value, 
biochemical composition, taking into account the presence of nutrients and bioactive 
compounds) and testing their biological activity, namely antioxidant, antimicrobial 
and antitumour capacity. Consequently, it is intended to enhance the traditional use 
and consumption of mushrooms, valuing them as a possible source of functional 
ingredients and/or nutraceuticals.  
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To the accomplishment of the main goal, the following specific aims were established: 
 
1. Chemical characterization of the studied species (wild and cultivated mushrooms) 
through the evaluation of their nutritional value, and the presence of compounds with 
nutritional and bioactive interest; 
2. Evaluation of the biological activity of the mushroom extracts: in vitro antioxidant 
activity, antimicrobial activity against pathogenic bacteria and fungi, and cytotoxicity 
effects in human tumour cell lines and in non-tumour cells;  
3. Attempt to elucidate the antitumoural mechanism of action of the mushroom extracts 
on human tumour cell lines (effects on cell proliferation, cell cycle arrest and on 
programmed cell death).  
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Ámbito de Aplicación y Objetivos 
 
La Península Ibérica, y en particular Bragança (Portugal), es una de las regiones de Europa 
con mayor biodiversidad micológica, donde existe una arraigada tradición de recolección y 
consumo de setas. De modo que con este estudio se espera llevar a cabo la caracterización 
química de algunas de las especies de setas silvestres más valoradas, intentando contribuir al 
desarrollo de bases de datos y revalorización del consumo tradicional de las mismas por ser 
alimentos con gran valor nutricional. Además de su importancia gastronómica y culinaria, las 
setas se conocen y se utilizan desde la antigüedad por sus propiedades medicinales y 
terapeuticas, por su potencial antioxidante, anticancerígeno, inmunomodulador, anti-
inflamatorio, anti-microbiano, hipoglucemiante y prebiótico, de modo que hoy en día existe 
un marcado interés por promover estas matrices alimentarias como precursores 
“bioterapéuticos” de nueva generación por su como alimentos funcionales y como fuente de 
compuestos bioactivos. 
  
Dada la importancia de las setas desde el punto de vista funcional, hoy en día también se está 
tratando de identificar extractos de setas potencialmente bioactivos, poniendo a prueba el 
potencial antioxidante, antimicrobiano y antitumoral de las especies estudiadas. Por lo tanto, 
este trabajo pretende dar un paso adelante hacia la consideración de las setas objeto de estudio 
como alimentos funcionales.  
 
Por todo ello, el presente trabajo de investigación tiene como objetivo principal:  
 
El estudio de las setas comestibles del Noreste de Portugal, mediante la 
caracterización química (incluyendo la evaluación de su valor nutricional, 
composición de nutrientes y compuestos bioactivos) y evaluación de su actividad 
biológica (capacidad antioxidante, antimicrobiana y antitumoral). Con la finalidad de 
promover el consumo y uso tradicional de estas setas, valorándolas como una posible 
fuente de ingredientes funcionales y/o nutracéuticos. 
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Para ello se plantearon los siguientes objetivos específicos: 
 
1. Caracterización química de las especies seleccionadas (silvestres y cultivadas) 
mediante la evaluación de su valor nutricional y contenido de compuestos bioactivos; 
2. Evaluación de la actividad biológica de los extractos de setas seleccionadas: actividad 
antioxidante in vitro; actividad antimicrobiana frente a bacterias y hongos patógenos; 
y evaluación de la citotoxicidad en líneas celulares tumorales humanas y en células no 
tumorales; 
3. Primera aproximación a la elucidación del mecanismo de acción antitumoral de los 
extractos de las setas estudiadas en las líneas de células tumorales humanas (efectos 
sobre la proliferación celular, modulación del ciclo celular y inducción de la muerte 
celular programada). 
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Working Plan 
 
Given the main objective of the present work, the study of edible wild mushrooms from the 
Northeastern region of Portugal, performing their chemical characterization and testing their 
biological activity and valuing them as a possible source of functional ingredients and/or 
nutraceuticals, the following working plan was followed. 
 
Task 1. Mushrooms selection 
In order to comply with the proposed objectives, in the first phase, the samples under study 
were selected. A total of 17 different species of edible mushrooms were selected and studied. 
Regarding the cultivated species, these were selected according to the season availability in 
the market and consumer preferences. Regarding the wild species, these were selected 
considering their availability and suitability for the proposed objectives. This species were 
collected and identified by researchers of our group with expertise in mycology. Once 
comparative studies between wild species from Portugal and Serbia (Suillus granulatus (L.) 
Roussel) were also conducted, the same criteria were followed for the Serbian samples. 
Cordyceps militaris (L.) Link was provided by the  Department of Applied Biology, Kangwon 
National University, Chuncheon, Republic of Korea and Phellinus linteus (Berkeley & Curtis) 
Teng) was provided by Amazing Grace Health Industries, Bangkok, Thailand.  
 
Task 2. Chemical characterization of the studied species 
For the species under study a detailed chemical characterization was carried out. The 
nutritional value, nutrient and non-nutrient composition, taking into account biologically 
active compounds, were evaluated. Therefore, the nutritional value of the samples was 
assessed based on protein, fat, carbohydrate and ash contents obtained following standard 
procedures (AOAC, 2012). Energy was calculated according to Regulation (EC) No. 1169/ 
2011 of the European Parliament and of the Council, of 25 October 2011, on the provision of 
food information to consumers.  
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For the nutritional evaluation, chromatographic determinations of soluble sugars, tocopherols 
and fatty acids were carried out. For this purpose High Performance Liquid Chromatography 
(HPLC) coupled to different detectors (soluble sugars, tocopherols) and Gas Chromatography 
(GC) coupled to a flame ionization detector (FID) (fatty acids) systems were used.  
Regarding the non-nutrient composition, phenolic acids and related compounds, as well as 
other organic acids were assessed. Herein, liquid chromatography systems coupled to 
different detectors were used.  
 
Task 3. Evaluation of the bioactive properties of the studied species 
After characterizing the compounds present in the samples, the bioactivity of their extracts 
was assessed. Thus, the antioxidant, antimicrobial and antitumour potential were evaluated. 
Given the presence of phenolic acids in all the studied species, especially in the wild samples 
(the main focus of this study), the methanolic extract of the samples was selected for such 
evaluations. The antioxidant potential was assessed with different in vitro assays; the 
antimicrobial activity was evaluated testing the extracts against different pathogenic bacteria 
and fungi; and the antitumour potential verified in different human tumour cell lines. In 
addition, for some species, it was possible to infer a possible mechanism of action. The safety 
of the extracts was also evaluated in non-tumour cells, namely in cell cultures obtained from 
porcine liver (PLP2). 
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Figure 11. Depiction of the different tasks. 
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4.1. Mushrooms: selection and description 
 
Mushrooms have a well-known structure (Figure 12). Almost all the mushroom species 
studied in the present work belong to the phylum Basidiomycota. The only exception was 
Cordyceps militaris, a species belonging to the phylum Ascomycota (Kirk et al., 2008).  
The major difference between these two groups resides in their spore-producing structures. 
Fungi belonging to Basidiomycota phylum produce sexual spores (basidiospores) externally 
in spore-producing specialized cells – basidia. Basidia are found on the hymenophore 
(hymenium-bearing structure) of the fruiting bodies. Spores are quit from basidia and then 
dropped from the gills (or tubes, in boletes case) located underneath the cap (Barceloux, 
2012). Spores from Ascomycota phylum (ascospores) are formed inside a tube-like or bag-
like structure (ascus). This structure expels the ascospores through a small lid or tip, usually 
by bursting. That is why sometimes they are called spore-shooters (Barceloux, 2012; Jordan, 
2015).       
Most of the commercially cultivated mushrooms belong also to the phylum Basidiomycota 
(Chikthimmah, 2006), and the studied species were not exception.  Agaricus bisporus, 
Lentinula edodes, Pleurotus sp. and Flammulina velutipes constitutes the most cultivated 
species worldwide (Aida et al., 2009; Chang & Miles, 2004).  Besides their pleasant flavour, 
these mushrooms required shorter growth time when compared to other edible mushrooms, 
claim few environmental controls, and their cultivation is quite simple and cheap (Bonatti et 
al., 2004).  
 
 
Figure 12. Typical structure of a mushroom (based on Telander (2012), with some alterations). 
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In the present work, 17 different edible mushroom species were studied (Table 3). The 
general information about each species is presented below.  
 
 
 
 
 
 
 
                                                                                                                                                                   Material and Methods 
55 
 
 
Table 3. Species selected to carry out the present work. 
 
Scientific name Origin Photo 
Common name /  
English name 
Ecology 
Date of 
purchase / 
collection 
Studied 
sample 
Country 
Studied extract / 
fraction 
Agaricus bisporus (J.E. 
Lange) Imbach 
Cultivated 
 
White button mushroom; 
Champignon 
Saprotrophic 
Spring 2011 
Fruiting body 
Mycelium 
Portugal Methanolic 
Cultivated 
 
Brown mushroom; 
Portobello 
Spring 2011 
Fruiting body 
Mycelium 
Portugal Methanolic 
Cordyceps militaris (L.) 
Link 
Cultivated 
 
Scarlet caterpillarclub Entomopathogenic 
Autumn 
2012  
Fruiting body Korea Methanolic 
Flammulina velutipes 
(Curtis) Singer 
Cultivated 
 
Golden needle 
mushroom; Velvet shank; 
Enoki 
Saprotrophic Spring 2011 Fruiting body Portugal Methanolic 
Lentinula edodes 
(Berk.) Pegler 
Cultivated 
 
Shiitake Saprotrophic Spring 2011 
Fruiting body 
Mycelium 
Portugal Methanolic 
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Table 3 (Cont.) 
 
Scientific name Origin Photo 
Common name /  
English name 
Ecology 
Date of 
purchase / 
collection 
Studied 
sample 
Country 
Studied extract / 
fraction 
Phellinus linteus 
(Berkeley & 
Curtis) Teng 
Cultivated 
 
Meshima; black hoof 
mushroom 
Parasitic Autumn 2012 
Food 
supplement 
Thailand 
Ethanolic 
Methanolic 
Fractions: 
Polysaccharides 
Glucans  
Triterpenoids 
 
Pleurotus ostreatus 
(Jacq. Ex Fr.) P. 
Kumm. 
Cultivated 
 
Oyster mushroom Saprotrophic Spring 2011 
Fruiting body 
Mycelium 
Portugal Methanolic 
Pleurotus eryngii 
(DC.) Quél. 
Cultivated 
 
King trumpet 
mushroom; French 
horn mushroom; king 
oyster mushroom; king 
brown mushroom; 
boletus of the steppes; 
trumpet royale 
Saprotrophic 
(sometimes 
parasite on the 
roots of 
herbaceous 
plants) 
Spring 2011 
Fruiting body 
Mycelium 
Portugal Methanolic 
Wild Autumn 2011 
Fruiting body 
Mycelium 
Portugal Methanolic 
Agaricus albertii 
(Bon.) 
Wild 
 
Unknown Saprotrophic Autumn 2011 Fruiting body Portugal Methanolic 
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Table 3 (Cont.) 
 
Scientific name Origin Photo 
Common name /  
English name 
Ecology 
Date of 
purchase / 
collection 
Studied 
sample 
Country 
Studied extract / 
fraction 
Agaricus urinascens var. 
excellens (F.H. Møller) 
Nauta 
Wild 
 
Macro mushroom Saprotrophic Autumn 2011 Fruiting body Portugal Methanolic 
Amanita caesarea (Scop.) 
Pers  
Wild 
 
Caesar’s mushroom Mycorrhizal Autumn 2009 Fruiting body Portugal Methanolic 
Cortinarius violaceus (L.: 
Fr.) Gray  
Wild 
 
Violet webcap Mycorrhizal Autumn 2009 Fruiting body Portugal Methanolic 
Ganoderma lucidum 
(Curtis) P. Karst. 
Wild 
 
Lacquered Bracket; 
Lingzhi 
Saprotrophic; 
parasitic 
Summer 2011 Fruiting body Portugal Methanolic 
Lactarius volemus (Fr.) 
Fr.  
Wild 
 
Weeping milk cap; 
Fishy milkcap; 
Voluminous - latex 
milky 
Mycorrhizal Autumn 2009 Fruiting body Portugal Methanolic 
 
                                                                                                                                                                   Material and Methods 
58 
 
 
Table 3 (Cont.) 
 
Scientific name Origin Photo 
Common name /  
English name Ecology 
Date of 
purchase / 
collection 
Studied 
sample 
Country 
Studied extract / 
fraction 
Leccinum molle Bon 
(Bon) 
Wild 
 
Unknown Mycorrhizal Autumn 2012 Fruiting body Portugal Methanolic 
Leccinum vulpinum 
Watling 
Wild 
 
Foxy bolete Mycorrhizal Autumn 2012 Fruiting body Portugal Methanolic 
Suillus granulatus (L.) 
Roussel 
Wild 
 
Weeping bolete; 
granulated bolete 
Mycorrhizal Autumn 2012 Fruiting body 
Portugal 
Serbia 
Methanolic 
Suillus luteus (L.: Fries) 
Gray  
Wild 
 
Slippery jack; Sticky 
bun 
Mycorrhizal Autumn 2009 Fruiting body Portugal Methanolic 
Images from Wikipedia or by Filipa Reis 
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Agaricus bisporus (J.E. Lange) Imbach 
Phylum: Basidiomycota;  
Class: Agaricomycetes;  
Order: Agaricales;  
Family: Agaricaceae  
 
A. bisporus, mostly known as champignon (white mushroom) and portobello (brown 
mushroom), is the most commonly consumed species worldwide, due to its aroma and 
flavour, both as fresh and canned form. This species is typically cultivated on a compost 
medium (Chikthimmah, 2006; Lyle, 2010), and thus not so common the consumption of wild 
species.   
Both white and brown mushrooms have similar features. The cap, initially with a square 
shape, becomes convex to broadly convex, almost flat in mature mushrooms. However, in 
champignon, the cap’s colour is white at first, becoming pale brown with age; and portobello 
has a cap with a brownish colour, that has throughout its surface some hair like strands that 
can form tangles with a darker shade. Note that with the advanced state of maturation, these 
wires may be lost or, in the case of wild species, may not be visible especially after rain. Like 
other Agaricus, in young specimens it can be observed a protective structure (a partial veil) 
that connects the base of the cap with the stalk. This structure turns out to fade with the 
fruiting body growth, exposing the gills and allowing the spread of spores (reproductive 
structures) and the species dissemination (wild species).  The gills of both mushrooms are 
firstly pinkish to pinkish brown, becoming dark brown to blackish with age. The stalk of these 
mushrooms is white to brownish, smooth or with small scales below the ring (especially in 
portobello) broader near the base. The ring may disappear with age (or may be absent 
especially in wild species after rain) (Biswas et al., 2011; McFarland & Mueller, 2009). Wild 
species usually arises in autumn, single (not in clusters) (Biswas et al., 2011). 
Concerning to its consumption, A. bisporus is a very versatile species, being consumed in 
several dishes, raw (e.g., salads) or cooked (e.g., widely used in pizzas or stir fries). It is also 
incorporated in cream and tomato sauces (Brodeur, 2014).    
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Cordyceps militaris (L.) Link 
Phylum: Ascomycota 
Class: Sordariomycetes  
Order: Hypocreales 
Family: Cordycipitaceae  
 
As previously referred this mushroom belongs to the phylum Ascomycota, so it differs a bit 
from the others. While Basidiomycota normally have the more traditional mushroom shape 
(similar to an umbrella), the cap from Ascomycota is similar to a bag. 
C. militaris has an orange colour (both cap and stalk) being whitish at the base of the stalk, 
which emerges single or in clumps from insect pupae buried in the ground (entomopathogenic 
species). 
Usually it arises in late autumn. Although, it is considered unpalatable and is not widely 
consumed in Europe, its use in Asia (mainly in soups) is mainly due to its pharmacological 
potential with a known and long history of use in traditional medicine (McKnight & 
McKnight, 1998). 
 
Flammulina velutipes (Curtis) Singer 
Phylum: Basidiomycota  
Class: Agaricomycetes 
Order: Agaricales 
Family: Physalacriaceae  
 
F. velutipes has both the cap and the stalk very thin (especially the cultivated mushrooms). 
Both are white to pale brown, and this later is equal in width along the length. It has tiny hairs 
that provide a velvety texture. The gills are whitish or creamy (Telander, 2012).  
The wild mushrooms are a little bigger with a smooth surface golden brown or reddish, being 
darker in the center. The mushrooms have a brown velvety stalk and yellowish white gills. 
This saprotrophic species fructifies in late autumn to early spring on old trees or stumps and 
fallen branches. Both cultivated and wild mushrooms grow in clusters (the stalks are usually 
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fused with other stalks at the base) (Jordan, 2015; McKnight & McKnight, 1998, Telander, 
2012). 
This velvet shank mushroom could be used fresh or sautéed. The fresh mushrooms are usually 
included in salads and when cooked, it is used in stir-fries, soups, stews and sauces (Brodeur, 
2014; Jordan, 2015; McKnight & McKnight, 1998; Telander, 2012). 
 
Lentinula edodes (Berk.) Pegler 
Phylum: Basidiomycota  
Class: Agaricomycetes  
Order: Agaricales  
Family: Marasmiaceae  
 
L. edodes, widely known as shiitake, is a widely cultivated and marked species. It is a brown 
mushroom with whitish gills, with a fibrous texture and woody cream-colored stalks. The 
wild mushrooms grow especially on oak logs (Brodeur, 2014; Lyle, 2010).   
This species is highly appreciated, and known also for its medicinal properties (Bisen et al., 
2010; Dai et al., 2015; Israilides et al., 2008).  
Shiitake is consumed either fresh as in dried form. It woody stems are usually removed, and 
this mushroom is typically consumed sautéed and served over wild rice. When used the 
dried/lyophilized form, the mushroom should be reconstituted in warm water before cooking. 
Shiitake has a nice consistency and a smoked flavour, such as meat, and can be cooked slowly 
(Lyle, 2010). It is quite good grilled, and widely used in risottos, pastas, stir fries, fondues, 
egg dishes, and casseroles (Brodeur, 2014).   
 
Phellinus linteus (Berkeley & Curtis) Teng 
Phylum: Basidiomycota  
Class: Agaricomycetes 
Order: Hymenochaetales  
Family: Hymenochaetaceae  
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P. linteus is widely known for its medicinal properties (Ferreira et al., 2010; Sliva, 2010; 
Wasser, 2010 and 2011; Wu et al., 2013; Zhu et al., 2008).  
It is thick, hard, woody, silky, velvet and it is shaped like a hoof. It has a pale brown to light 
yellow cap, and the stalk (also stick), ranges from dark brown to black and sometimes is 
absent. This parasitic fungus is usually found in branches and stems of the host trees, 
preferentially on mulberry trees (Halpern, 2007; Jais, 2014; Rogers, 2012; Sliva, 2010).  
Due to its morphological features and the bitter taste, P. linteus is usually consumed as a 
decoction especially in Korea, China and Japan, to take advantage of its medicinal properties 
(Halpern, 2007; Rogers, 2012; Sliva, 2010).   
 
Pleurotus ostreatus (Jacq. Ex Fr.) P. Kumm. 
Phylum: Basidiomycota  
Class: Agaricomycetes 
Order: Agaricales 
Family: Pleurotaceae  
 
P. ostreatus has a white to brownish or silvery grey cap, wavy and convex to flattened, 
rounded down at the margins with irregular size (like an oyster shell). The gills are white to 
yellowish, descending down to the base. The stalks are minimal (sometimes absent), tough 
and off-centre (Jordan 2015; Lyle, 2010; Telander, 2012).  
Oyster mushrooms are saprotrophic, grow in clusters, and the wild species fructify essentially 
in autumn on fallen/dead trees or their stumps especially from elm, oak and beech (Jordan 
2015; Lyle, 2010; Telander, 2012).  
P. ostreatus is marketed and highly sought due to its delicate odour and flavour, and is 
commonly used in many recipes sliced, sautéed, and made into soup or a casserole. It is a 
great companion both for meats and fish dishes, and with other mushroom species with 
stronger flavours. It is also advisable for sauces (Jordan, 2015; Lyle, 2010; Telander, 2012).  
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Pleurotus eryngii (DC.) Quél. 
Phylum: Basidiomycota  
Class: Agaricomycetes  
Order: Agaricales  
Family: Pleurotaceae  
 
P. eryngii is usually cultivated for consumption and widely appreciated. This species has a 
convex cap, centrally depressed, with a turning point margin down, and the colour ranges 
from beige to brown. The gills are whitish or greyish and it has a whitish stalk. Wild 
mushrooms arise in spring to autumn and, although being reported as saprotrophic species, 
sometimes they are also parasitic of some species roots (Chang & Hayes, 2013; Phillips, 
2013).  
It has a very pleasant aroma and flavour, being one of the most appreciated species from this 
genus and used in various dishes (Chang & Hayes, 2013). Since it has a slight scallop-oyster 
flavour, it is often used as seafood accompaniment. Actually P. eryngii fruiting bodies may 
give a seafood flavour to the dishes when inserted in sauces and soups. They are also 
consumed stir-fried (Brodeur, 2014).  
 
Agaricus albertii (Bon.) 
Phylum: Basidiomycota  
Class: Agaricomycetes  
Order: Agaricales  
Family: Agaricaceae  
 
A. albertii has a convex whitish cap with a margin that becomes toothed with age. The gills 
are grey in young specimens, turning dark brown. The stalk is cream to grey and with a ring 
very thick and scaly on the upper of the stalk.  
Its aroma and taste are pleasant, quite aniseed (Mohamad et al., 2009). As far as we know, 
there are no uses/recipes available containing this mushroom. However, given its properties, 
the use should be similar to that of other Agaricus. 
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Agaricus urinascens var. excellens (F.H. Møller) Nauta 
Phylum: Basidiomycota  
Class: Agaricomycetes 
Order: Agaricales 
Family: Agaricaceae  
 
This species is similar to another Agaricus, namely Agaricus campestris (also an edible 
species), besides it is larger and thicker. The cap has a domed shape and is white, turning a 
little brown with age. The gills are initially whitish grey, becoming dark brown along the 
maturation process. This mushroom has also the distinct veil when young, which breaks to 
reveal the light-coloured gills. Although it can grow in clusters, usually it grows single 
forming fairy rings, typically in pasture fields in early summer to autumn (Jordan, 2015). 
It has a week aniseed odour, which turns more like ammonia with age. Since it has a steady 
texture, it is good in all mushroom dishes and the young specimens are quite good sliced raw 
in salads (Jordan, 2015). 
 
Amanita caesarea (Scop.) Pers 
Phylum: Basidiomycota  
Class: Agaricomycetes  
Order: Agaricales  
Family: Amanitaceae 
 
This widely appreciated Amanita, known as Caesar’s mushroom, is characterized by a convex 
becoming flattened cap, with a finely striated margin. It has an orange-to yellow colour, 
darkest in the centre, fading overall with age. The gills are cream or yellowish. The stalk is 
smooth or with small scales and with the same colour as the cap, and a membranous ring 
under this. At the base of the mushroom is a distinct volval sac (typically from the genus 
Amanita) (Jordan, 2015; Telander, 2012).  
This mycorrhizal species usually appears singly or in fairy rings in pine or oak woodlands 
during the summer and autumn, especially after summer storms (Jordan, 2015; Telander, 
2012).  
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This mushroom has a pleasant aroma and flavour. For that it could be inserted in many dishes 
or consumed raw to get the full flavour. Like all mushrooms, but especially this genus, should 
be consumed very carefully because it includes some deadly species (i.e., Amanita 
phalloides). Actually, it is easily mixed up with Amanita muscaria, a hallucinogenic 
mushroom known as fly agaric. 
 
Cortinarius violaceus (L.: Fr.) Gray 
Phylum: Basidiomycota  
Class: Agaricomycetes 
Order: Agaricales 
Family: Cortinariaceae  
 
Violet webcap has a dark violet to dark purple overall (cap and stalk). Its cap is convex, 
becoming flattened, dry and rough with tiny scales. As some Agaricus species, it has a 
“cortina” developing from the cap margin to the upper stalk (which in fact contributed for the 
nomination of the genus – Cortinarius). Gills have the same colour as the cap and stalk. Its 
stalk is tough and fibrous, and somewhat enlarged at the base. C. violaceus could be found 
during the autumn, solitary or disseminated on the ground, associated with coniferous trees 
(Telander, 2012).  
Although it is considered edible, the taste is not very appreciated (McKnight & McKnight, 
1998). However, it is consumed by the great lovers of mushrooms, especially in soups, stews 
and stir fries.  
  
Ganoderma lucidum (Curtis) P. Karst.  
Phylum: Basidiomycota  
Class: Agaricomycetes  
Order: Polyporales  
Family: Ganodermataceae  
 
Lingzhi mushroom is the most studied medicinal mushroom worldwide (Ferreira et al., 2010; 
Halpern, 2007; Lai et al., 2010; Wachtel-Galor et al., 2011; Wasser, 2010 and 2011). 
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The fruiting bodies of G. lucidum are kidney shaped bright reddish brown. It has very tiny 
pores and the stalk, which could be absent, has the same colour of the cap.  
G. lucidum arises single or in small clusters, usually as a shelf at the basis of hardwood trees, 
shrubs, or roots from removed trees, favouring the decaying stumps of chestnut, oak and other 
broad-leaf trees (Davis et al., 2012). 
As P. linteus, this species is not consumed as other mushrooms, because of its bitter and 
woody taste. So, it is used mainly in decoctions and other alternative medicines (e.g., tonics) 
for medicinal purposes (Halpern, 2007; Davis et al., 2012).   
 
Lactarius volemus (Fr.) Fr. 
Phylum: Basidiomycota  
Class: Agaricomycetes 
Order: Agaricales 
Family: Russulaceae 
 
L. volemus possess a convex cap, depressed in the centre with a flat or incurved margin. It has 
a uniform reddish-orange colour and a straight, smooth, and pale orange-brown stalk.  As all 
the Lactarius species, when cut, the flesh exudes latex (hence the name of the genus). The 
latex colour should be taken into consideration, because it is white initially and then turns 
brown; if it turns yellow or lilac, is not advisable its consumption, as it is referred to as poison 
(McKnight & McKnight, 1998; Ostry et al., 2011; Telander, 2012).  
L. volemus is a mycorrhizal species that usually grows in deciduous woodlands during the 
summer and autumn and can be associated with conifers and hardwood trees (McKnight & 
McKnight, 1998; Ostry et al., 2011; Telander, 2012). The release of latex should be taken into 
account in its preparation for consumption. It may be consumed raw, but it is also considered 
an excellent choice for dishes with grains/seeds, since it has a meaty taste and a firm and 
fibrous texture (Brill, 2010; Garibay-Orijel et al., 2007). 
 
 
 
 
                                                                                Material and Methods 
67 
 
 
Leccinum molle Bon (Bon) 
Phylum: Basidiomycota  
Class: Agaricomycetes 
Order: Agaricales 
Family: Boletaceae  
 
Although not very know species, maybe because it was knew for many years as L. umbrinum 
J. Blum, which name cannot be used for nomenclatural reasons (Kibby, 2000). This species 
has very soft and dented cap, adopting the fingerprint at the lowest pressure. It is brown, 
grayish with a lemon tonality, ochre and then clearly olive by the margin. The stipe is is 
grayish beige, becaming reddish or dirty, and yellowish green under the hymenium (tubes), 
with gray, later reddish lax scales. The flesh is greenish gray, slightly reddish, and yellow 
green on top of stipe (Courtecuisse & Duhem, 2005). It is usually found in very wet locations 
under birch (Kibby, 2000). 
 
Leccinum vulpinum Watling 
Phylum: Basidiomycota  
Class: Agaricomycetes 
Order: Agaricales 
Family: Boletaceae  
 
This is also not a much common and known species. It has a dark brick red to purplish 
chestnut cap, with a porous whitish or pale cream hymenium. The stalk is white or cream, 
bruising bluish green at the base. This stalk is characterized by possessing some scales, firstly 
white, turning then the chestnut colour (Ellis & Ellis, 1990). 
The foxy bolete is a mycorrhizal species that usually stablish the association with the genus 
Pinaceae and Bearberry. It is an edible species and good if adequately cooked (Gry & 
Andersson, 2014).    
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Suillus granulatus (L.) Roussel 
Phylum: Basidiomycota  
Class: Agaricomycetes  
Order: Boletales  
Family: Suillaceae 
 
The granulated bolete has sticky brown to yellowish cap with a very tinny membranous 
margin. As other Suillus, this cap is shiny when dry. The stem is lemon yellow and the 
hymenium is composed by yellow tubes (Jordan, 2015). Note that Suillus species, as boletes, 
are important food for many invertebrates such as insect larvae, snails and slugs, and as their 
hymenium is porous, is quite common to find such animals in the fruiting bodies (Ostry et al., 
2011). 
This mycorrhizal species appears in summer or autumn, being more common in the latter 
season.  It is usually associated with coniferous trees, appearing scattered or in clusters 
(Jordan, 2015; McKnight & McKnight, 1998).  
S. granulatus has an aroma and taste slender but enjoyable. For consumption, as Suillus sp. in 
general, the removal of the skin of the cap is advisable. Due to its flavour (not too intense), it 
is appreciated mixed with other mushroom species, being advisable its dehydration first 
(Jordan, 2015).  
 
Suillus luteus (L.: Fries) Gray 
Phylum: Basidiomycota  
Class: Agaricomycetes  
Order: Boletales  
Family: Suillaceae 
 
This species, also known as slippery jack mushroom, own a convex cap becoming flattened, 
with various shades of red-orange, brown, or yellow. The surface is slimy when wet and shiny 
even when dry (since it is covered by a kind of mucus). The stalk is thick, yellowish above 
and smudged purple below, with a membranous collar that is part whitish and part purplish. 
The hymenium has a spongy surface whitish to yellow, becoming darker with age (Telander, 
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2012). S. luteus usually arises in late summer-autumn and stablish a symbiosis with especially 
with pine trees, being often found along pathways on the forest edges, single or in goups 
(Jordan, 2015; McKnight & McKnight, 1998; Ostry et al., 2011; Telander, 2012). 
Its edibility is good, so it can be cook on its own or with other Suillus. Often, the juice is 
strained and used to make a sauce. This mushroom softens well when cooked, so is excellent 
for soups, being advisable to dry the mushrooms first (Jordan, 2015).  
 
 
4.2. Standards and reagents 
 
4.2.1. For chemical analyses 
Acetonitrile 99.9%, n-hexane 95% and ethyl acetate 99.8% were of HPLC grade from Fisher 
Scientific (Lisbon, Portugal). The fatty acids methyl ester (FAME) reference standard mixture 
37 (standard 47885-U) was purchased from Sigma (St. Louis, MO, USA), as also other 
individual fatty acid isomers, ascorbic acid, sugars (D(-)-fructose, D(-)-mannitol, D(+)-
raffinose pentahydrate, D(+)-trehalose), tocopherols (α-, β-, γ-, and δ-isoforms) standards, 
phenolic standards (gallic acid, p-hydroxybenzoic acid, p-coumaric acid, protocatechuic acid) 
and cinnamic acid and all organic acids all organic acids standards (oxalic acid, quinic acid, 
malic acid, citric acid, and fumaric acid). Racemic tocol, 50 mg/mL, was purchased from 
Matreya (PA, USA). Methanol and all other chemicals and solvents were of analytical grade 
and purchased from common sources. Water was treated in a Milli-Q water purification 
system (TGI Pure Water Systems, USA). 
 
4.2.2. For bioactivity evaluation 
Antioxidant activity assays. Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic 
acid) was purchased from Sigma (St. Louis, MO, USA). 2,2-Diphenyl-1-picrylhydrazyl 
(DPPH) was obtained from Alfa Aesar (Ward Hill, MA, USA). β-carotene and linoleic acid 
were acquired from Sigma and Tween 80 from Panreac. All other solvents and reagents were 
purchased from scientific retailers. Methanol and all other chemicals and solvents were of 
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analytical grade and purchased from common sources. Water was treated in a Milli-Q water 
purification system (TGI Pure Water Systems, USA). 
 
Antimicrobial activity assays. Mueller-Hinton agar (MH) and malt agar (MA) were obtained 
from the Institute of Immunology and Virology, Torlak (Belgrade, Serbia). Dimethylsulfoxide 
(DMSO) (Merck KGaA, Germany) was used as a solvent. Streptomycin, ampicillin, 
ketoconazole and tryptic soy broth (TSB) were acquired from Sigma-Aldrich (St. Louis, MO, 
USA), bifonazole from Srbolek (Belgrade, Serbia), tween 80 from Sineks (Belgrade, Serbia). 
Iodonitrotetrazolium chloride (INT) was acquired from Biochemica (Panreac, Barcelona, 
Spain) and all other chemicals and solvents were purchased from scientific retailers.  
 
Antitumour activity and cytotoxicity assays. Dimethylsulfoxide (DMSO) (Merck KGaA, 
Germany) was used as a solvent. Fetal bovine serum (FBS), L-glutamine, Hank’s balanced 
salt solution (HBSS), trypsine, EDTA (ethylenediaminetetraacetic acid), nonessential amino 
acids solution (2 mM), penicillin/streptomycin solution (100 U/mL and 100 mg/mL, 
respectively), RPMI-1640 and DMEM media were from Hyclone (Logan, USA). Phosphate 
buffered saline (PBS), acetic acid, ellipticine, sulforhodamine B (SRB), trypan blue, 
trichloroacetic acid (TCA), Tris, insulin, hydrocortisone, epidermal growth factor (EGF), 
cholera toxin, and bromodeoxyuridine (5-bromo-2'-deoxyuridine; BrdU) were acquired from 
Sigma Chemical Co. (Saint Louis, USA). Paraformaldehyde (PFA) was purchased from 
Panreac, (Barcelona, Spain). The antibodies mouse anti-BrdU, anti-mouse-Ig-FITC and 
mouse anti-BCl2 were from Dako (Agilent Technologies, Santa Clara, USA). The antibodies 
mouse anti-p53, mouse anti-PUMA, mouse anti-Bax, rabbit BClxL, rabbit anti-PARP, rabbit 
anti-p-H2A.X, goat anti-actin, goat anti-mouse IgG-HRP, goat anti-rabbit IgG-HRP and 
donkey anti-goat IgG-HRP were purchased from Santa Cruz Biotechnology (Heidelberg, 
Germany), and the antibody mouse anti-p21 from Calbiochem (Merck KGaA, Germany). The 
antibodies rabbit anti-caspase and rabbit anti-VPS34, rabbit Beclin-1 and rabbit anti-Light 
Chain 3 B (LC3) were from Cell Signalling Technology (Danvers, MA, USA). The antibody 
rabbit anti-p62 was acquired from Enzo (New York, NY, USA). Protease inhibitor cocktail 
was purchased from Roche Holding AG (Basel, Switzerland), DC™ Protein Assay kit from 
Bio-Rad (Hercules, CA, USA) and nitrocellulose membranes from Amersham (Pittsburgh, 
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PA, USA). The Amersham™ ECL Western Blotting Detection Reagents and the Amersham 
Hyperfilm ECL were purchased from GE Healthcare (Little Chalfont, United Kingdom) and 
the Kodak GBX developer and fixer from (Sigma-Aldrich, Sintra, Portugal). The lysossomal 
inhibitor E-64d was purchased from AppliChem (Darmstadt, Germany) and pepstatin A from 
Cayman Chemical (Ann Arbor, MI, USA). LC3-mCherry was a kind gift from Prof. T. 
Johansen (Institute of Medical Biology, University of Tromsø, Norway). Lipofectamine was 
acquired from Invitrogen (Carlsbad, California, United States). Human Annexin V-FITC/PI 
apoptosis kit was purshased from Bender MedSystems (Vienna, Austria).  
 
 
4.3. Chemical characterization 
As abovementioned, the studied mushroom species were chemically characterized regarding 
their nutritional value, nutrients and non-nutrients composition, taking into account that some 
of the survey compounds are known for their bioactive potential (Figure 13).  
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Figure 13. Schematic representation of the evaluated parameters and techniques used to perform the 
chemical characterization of the mushroom species. 
 
 
4.3.1. Nutritional value 
 
The samples were analysed for chemical composition (moisture, proteins, fat, carbohydrates 
and ash) using the AOAC procedures (AOAC, 2012). The crude protein content (N × 4.38) of 
the samples was estimated by the macro-Kjeldahl method; the crude fat was determined by 
extracting a known weight of powdered sample with petroleum ether, using a Soxhlet 
apparatus; the ash content was determined by incineration at 600 ± 15 ºC. Total carbohydrates 
were calculated by difference. Energy was calculated according to Regulation (EC) No. 
1169/2011 of the European Parliament and of the Council, of 25 October 2011, on the 
Provision of Food Information to Consumers, following the Equation 7:  
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Energy (kcal/100g dw) = 4 × (𝑔 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 + 𝑔 𝑐𝑎𝑟𝑏𝑜ℎ𝑦𝑑𝑟𝑎𝑡𝑒) + 9 × (𝑔 𝑓𝑎𝑡) 
 Equation 7. Equation for energy determination. 
 
 
4.3.2. Nutrient composition 
 
For the nutrient composition, the content in soluble sugars and fatty acids was considered.  
 
Soluble sugars 
The lyophilized samples (1 g) were spiked with raffinose as internal standard (IS, 5 mg/mL) 
and were extracted with 40 mL of 80% aqueous ethanol at 80ºC for 30 min. The resulting 
suspension was centrifuged at 15,000g for 10 min. The supernatant was concentrated at 60ºC 
and defatted three times with 10 mL of ethyl ether, successively. After concentration at 40ºC, 
the solid residues were dissolved in water to a final volume of 5 mL and filtered through 0.2 
µm nylon filters for analysis by high performance liquid chromatography coupled to a 
refraction index detector (HPLC-RI), as previously optimized by Heleno et al. (2009). The 
HPLC equipment consisted of an integrated system with a Smartline 1000 pump (Knauer, 
Berlin, Germany), a Smartline manager 5000 degasser, an AS-2057 auto-sampler (Jasco, 
Easton, MD) and a Smartline 2300 refraction index (RI) detector (Knauer). Data were 
analysed using Clarity 2.4 Software (DataApex). The chromatographic separation was 
achieved with a Eurospher 100-5 NH2 column (5 µm, 4.6 × 250 mm, Knauer) operating at 
30ºC. The mobile phase was acetonitrile/deionized water, 70:30 (v/v) at a flow rate of 1 
mL/min. Sugars identification was made by comparing the relative retention times of sample 
peaks with standards. Quantification was made by the internal standard method and the results 
were expressed in g per 100 g of fresh weight (fw) or in g per 100 g of dry weight (dw). 
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Fatty acids  
Before the analysis of fatty acids profile, a trans-esterification procedure was performed, 
following a procedure previously reported by Reis et al., 2012a. The detection was also made 
by chromatographic techniques, in this specific case, by Gas Chromatography (GC). The GC 
equipment was composed by a gas chromatograph (DANI 1000, Contone, Switzerland), 
equipped with a split/splitless injector and a flame ionization detector (FID). Separation was 
achieved using a Macherey–Nagel (Düren, Germany) column (50% cyanopropyl-methyl-50% 
phenylmethylpolysiloxane, 30 m × 0.32 mm i.d. × 0.25 µm df). The oven temperature 
program was as follows: the initial temperature of the column was 50ºC, held for 2 min, then 
a 30ºC/min ramp to 125ºC, 5ºC/min ramp to 160ºC, 20ºC/ min ramp to 180ºC, 3ºC/min ramp 
to 200ºC, 20ºC/min ramp to 220ºC and held for 15 min. The carrier gas (hydrogen) flow-rate 
was 4.0 mL/min (0.61 bar), measured at 50ºC. Split injection (1:40) was carried out at 250ºC. 
The identification was carried out by comparing the relative retention times of the fatty acid 
methyl esters (FAME) of the samples with commercial standards. The quantification was 
made using the Clarity 4.0.1.7 Software (DataApex), being the results expressed as relative 
percentages of each fatty acid. 
 
 
4.3.3. Bioactive compounds 
 
For bioactive compounds composition, the content in ascorbic acids (vitamin C), other 
organic acids, phenolic acids and related compounds, as well as tocopherols (vitamin E) was 
considered. 
 
Ascorbic acid (Vitamin C) 
The lyophilized powder (150 mg) was extracted with metaphosphoric acid (1%, 10 mL) for 
45 min at room temperature and filtered through a Whatman No. 4 filter paper. The filtrate (1 
mL) was mixed with 2,6-dichloroindophenol (9 mL) and the absorbance was measured within 
30 min at 515 nm. The content of ascorbic acid was calculated on the basis of the calibration 
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curve of authentic L-ascorbic acid (0.006 to 0.1 mg/mL), and the results were expressed in mg 
per 100 g of dry weight (dw). 
For some samples (most recently analysed), the methodology followed was that of the organic 
acids, once the UFLC system was acquired in the laboratory (please see section 4.3.3.1). 
 
Other organic acids 
Organic acids were determined following a procedure previously described by the authors 
Barros et al. (2013). The analysis was performed using a Shimadzu 20A series UFLC 
(Shimadzu Corporation, Kyoto, Japan). Separation was achieved on a SphereClone 
(Phenomenex, Torrance, CA, USA) reverse phase C18 column (5 μm, 250 mm × 4.6 mm i.d.) 
thermostatted at 35°C. The elution was performed with 3.6 mM sulphuric acid using a flow 
rate of 0.8 mL min
-1
. Detection was carried out in a DAD, using 215 nm and 245 nm (for 
ascorbic acid) as preferred wavelengths. The organic acids found were quantified by 
comparison of the area of their peaks recorded at 215 nm with calibration curves obtained 
from commercial standards of each compound. The results were expressed in g per 100 g of 
dry weight. 
 
Phenolic acids and related compounds 
Phenolic acids and related compounds determination was performed using the system 
previously described for organic acids. Separation was achieved using a Waters Spherisorb S3 
ODS-2 C18 (3 µm, 4.6 mm × 150 mm) column thermostatted at 35ºC. The solvents used 
were: (A) 0.1% formic acid in water; (B) acetonitrile. The elution gradient established was 
10% A to 15% B over 5 min, 15% – 25% A in B over 5 min, 25% – 35% A in B over 10 min, 
isocratic 50% B for 10 min, and re-equilibration of the column, using a flow rate of 0.5 
mL/min. Double online detection was carried out in the PDA using 280 nm as preferred 
wavelength and in a mass spectrometer (MS) connected to HPLC system via the DAD cell 
outlet. The phenolic acids and related compounds were quantified by comparison of the area 
of their peaks recorded at 280 nm with calibration curves obtained from commercial standards 
of each compound. The results were expressed in mg per 100 g of dry weight. 
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Tocopherols (Vitamin E)  
Vitamin E isoforms were separated by the HPLC equipment above mentioned and described, 
according to a procedure previously described by other authors (Heleno et al., 2010). The 
analysis was performed by coupling with a fluorescence detector (FP-2020; Jasco, Easton, 
MD, USA), which was programmed for excitation at 290 nm and emission at 330 nm. The 
chromatographic separation was achieved with a Polyamide II (5 µm, 250 × 4.6 mm) normal-
phase column from YMCWaters (YMC America, Inc., Allentown, PA, USA) operating at 
30ºC. The mobile phase used was a mixture of n-hexane and ethyl acetate (70:30, v/v) at a 
flow rate of 1 mL/min. The peaks detected were compared with commercial standards, being 
the quantification based on the fluorescence signal, using the internal standard (tocol) method. 
The results were expressed in µg per 100 g of fresh weight (fw) or µg per 100 g of dry weight. 
 
 
4.4. Antioxidant activity  
 
The antioxidant properties of the mushroom species were evaluated according to their 
reducing power, free radicals scavenging activity and ability to inhibit the lipid peroxidation. 
There is no a single assay that reveals precisely the mechanism of action of all radical sources 
or all antioxidants in a complex system (Prior et al., 2005). That is why five different methods 
were performed (Figure 14).  
The biological systems are very complex and there are several free radicals: reactive oxygen 
species (ROS; e.g., O2•-, HO•, or H2O2 and LOOH as non-radicals), and reactive nitrogen 
species (mainly NO), as well as several oxidant sources (the main is the mitochondria - 
electron chain transport). Free radical species are very unstable molecules and highly reactive. 
Actually, they could react with proteins, lipids, carbohydrates and even with DNA 
(Badarinath et al., 2010; Prior et al., 2005). The sources of antioxidants are also diversified 
(i.e., enzymes such as superoxide dismutase; large molecules like albumin; small molecules 
such as ascorbic acid; and some hormones for instance estrogen). Because of all these 
variations and to the different physicochemical properties of oxidants and antioxidants, the 
latter may act through different mechanisms/reactions. For example, the same antioxidant 
may exert its protective effect through the alteration of the GSH metabolism, by quenching 
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ROS or inhibiting the Ca
2+
 influx, as well as can effectively act on different or specific 
oxidants. Therefore, and as stated before, no single assay is able to capture the different 
modes of action of each antioxidant (Badarinath et al., 2010; Gülçin, 2012; Ishige et al., 2001; 
Prior et al., 2005). In recent times, there has been an attempt to find a method to evaluate the 
antioxidant ability, yet it has not been an easy task. In addition to the above issues, plus the 
fact that, whatever method is selected as the ideal to determine the antioxidant capacity of 
certain food/ingredient, this should evaluate its effect in reaction conditions similar to those 
that occur in vivo, which could be a major limitation for an in vitro screening (Badarinath et 
al., 2010; Magalhães et al., 2008). 
 
In the present work, the used methodologies were reducing power through the Folin-
Ciocalteu assay and the ferricyanide/Prussian blue assay, DPPH (2,2-diphenil-1-
picrilhydrazil) radical scavenging activity, β-carotene bleaching inhibition and inhibition of 
thiobarbituric reactive species (TBARS) (Figure 14). 
 
 
 
 
Figure 14. Schematic representation of the assays used to evaluate the antioxidant activity of the 
mushroom species. 
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4.4.1. Extracts preparation 
 
The lyophilized samples (1 g) were extracted by stirring with 40 mL of methanol at room 
temperature for 1 h and subsequently filtered through Whatman No. 4 paper. The residue was 
then extracted with an additional portion of methanol (20 mL) for 1 h. The combined 
methanolic extracts were evaporated under reduced pressure at 40ºC (R-210 rotary 
evaporator, Büchi, Flawil, Switzerland), re-dissolved in methanol (20 mg/mL) and stored at 
4ºC for further use. Sequential dilutions were made from the stock solution (20 mg/mL) and 
the results are expressed in EC50 values, which corresponds to the concentration at the extract 
is able to inhibit 50% of any oxidative process, involving free radicals or lipid peroxidation 
(Reis et al., 2012b). EC50 values were calculated according the Equation 8. 
 
 
 
 
Equation 8. Equation for EC50 values determination. 
 
Where: 
• x1 is the concentration of the extract whose inhibition percentage is under 50% 
• x2 is the concentration of the extract whose inhibition percentage is over 50% 
• y1 inhibitory percentage under 50% 
• y2 inhibitory percentage over 50% 
 
4.4.2. Reducing power 
 
To evaluate the reducing power of the studied species, two methodologies were performed: 
Folin-Ciocalteu and Ferricyanide/ Prussian blue assays.  
 
EC50=  
  (x2 – x1) x (50 – y1) + x1 
  (y2 – y1) 
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Folin-Ciocalteu reagent contains, in its constitution, phosphomolybdic/phosphotungstic acid 
complexes. The assay is based on the transfer of electrons in alkaline medium from phenolic 
compounds and other reducing species to molybdenum, forming blue complexes (Figure 15) 
that can be monitored spectrophotometrically at 750–765 nm (Magalhães et al., 2008), 
according to the following equations: 
 
Na2WO4 / Na2MoO4 → (phenol - MoW11O40)
-4
 
Mo(VI) (yellow) + e- → Mo(V) (blue) 
 
Equation 9. Two reaction pairs for the reducing power assay. 
 
 
One of the extract solutions (5 mg/mL; 1 mL) was mixed with the Folin-Ciocalteu reagent (5 
mL, previously diluted with water 1:10, v/v) and sodium carbonate (75 g/L, 4 mL). The tubes 
were vortex mixed for 15 s and allowed to stand for 30 min at 40ºC for colour development. 
Absorbance was then measured at 765 nm (Analytikjena spectrophotometer; Jena, Germany). 
Gallic acid was used to obtain the standard curve (0.0094 – 0.15 mg/mL), and the reduction of 
Folin-Ciocalteu reagent by the samples was expressed as mg of gallic acid equivalents (GAE) 
per g of extract. 
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Figure 15. Example of testing tubes containing solutions after treatment with the Folin-Ciocalteu 
reagent for reducing power determination (photo by F. Reis). 
 
 
The reducing power assay is based on the ability of phenolics to reduce yellow ferric form to 
blue ferrous form by the action of electron-donating antioxidants (Benzie et al., 1999). When 
the antioxidant species is either Fe (III) or Fe(CN)6
3-
 in the composite ferricyanide reagent, 
either Fe(II) or Fe(CN)6
4-
 is formed as the reduction product with the antioxidant, and 
combines with the other reagent component to produce Prussian blue, KFe[Fe(CN)6], as the 
colored product. Thus, when Fe
3+
 is used along with Fe(CN)6
3-
 as the oxidizing agent, either 
one of the two reaction pairs occur, both ending up with the same colored product (Berker et 
al., 2007): 
 
Fe3++ antioxidant ⇄ Fe2+ + oxidized antioxidant, 
Fe2++ Fe(CN)
6
3- ⇄ Fe[Fe(CN)
6
]- 
or 
Fe(CN)
6
3-+ antioxidant ⇄ Fe(CN)
6
4-+ oxidized antioxidant, 
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Fe(CN)
6
4-+ Fe3+ ⇄ Fe[Fe(CN)
6
]- 
 
Equation 10. Reaction pairs that may occur, allowing to evaluate the reducing power of the samples. 
 
The resulting blue color could be measured spectrophotometrically at 700 nm and it is taken 
as linearly related to the total reducing capacity of electron-donating antioxidants (Huang et 
al., 2005) (Figure 16). 
 
The extract solutions with different concentrations (0.5 mL) were mixed with sodium 
phosphate buffer (200 mmol/L, pH 6.6, 0.5 mL) and potassium ferricyanide (1% w/v, 0.5 
mL). The mixture was incubated at 50ºC for 20 min, and trichloroacetic acid (10% w/v, 0.5 
mL) was added. The mixture (0.8 mL) was poured in the 48-wells plate, as also deionised 
water (0.8 mL) and ferric chloride (0.1% w/v, 0.16 mL), and the absorbance was measured at 
690 nm in ELX800 Microplate Reader (Bio-Tek Instruments, Inc; Winooski, United States). 
The reducing power was obtained directly from the absorbances. 
 
 
Figure 16. Example of a testing 48-well plate for the evaluation of the reducing power (photo by F. 
Reis). 
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4.4.3. DPPH radical scavenging activity 
 
The 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical is a longlived organic nitrogen radical with 
a deep purple color. In the performed method, the purple chromogen radical is reduced by 
antioxidant / reducing compounds to the corresponding pale yellow hydrazine, according to 
the following equation: 
Z. + AH → ZH + A. 
Equation 11. Equation for EC50 values determination. 
 
Where: 
• Z• represents the DPPH radical 
• AH represents the donor molecule  
• ZH is the reduced form 
• A• is the free radical produced in this first step 
 
This latter radical will then undergo further reactions which control the overall stoichiometry, 
that is, the number of molecules of DPPH reduced (decolorised) by one molecule of the 
reductant (Molyneux, 2004). This reduction could be monitored measuring the absorbance 
decrease at 515-528 nm until the absorbance remains stable in organic media (Karadag et al., 
2009), and free radical scavenging activity can be determined by the discoloration of the 
DPPH solution (Ndhlala et al., 2010) (Figure 17). 
 
This methodology was performed using the Microplate Reader mentioned above. The reaction 
mixture on 96 wells plate consisted of a solution by well of the extract solutions with different 
concentrations (30 µL) and methanolic solution (270 µL) containing DPPH radicals (610-5 
mol/L). The mixture was left to stand for 30 min in the dark, and the absorption was measured 
at 515 nm. The radical scavenging activity (RSA) was calculated as a percentage of DPPH 
discolouration using the equation:  
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Equation 12. Equation for RSA determination in the DPPH method. 
 
Where AS is the absorbance of the solution containing the sample, and ADPPH is the 
absorbance of the DPPH solution.  
 
 
Figure 17. Example of a testing 96-well plate for the evaluation of the DPPH radical scavenging 
activity (photo by F. Reis). 
 
 
4.4.4. Lipid peroxidation inhibition 
 
The evaluation of the lipid peroxidation inhibition of the studied species was carried out 
through two different methods: β-carotene/linoleate (or β-carotene bleaching inhibition assay) 
and TBARS assays.  
In the first method, the antioxidant capacity is determined by measuring the inhibition of the 
production of volatile organic compounds and the formation of conjugated diene 
hydroperoxides due to linoleic acid oxidation, which bleach the β-carotene in the emulsion. 
The reaction mechanism involves the bleaching of carotenoids via heat-induced oxidation and 
% RSA =  
  (ADPPH - AS) x 100 
ADPPH 
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the resultant discoloration being inhibited or diminished by antioxidants that donate hydrogen 
atoms to quench radicals (Figure 18). Absorbance of β-carotene is measured at 470 nm 
(Ndhlala et al., 2010). Thus, the reaction mechanism can be described as follows (Kaur & 
Geetha, 2006): 
 
β-carotene - H (orange) + ROOH → β-carotene. (discoloured) + ROOH  
β-carotene - H (orange)+ ROOH + AH → β-carotene - H (orange) + ROOH + A. 
 
Equation 13. β-carotene bleaching inhibition reaction. 
 
 
A solution of -carotene was prepared by dissolving -carotene (2 mg) in chloroform (10 
mL). Two millilitres of this solution were pipetted into a round-bottom flask. The chloroform 
was removed at 40ºC under vacuum and linoleic acid (40 mg), Tween 80 emulsifier (400 mg), 
and distilled water (100 mL) were added to the flask with vigorous shaking. Aliquots (4.8 
mL) of this emulsion were transferred into test tubes containing extract solutions with 
different concentrations (0.2 mL). The tubes were shaken and incubated at 50ºC in a water 
bath. As soon as the emulsion was added to each tube, the zero time absorbance was 
measured at 470 nm. β-Carotene bleaching inhibition was calculated using the following 
equation:  
 
 
 
Equation 14. Equation of the β-carotene bleaching inhibition assay. 
 
 
 
β-carotene bleaching inhibition =  
β-carotene content after 2 h of assay  
initial β-carotene content  
x 100 
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Figure 18. Example of testing tubes for the β-carotene/linoleate assay (photo by F. Reis).  
 
 
Lipid peroxidation can be determined by the products of the oxidation that react with 
thiobarbituric acid (TBA) giving rise to pink compounds that are known as thiobarbituric acid 
reactive species (TBARS). One of the products commonly used as a biomarker of lipid 
peroxidation is malodialdehyde (MDA) that associated with TBA in the presence of H
+
 ions 
to form a chromogen (MDA-TBA) according to the reaction shown in Figure 19. In this 
methodology, the oxidation of a lipid-rich preparation is induced by addition of a metallic ion 
(iron or copper), and the extension of the reaction with thiobarbituric acid is determined by 
the ability of the antioxidants present in the samples to stop the oxidation process, thus 
inhibiting the formation of the chromogen (Figure 20) (Gutteridge, 1995; Kaur & Geetha, 
2006; Ng et al., 2000). 
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Figure 19. TBARS assay reaction, with the formation of the complex MDA-TBA.  
 
 
Porcine (Sus scrofa) brains were obtained from official slaughtering animals, dissected, and 
homogenized in ice cold Tris-HCl buffer (20 mM, pH 7.4) to produce a 1:2 w/v brain tissue 
homogenate which was centrifuged at 3000g for 10 min. An aliquot (100 µL) of the 
supernatant was incubated with the different concentrations of the samples solutions (200 µL) 
in the presence of FeSO4 (10 mM; 100 µL) and ascorbic acid (0.1 mM; 100 µL) at 37ºC for 1 
h. The reaction was stopped by the addition of trichloroacetic acid (28% w/v, 500 µL), 
followed by thiobarbituric acid (TBA, 2%, w/v, 380 µL), and the mixture was then heated at 
80ºC for 20 min. After centrifugation at 3000g for 10 min to remove the precipitated protein, 
the colour intensity of the malondialdehyde (MDA)-TBA complex in the supernatant was 
measured by its absorbance at 532 nm. The inhibition ratio (%) was calculated using the 
following formula:  
 
 
 
Equation 15. Equation of the inhibition ratio determination in TBARS assay. 
 
Where A and B were the absorbance of the control and the sample solution, respectively. 
 
Inhibition ratio (%) =  
  (A-B) 
A 
x 100 
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Figure 20. Example of testing tubes for the TBARS assay (photo by F. Reis). 
 
 
4.5. Antimicrobial activity  
 
To evaluate the antimicrobial activity of the edible mushrooms, different Gram-positive and 
Gram-negative bacteria were used, as well as different strains of pathogenic fungi, in order to 
verify whether they inhibited their growth (Figure 21). 
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Figure 21. Schematic representation of the assays used to evaluate the antimicrobial activity of the 
mushroom species. 
 
 
The antimicrobial activity was carried out to verify if the extracts had any activity towards 
some food contaminants. Therefore, both the antibacterial and the antifungal activity were 
evaluated. For each one, the minimum inhibitory concentration (MIC) and the minimum 
bactericidal concentration (MBC) or minimum fungicidal concentration (MFC) were 
calculated. 
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4.5.1. Antibacterial activity 
 
For the antibacterial activity determination, the following Gram-negative bacteria: 
Escherichia coli (ATCC 35210), Pseudomonas aeruginosa (ATCC 27853), Salmonella 
typhimurium (ATCC 13311), Enterobacter cloacae (ATCC 35030), and Gram-positive 
bacteria: Staphylococcus aureus (ATCC 6538), Bacillus cereus (clinical isolate), Micrococcus 
flavus (ATCC 10240), and Listeria monocytogenes (NCTC 7973) were used.  The 
microorganisms were obtained from the Mycological laboratory, Department of Plant 
Physiology, Institute for biological research “Sinisa Stanković”, University of Belgrade, 
Serbia.  
The assay was carried out in 96 well plates (Figure 22), and the minimum inhibitory (MIC) 
and minimum bactericidal (MBC) concentrations were determined by the microdilution 
method (Espinel-Ingroff, 2001). Briefly, fresh overnight culture of bacteria was adjusted by 
the spectrophotometer to a concentration of 1×10
5 
CFU/mL. The requested CFU/mL 
corresponded to a bacterial suspension determined in a spectrophotometer at 625 nm. 
Dilutions of inocula were cultured on solid medium to verify the absence of contamination 
and check the validity of the inoculum. Different solvent dilutions of methanolic extract were 
were pipetted into the wells containing 100 μL of Tryptic Soy Broth (TSB) and afterwards, 10 
μL of inoculum was added to all the wells. The microplates were incubated for 24 h at 37°C. 
The MIC of the samples was detected following the addition of 40 μL of iodonitrotetrazolium 
chloride (INT) (0.2 mg/mL) and incubation at 37°C for 30 min. The lowest concentration that 
produced a significant inhibition (around 50%) of the growth of the bacteria in comparison 
with the positive control was identified as the MIC. The minimum inhibitory concentrations 
(MIC’s) obtained from the susceptibility testing of various bacteria to tested extract were 
determined also by a colorimetric microbial viability assay based on reduction of a INT color 
and compared with positive control for each bacterial strains (CSLI, 2006; Tsukatani et al., 
2012). MBC was determined by serial sub-cultivation of 10 μL into microplates containing 
100 μL of TSB. The lowest concentration that shows no growth after this sub-culturing was 
read as the MBC. Standard drugs, namely streptomycin and ampicillin were used as positive 
controls. 5% DMSO was used as negative control. 
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Figure 22. Example of a testing 96 well plate for MIC and MBC determinations (photo by S. 
Heleno). 
 
 
4.5.2. Antifungal activity  
 
For the antifungal bioassays, the following microfungi were used: Aspergillus fumigatus 
(1022), Aspergillus ochraceus (ATCC 12066), Aspergillus versicolor (ATCC 11730), 
Aspergillus niger (ATCC 6275), Trichoderma viride (IAM 5061), Penicillium funiculosum 
(ATCC 36839), Penicillium ochrochloron (ATCC 9112) and Penicillium verrucosum var. 
cyclopium (strain). The organisms were obtained from the Mycological Laboratory, 
Department of Plant Physiology, Institute for Biological Research “Siniša Stanković´”, 
Belgrade, Serbia. The micromycetes were maintained on malt agar (MA) and the cultures 
were stored at 4°C and sub-cultured once a month (Booth, 1971). 
The fungal spores were washed from the surface of agar plates with sterile 0.85% saline 
containing 0.1% Tween 80 (v/v). The spore suspension was adjusted with sterile saline to a 
concentration of approximately 1.0×10
5
 in a final volume of 100 µL/well. The inocula were 
stored at 4°C for further use. Dilutions of the inocula were cultured on solid MA to verify the 
absence of contamination and to check the validity of the inoculum. 
Minimum inhibitory concentrations (MIC’s) determination was performed by a serial dilution 
technique using 96-well microtitre plates (Figure 23). The investigated extract was dissolved 
in 5% solution of DMSO and added to broth malt medium with fungal inoculum. The 
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microplates were incubated for 72 h at 28°C. The lowest concentrations without visible 
growth (at the binocular microscope) were defined as MIC. The minimum fungicidal 
concentrations (MFCs) were determined by serial subcultivation of 2 µL in microtitre plates 
containing 100 µL of malt broth per well and further incubation for 72h at 28°C. The lowest 
concentration with no visible growth was defined as the MFC, indicating 99.5% killing of the 
original inoculum. 5 % DMSO was used as a negative control, while bionazole and 
ketokonazole were used as positive controls. 
 
 
Figure 23. Example of a testing 96 well plate for MIC and MFC determinations (photo by S. 
Heleno). 
 
 
4.6. Antitumour activity  
 
4.6.1. Citotoxicity evaluation 
 
Despite the small number of human trials for mushrooms consumption, there is evidence that 
mushrooms, as well as their fractions, are usually well tolerated with few, or any, side effects 
(Roupas et al., 2012). However, to initiate studies of the safety of the studied extracts for 
therapeutic uses, their hepatotoxicity was evaluated on a primary culture of porcine liver cells, 
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designed as PLP2 (Abreu et al., 2011). It is important to remember that no in vitro assay is 
able to measure the toxicity and particularly hepatotoxicity by itself. Nevertheless, it is always 
important to perform some assay, using models similar to human in terms of cellular and 
physiological function, providing preliminary data (Abreu et al., 2011). The effects of the 
extracts on the cell growth were evaluated according to the procedure adopted in the NCI’s in 
vitro anticancer drug screen, which uses the sulforhodamine B (SRB) assay to assess cell 
growth inhibition (Monks et al., 1991; Vichai & Kirtikara, 2006). This colorimetric assay 
estimates the cell number indirectly, by staining cellular protein with SRB, bright-pink 
aminoxanthene dye which binds to cell protein components. It can be spectrophotometrically 
measured at 515 nm. It is possible to infer that an increased amount of protein produced by 
cells (as they divide), will correspond to an increase in O.D. at 515 nm.  
A screening of the growth inhibitory activity in human tumour cell lines was performed. For 
that,  the procedure referred above for the citotoxicity effects (SRB assay) was followed 
(Figure 24).  
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Figure 24. Schematic representation of the assays used to evaluate the citotoxicity activity of the 
mushroom species. 
 
The extracts and fractions were re-dissolved in different solvents (including water or DMSO) 
at different stock concentrations. Successive dilutions were made from the stock solution and 
tested against different human tumour cell lines: MCF-7 (breast adenocarcinoma), NCI-H460 
(non-small cell lung cancer), HCT-15 (colorectal adenocarcinoma), HeLa (cervical 
adenocarcinoma), HepG2 (hepatocellular carcinoma) and AGS (gastric adenocarcinoma). 
Cells were routinely maintained as adherent cell cultures in RPMI-1640 medium containing 
10% heat-inactivated FBS (MCF-7, NCI-H460, HCT-15 and AGS) and 2 mM glutamine or in 
DMEM supplemented with 10% FBS, 2 mM glutamine, 100 U/mL penicillin and 100 mg/mL 
streptomycin (HeLa and HepG2 cells) (Reis et al., 2013, Reis et al., 2016b). Cells were plated 
in 96-well plates at an appropriate density (5.0 × 10
3
 cells/well for MCF-7 and NCI-H460; 1.0 
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× 10
4
 cells/well for HCT-15, HeLa and HepG2; and 7.5 × 10
3
 cells/well for AGS) and treated 
for 48 h with the diluted extracts/fractions solutions (Figure 25). Following 48 h of 
incubation with the extract/fraction (or immediately for the T0 plate), plates were fixed by 
adding ice-cold 10% trichloroacetic acid (w/v, final concentration) and incubated for 60 min 
at 4ºC. Plates were then washed with deionized water and dried; sulforhodamine B solution 
was then added to each plate well and incubated for 30 min at room temperature. Unbound 
SRB was removed by washing with 1% acetic acid. Plates were air-dried, and the bound dye 
was solubilised by adding 10 mM Tris base and the absorbance was measured at 510 – 540 
nm (Monks et al., 1991). The results were expressed in GI50 values (sample concentration that 
inhibited 50% of the net cell growth). Ellipticine, doxorubicin or etoposide were used as 
positive control.  
 
For the possible hepatotoxicity evaluation, a hepatic cell, designed as PLP2, was used (Abreu 
et al., 2011). PLP2 cells were cultured and maintained in DMEM supplemented with 10% 
heat-inactivated FBS, 2 mM nonessential amino acids and 100 U/mL penicillin, 100 mg/mL 
streptomycin (Reis et al., 2013). Cells were plated in 96-well plates at an appropriate density 
(1.0 × 10
4
 cells/well) and treated for 48 h with the different diluted sample solutions. The 
same procedure described above for the SRB assay was followed. The results were expressed 
in GI50 values. Ellipticine was used as positive control. 
 
Some extracts, were also tested on a human breast non-malignant cell line, designed as MCF-
10A. MCF-10A cells were cultured and maintained in Dulbecco's modified Eagle's medium 
(DMEM): F12, supplemented with 5% heat inactivated horse serum, 10 mg/mL insulin, 0.5 
mg/mL hydrocortisone, 20 ng/mL epidermal growth factor (EGF), and 100 ng/mL cholera 
toxin (Reis et al., 2016b).  Cells were plated in 96-well plates at an appropriate density (5.0 × 
10
3
 cells/well) and treated for 48 h with the different diluted sample solutions. The same 
procedure described above for the SRB assay was performed. The results were also expressed 
as GI50 values and doxorubicin was used as a positive control. 
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Figure 25. Example of a testing 96 well plate for cytotoxicity evaluation (photo by A. Ribeiro) 
 
 
4.6.2. Elucidation of the possible mechanism of action 
Mushroom extracts/compounds may affect tumour cell growth by different mechanisms. 
Hence, the mechanism of action of the studied extracts was further studied with different 
assays. It was sought to determine whether those extracts affected cell proliferation (checking 
levels of DNA synthesis), caused cell cycle arrest or induced programmed cell death 
(studying essentially apoptosis and autophagy) (Figure 26).  
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Figure 26. Schematic representation of the assays used to infer the possible mechanism of antitumour 
activity of the mushroom species. 
 
 
For these assays, cells were plated on 6-well plates in the following concentrations: 1.0 × 10
5
 
cells/well for MCF-7 cells and 1.5 × 10
5
 cells/well for AGS cells, and incubated for 24 h to 
adhere to the plates. Cells were then treated with the mushroom extracts, at their GI50, GI75 or 
2 × GI50 concentrations.  
 
Cell proliferation analysis 
Cell proliferation was analysed with the BrdU (bromodeoxyuridine) assay, according to the 
protocol previously described by Palmeira et al. (2010). Cells were treated for 48 h with the 
different concentrations of the extract and one hour before harvesting, cells were incubated 
with 10 mM BrdU. Afterwards, cells harvested and fixed in 4% paraformaldehyde in PBS for 
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30 min at room temperature. After centrifugation, cell pellets were re-suspended in PBS and 
stored at 4ºC. Cell cytospins were prepared and incubated in 2M HCl for 20 min. Following 
incubation with mouse anti-BrdU antibody for 1 h at room temperature, cells were incubated 
with anti-mouse-Ig-FITC for 30 min at room temperature. Slides were then prepared with 
Vectashield mounting medium (with DAPI). BrdU incorporation was observed in a DM2000 
microscope (LEICA; Wetzlar, Germany) and a semi-quantitative evaluation was carried out 
by counting a minimum of 500 cells per slide. 
 
Cell cycle distribution analysis 
Following the 48 h treatments, cells were harvested and fixed with ice-cold 70% ethanol and 
stored at 4ºC for at least 12 h, until further analysis. Cells were re-suspended in PBS 
containing RNase A (0.1 mg/mL) and propidium iodide (5 mg/mL). Cellular DNA content 
was analysed by flow cytometry (BD Accuri™ C6 Flow cytometer, USA) and the percentage 
of cells in the G1, S and G2/M phases of the cell cycle (as well as the percentage of cells in 
the sub-G1 peak) was determined using the FlowJo 7.6.5 software (Tree Star, Inc., Ashland, 
OR, USA) after cell debris and aggregates exclusion and plotting at least 15 000 events per 
sample (Vasconcelos et al., 2000). 
 
Apoptosis analysis 
Induced apoptosis was assayed by Flow cytometry using the Human Annexin V-FITC/PI 
apoptosis kit, according to the manufacturer's instructions, as previously described (Queiroz et 
al., 2013). Flow cytometry was carried out using the flow cytometer mentioned above and 
plotting at least 15 000 events per sample. Data were analysed using the BD Accuri C6 
Software (version 1.0.264.21). 
 
Autophagy analysis 
Transfection with LC3-mCherry expression vector. Cells were plated in 24-well plates and 
allowed to adhere for 24 h. Transfection with the vector LC3-mCherry was then carried out 
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using lipofectamine according to manufacturer’s instructions. As described by Birame et al. 
(2012) during the initial 4 h of transfection, cells were incubated with medium containing 5% 
FBS, which was then replaced by medium containing 10% FBS. Following 24 h of 
transfection, medium was removed and cells were treated for 48 h with the mushroom extract 
(G. lucidum) (at GI50 concentration and 2 × GI50 concentration; previously determined with 
the SRB assay). Cells were then fixed in 4% paraformaldehyde in PBS and analyzed in a 
fluorescence microscope (Axio Imager.Z1 coupled with ApoTome Imaging System 
microscope, Zeiss, Oberkochen, Germany). 
 
Treatment with autophagy inhibitors E-64d/Pepstatin. Cells were plated in 6-well plates and 
allowed to adhere for 24 h. Cells were then treated for 1 h with 15 μg/mL of the lysossomal 
inhibitors E-64d and Pepstatin A and then co-incubated for 48 h with the GI50 and 2 × GI50 
concentrations of the studied extract. Protein expression analysis was carried out by Western 
blot, as described below. 
 
Protein expression analysis 
For analysis of protein expression, following 48 h of treatments, cell pellets were lysed in 
Winman's buffer (1% NP-40, 0.1 M Tris – HCl pH 8.0, 0.15M NaCl and 5 mM EDTA) 
complemented with protease inhibitor cocktail. The total protein content was quantified using 
the DC™ Protein Assay kit, according to manufacturer's instructions. Proteins (20 mg) were 
loaded on 12% SDS-PAGE gel and transferred into a nitrocellulose membrane. Different 
primary and secondary antibodies were used, according with the objectives (survey proteins 
involved in apoptosis or autophagy). The Amersham™ ECL Western Blotting Detection 
Reagents, the Amersham Hyperfilm ECL and the Kodak GBX developer and fixer were used 
for signal detection, as previously described (Lima et al., 2006). 
 
Analysis of DNA damage 
DNA damage was analysed with the Alkaline Comet Assay 24 h after treatment with the 
tested extract. Hydrogen peroxide was used as positive control (1 mM) and was added 10 min 
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before cells harvesting. Harvested cells were stored in 10% DMSO in FBS at -80ºC, 
following a procedure previously described by other authors (Seca et al., 2014). After 
thawing, cells were washed with PBS, re-suspended in 0.6% low melting point agarose and 
quickly poured onto slides, precoated with 1% agarose in water, with the aid of a coverslip. 
Slides were kept 10 min on ice. After removing the coverslip, cells were lysed with ice-cold 
lysis buffer (100 mM Na2EDTA, 2.5 M NaCl, 10 mM Tris – HCl, pH 10.0, 1% Triton X-100) 
for 2 h, in the dark, at 4ºC, and then washed twice in ice-cold distilled water for 10 min. 
Slides were placed on an electrophoresis tank filled with electrophoresis buffer (10M NaOH; 
200 mM Na2EDTA) and incubated for 20 min to let DNA to unwind. Electrophoresis was 
carried out for 20 min at 23 V, 300 mA. After this period, slides were flooded with 
neutralisation buffer (0.4 M Tris, pH 7.5) for 20 min and then rinsed in ice cold water for 10 
min before being allowed to dry at room temperature overnight. Slides were rehydrated with 
distilled water (for 30 min), covered with 2.5 mg/mL of propidium iodide solution and 
incubated for 20 min at room temperature in the dark. Propidium iodide was rinsed with 
distilled water for 30 min and slides dried at 37ºC. Comets were visualized using the 
fluorescent microscope mentioned above and representative photographs were taken. The 
analysis was made using the ‘Comet Assay IV v4.3’ imaging system (Perceptive 
Instruments). A minimum of 100 cells per condition were analysed. 
 
 
4.7. Statistical analysis 
The results obtained throughout the different evaluation studies were analysed by applying 
different statistical tools, selected according to the results and considering the defined 
research purposes. The software used was Statistics Package for Social Sciences (SPSS) 
version 22 (IBM Corporation, New York, USA). All results were expressed as mean values ± 
standard deviations (SD) or standard errors (SE), maintaining the decimal places allowed by 
the magnitude of standard deviation. All tests were performed at a 5% significance level. For 
all methods, three samples were mixed to have a representative pool and all assays were 
carried out in triplicate. 
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Analysis of variance (ANOVA). Analysis of variance is the most effective method available 
for analysing more complex data sets (Armstrong & Hilton, 2014). Prior to carrying out the 
ANOVA test, some preliminary assumptions were verified, namely the homoscedasticity of 
variances by applying the Levene’s test); the normality of distributions (tested by means of 
the Shapiro Wilks’ test); and the existence of statistically significant differences (through the 
Welch’s statistics). The ANOVA results were classified according to the results obtained in 
the previous tests. In the cases where statistical significance differences were identified, the 
dependent variable were compared using Tukey’s honestly significant difference (HSD) or 
Games-Howell test, when homoscedasticity was verified or not, respectively. The former 
applied for homoscedastic samples and the latter for non-homoscedastic samples.  
When a specific factor was studied using only two levels, a simple student’s t-test was used to 
classify the results. 
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Article 1: Chemical composition and nutritional value of the most widely 
appreciated cultivated mushrooms: An inter-species comparative study 
 
Reference: Filipa S. Reis, Lillian Barros, Anabela Martins, Isabel C.F.R. Ferreira. (2012). 
Food and Chemical Toxicology, 50, 191-197. 
DOI: 10.1016/j.fct.2011.10.056 
 
 
Resumen 
En este trabajo, se analizó y comparó la composición química y el valor nutricional de 
algunas de las especies de setas cultivadas más consumidas: Agaricus bisporus (champiñón 
común y portobello), Pleurotus ostreatus (gírgola o champiñón ostra), Pleurotus eryngii (seta 
de cardo), Lentinula edodes (shiitake) y Flammulina velutipes (seta de aguja de oro). La seta 
Shiitake presentó los valores más altos de macronutrientes, a excepción de las proteínas, así 
como los contenidos más elevados de azúcares solubles, tocoferoles y de AGPI, y los más 
bajos para los AGS. Los champiñones (común y portobello) mostraron una composición 
similar de macronutrientes, así como valores similares de hidratos de carbono totales, AGMI, 
AGPI y tocoferoles. Mientras que el champiñón ostra y la seta de cardo fueron las que 
presentaron los contenidos más altos de AGMI, con contenidos similares en AGPI, AGMI y 
AGS, en ambas muestras. También presentarón valores similares de humedad, cenizas, 
hidratos de carbono y energía. Este estudio contribuye a la elaboración de bases de datos 
nutricionales de algunas de las especies de setas más consumidas en todo el mundo, 
permitiendo la comparación entre ellas desde el punto de vista nutricional. Además, se 
comprobó que las muestras cultivadas y silvestres de la misma especie tienen una 
composición química diferente, incluyendo azúcares solubles, ácidos grasos y perfil de 
tocoferoles. 
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Abstract 
Herein, it was reported and compared the chemical composition and nutritional value of the 
most consumed species as fresh cultivated mushrooms: Agaricus bisporus (white and brown 
mushrooms), Pleurotus ostreatus (oyster mushroom), Pleurotus eryngii (King oyster 
mushroom), Lentinula edodes (shiitake) and Flammulina velutipes (Golden needle 
mushroom). Shiitake revealed the highest levels of macronutrients, unless proteins, as also the 
highest sugars, tocopherols and PUFA levels, and the lowest SFA content. White and brown 
mushrooms showed similar macronutrients composition, as also similar values of total sugars, 
MUFA, PUFA and total tocopherols. Oyster and king oyster mushrooms gave the highest 
MUFA contents with similar contents in PUFA, MUFA and SFA in both samples. They also 
revealed similar moisture, ash, carbohydrates and energy values. This study contributes to the 
elaboration of nutritional databases of the most consumed fungi species worldwide, allowing 
comparison between them. Moreover it was reported that cultivated and the wild samples of 
the same species have different chemical composition, including sugars, fatty acids and 
tocopherols profiles. 
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Figure 27. Graphical abstract article 1. 
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Article 2: Antioxidant properties and phenolic profile of the most widely 
appreciated cultivated mushrooms: A comparative study between in vivo 
and in vitro samples 
 
Reference: Filipa S. Reis, Anabela Martins, Lillian Barros, Isabel C.F.R. Ferreira. (2012). 
Food and Chemical Toxicology, 50, 1201-1207. 
DOI: 10.1016/j.fct.2012.02.013 
 
 
Resumen 
En el presente trabajo se aborda la caracterización y comparación de la capacidad 
antioxidantes y el perfil fenólico de algunas de las especies de setas cultivadas más 
consumidas y sus correspondientes micelios obtenidos mediante técnicas in vitro, como son: 
Agaricus bisporus (champiñón común y portobello), Pleurotus ostreatus (gírgola o 
champiñón ostra), Pleurotus eryngii (seta de cardo) y Lentinula edodes (shiitake). Para la 
determinación de la actividad antioxidante, se emplearon diferentes métodos analíticos, 
evaluando el poder reductor (ensayo de Folin-Ciocalteu y Ferricianide/Prussian blue), 
actividad antiradicalaria (ensayo 2,2-diphenil-1-picrilhydrazil (DPPH)) y la inhibición de la 
peroxidación lipídica (el ensayo de inhibición de la decoloración del β-caroteno y el ensayo 
de inhibición de especies reactivas del ácido tiobarbitúrico (TBARS)) de las muestras objeto d 
estudio. El análisis de compuestos fenólicos se realizó por HPLC/DAD. La especie estudiada 
con mayor potencial antioxidante fué A. bispous (portobello), mientras que el micelio 
obtenido a partir de L. edodes fue el que mayor actividad antioxidantes presentó frente al 
ensayo del poder reductor. Generalmente, las muestras obtenidas in vivo revelaron 
propiedades antioxidantes mayores que sus micelios obtenidos por técnicas in vitro. En 
relación a los compuestos fenólicos, se cuantificaron, tanto en setas y micelios, sin ninguna 
abundancia en particular. Los resultados mostraron que no existe correlación entre los hongos 
comerciales estudiados y sus micelios correspondientes, sin embargo, este estudio contribuye 
al aumento de los datos relativos a algunas de las especies consumidas en fresco y la 
posibilidad de su producción in vitro como fuente de compuestos bioactivos. 
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Abstract 
The present study reports a comparison of the antioxidant properties and phenolic profile of 
the most consumed species as fresh cultivated mushrooms and their mycelia produced in 
vitro: Agaricus bisporus (white and brown), Pleurotus ostreatus (oyster), Pleurotus eryngii 
(king oyster) and Lentinula edodes (shiitake). The antioxidant activity was evaluated through 
reducing power (Folin-Ciocalteu and Ferricyanide/Prussian blue assays), free radical 
scavenging activity (DPPH assay) and lipid peroxidation inhibition (β-carotene/linoleate and 
TBARS assays). The analysis of phenolic compounds was performed by HPLC/PAD. The 
mushroom species with the highest antioxidant potential was A. bispous (brown). However, 
concerning to the species obtained in vitro, it was L. edodes that demonstrate the highest 
reducing power. Generally, in vivo samples revealed higher antioxidant properties than their 
mycelia obtained by in vitro techniques. About the phenolic compounds researched, they were 
detected both in mushrooms and mycelia without any particular abundance. Results showed 
that there is no correlation between the studied commercial mushrooms and the corresponding 
mycelia obtained in vitro. Nevertheless, this study contributes to the rise of data relatively to 
the species consumed as fresh mushrooms and the possibility of their in vitro production as a 
source of bioactive compounds. 
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Figure 28. Graphical abstract article 2. 
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Article 3: Toward the antioxidant and chemical characterization of 
mycorrhizal mushrooms from Northeast Portugal 
 
Reference: Filipa S. Reis, Sandrina A. Heleno, Lillian Barros, Maria João Sousa, Anabela 
Martins, Celestino Santos-Buelgas, Isabel C.F.R. Ferreira. (2011). Journal of Food Science, 
76, 824-830.     
DOI: 10.1111/j.1750-3841.2011.02251.x 
 
 
Resumen 
Las setas son muy apreciadas en todo el mundo por sus propiedades nutritivas y por su 
posible potencial farmacológico como fuentes de importantes compuestos bioactivos. Los 
hongos micorrizicos establecen asociaciones simbióticas con las raíces de las plantas, dichas 
simbiosis pueden influir en la producción de metabolitos secundarios, incluyendo los 
denominados compuestos bioactivos. El presente estudio se centra en la evaluación de la  
composición química y potencial antioxidante de algunas especies de setas micorrizicas del 
nordeste de Portugal: Amanita caesarea, Cortinarius violaceus, Lactarius volemus y Suillus 
luteus. De los resultados obtenidos, se observó un perfil similar de los compuestos analizados 
en las especies estudiadas con el siguiente orden: azúcares solubles > grasa > ácido ascórbico 
> compuestos fenólicos > tocoferoles. Sin embargo, se observó la prevalencia de azúcares 
solubles en L. volemus, compuestos fenólicos en A. caesarea y C. violaceus, y tocoferoles en 
S. luteus. Además, esta última se destacó por su potencial antioxidante. 
 
 
Abstract 
Mushrooms are widely appreciated all over the world for their nutritional properties and 
pharmacological value as sources of important bioactive compounds. Mycorrhizal macrofungi 
associate with plant roots constituting a symbiotic relationship. This symbiosis could 
influence the production of secondary metabolites, including bioactive compounds. We 
focused on the evaluation of antioxidant potential and chemical composition of mycorrhizal 
mushrooms species from Northeast Portugal: Amanita caesarea, Cortinarius violaceus, 
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Lactarius volemus, and Suillus luteus. A similar profile of metabolites was observed in the 
studied species with the order sugars > fat > ascorbic acid > phenolic compounds > 
tocopherols. Nevertheless, the samples revealed different compositions: prevalence of sugars 
in L. volemus, phenolic compounds in A. caesarea and C. violaceus, and tocopherols and 
antioxidant activity in S. luteus.  
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Figure 29. Graphical abstract article 3. 
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Article 4: Analytical methods applied to the chemical characterization and 
antioxidant properties of three wild edible mushroom species from 
Northeastern Portugal 
 
Reference: Filipa S. Reis, Lillian Barros, Maria João Sousa, Anabela Martins, Isabel C.F.R. 
Ferreira. (2014). Food Analytical Methods, 7, 645-652.  
DOI: 10.1007/s12161-013-9668-7 
 
 
Resumen 
En el presente estudio se ha comparado la composición química y el potencial antioxidante de 
tres especies de hongos silvestres procedentes del nordeste de Portugal, concretamente 
Agaricus albertii, Agaricus urinascens var. excellens y Pleurotus eryngii. Para la evaluación 
del valor nutricional, se siguieron procedimientos estándars validados (AOAC), mientras que 
se emplearon diferentes métodos cromatográficos para analizar azúcares solubles, ácidos 
grasos, tocoferoles, compuestos fenólicos y ácidos orgánicos. La actividad antioxidante se 
evaluó a través de los ensayos de poder reductor, actividad antiradicalaria y la inhibición de la 
peroxidación lipídica. P. eryngii destacó por su contenido en todos los macronutrientes, 
excepto en proteínas, asi como por su contenido de azúcares solubles, tocoferoles y ácidos 
grasos monoinsaturados. A. albertii y A. urinascens var. excellens presentaron una 
composición similar de macronutrientes. Sin embargo, en A. albertii destacó por su contenido 
de AGPI y compuestos fenólicos. P. eryngii presentó los mejores resultados de actividad 
antioxidante frente al poder reductor y actividad antiradicalaria, y A. albertii frente el ensayo 
de inhibición de la peroxidación lipídica. 
Este estudio proporciona una caracterización química detallada, así como la evaluación del 
potencial antioxidante, de tres especies de setas silvestres procedentes de Portugal que todavía 
no habían sido estudiadas en detalle, contribuyendo al conocimiento y conservación de estos 
recursos como fuentes de compuestos de interés. 
 
 
 
                                                                                                        Results 
  
113 
 
 
Abstract 
The chemical composition and the antioxidant potential of three species of wild mushrooms 
from Northeastern Portugal, namely Agaricus albertii, Agaricus urinascens var. excellens, 
and Pleurotus eryngii, were compared. Standard procedures were followed in the nutritional 
value evaluation, while chromatographic procedures were used to analyze free sugars, fatty 
acids, tocopherols, phenolic compounds, and organic acids. To assess the antioxidant 
potential, reducing power, radical-scavenging activity, and lipid peroxidation inhibition were 
evaluated. P. eryngii revealed the highest levels of macronutrients, except proteins, as also the 
highest sugars, tocopherols, and monounsaturated fatty acids contents. A. albertii and A. 
urinascens var. excellens showed similar macronutrients composition. However, A. albertii 
revealed the highest content in PUFA and phenolic compounds. P. eryngii revealed the 
highest reducing power and radical-scavenging activity and A. albertii the highest lipid 
peroxidation inhibition.  
This study provides a detailed chemical characterization and antioxidant potential evaluation 
of three species of wild mushrooms from Portugal not yet previously reported. Thus, this 
work intended to contribute to the increase of information concerning species of edible 
mushrooms (directed to the scientific community and general population) as well as 
contribute to the conservation of these resources as sources of compounds of interest.  
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Figure 30. Graphical abstract article 4. 
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Article 5: Can Suillus granulatus (L.) Roussel be classified as a functional 
food? 
 
Reference: Filipa S. Reis, Dejan Stojković, Lillian Barros, Jasmina Glamočlija, Ana Ćirić, 
Marina Soković, Anabela Martins, M. Helena Vasconcelos, Patricia Morales, Isabel C. F. R. 
Ferreira. (2014). Food & Function, 5, 2861-2869. 
DOI: 10.1039/C4FO00619D 
 
 
Resumen 
El presente trabajo describe una caracterización química detallada de Suillus granulatus, 
además de evaluar las propiedades antioxidantes y antimicrobianas de sus extractos 
metanólicos. El estudio se realizó con muestras recolectadas en Portugal y Serbia para 
demostrar que, aunque las setas están fuertemente influenciadas por el medio en el que se 
desarrollan, tienen un perfil químico específico que puede ser típico de su género/especie. 
Ambas muestras demonstraron ser alimentos saludables, bajos en grasa y ricos en proteínas e 
hidratos de carbono, siendo el manitol y la trehalosa los principales azúcares solubles 
detectados. También demostraron ser fuente de ácidos orgánicos y compuesos fenólicos, así 
como ácidos grasos mono y poliinsaturados y tocoferoles. Las muestras procedentes de Serbia 
revelaron un mayor potencial antioxidante y antimicrobiano, en comparación con las muestras 
recolectadas en Portugal. En consecuencia, podríamos afirmar que S. granulatus puede 
considerarse un alimento funcional, ya que es una fuente de compuestos funcionales y 
biológicamente activos. 
 
 
Abstract 
The present work outlines a detailed chemical characterization of Suillus granulatus species, 
besides presenting the antioxidant and antimicrobial properties of their methanolic extracts. 
The study was carried out with samples drawn from Portugal and Serbia in order to prove that 
though mushrooms are strongly influenced by the environment in which they develop, they 
have a specific chemical profile that can be typical of their genus/species. The studied species 
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proved to be healthy foods, low in fat and rich in protein and carbohydrates, with mannitol 
and trehalose being the main free sugars detected. They also proved to be a source of organic 
and phenolic acids, as well as mono- and polyunsaturated fatty acids and tocopherols. The 
Serbian samples revealed higher antioxidant and antimicrobial potential. Accordingly, we find 
that the S. granulatus species can be considered to be a functional food, since it is a source of 
nutraceutical and biologically active compounds. 
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Figure 31. Graphical abstract article 5. 
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Article 6: The methanolic extract of Cordyceps militaris (L.) Link fruiting 
body shows antioxidant, antibacterial, antifungal and antihuman tumor cell 
lines properties 
 
Reference: Filipa S. Reis, Lillian Barros, Ricardo C. Calhelha, Ana Ćirić, Leo J.I.D. van 
Griensven, Marina Soković, Isabel C.F.R. Ferreira. (2013). Food and Chemical Toxicology, 
62, 91-98. 
DOI: 10.1016/j.fct.2013.08.033 
 
 
Resumen 
Como Cordyceps militaris (L.) Link se conoce como una seta comestible con propiedades 
medicinales, de modo que en este trabajo se pretende caracterizar algunos compuestos 
bioactivos interesantes que podrían aislarse de esta especie y justificar esas propiedades 
biológicas. Los compuestos hidrófilos y lipófilos se analizaron al través de técnicas 
cromatográficas acopladas a diferentes detectores. El extracto metanólico de C. militaris se 
empleó para evualuar las posibles propiedades antioxidantes, antibacterianas, antifúngicas y 
antiproliferativas en diferentes líneas de células tumorales humanas. El mannitol (2,01 g/100 
g) y trehalosa (24,71 g/100 g) fueron los azúcares solubles mayoritarios en C. militaris, así 
como se detectaron los ácidos oxálico, cítrico y fumárico (0,33, 7,97 y 0,13 g/100 g, 
respectivamente). El ácido p-hidroxibenzoico fue el único ácido fenólico cuantificado en esta 
especie (0,02 mg/100 g); aunque también se encontró ácido cinámico (0,11 mg/100 g). Los 
ácidos grasos poliinsaturados (68,87%) predominaron sobre los ácidos grasos saturados 
(23,40%) y el δ-tocoferol fue la única isoforma de la vitamina E detectada (55,86 µg/100 g). 
El extracto metanólico de C. militaris presentó buenos resultados frente al ensayo de 
inhibición la peroxidación lipídica, poder reductor y actividad antiradicalaria. Este extracto 
también demostró tener actividad antibacterianas y antifúngicas, así como la capacidad  de 
inhibir la proliferación de líneas celulares de carcinoma humano MCF-7 (mama), NCI-H460 
(pulmón), HCT-15 (colon) y HeLa (cervical). 
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Abstract  
Being Cordyceps militaris (L.) Link recognized as a medicinal and edible mushroom, this 
work intends to reveal new interesting bioactive molecules that could be isolated from this 
species. Hydrophilic and lipophilic compounds were analyzed by chromatographic techniques 
coupled to different detectors. The methanolic extract of C. militaris was tested for its 
antioxidant, antibacterial, antifungal and antiproliferative properties in different human tumor 
cell lines. Mannitol (2.01 g/100 g dw) and trehalose (24.71 g/100 g) were the free sugars 
found in C. militaris. Polyunsaturated fatty acids (68.87%) predominated over saturated fatty 
acids (23.40%) and d-tocopherol was the only isoform of vitamin E detected (55.86 lg/100 g). 
The organic acids found in this mushroom were oxalic, citric and fumaric acids (0.33, 7.97 
and 0.13 g/100 g, respectively). p-Hydroxybenzoic acid was the only phenolic acid quantified 
in this species (0.02 mg/100 g); although cinnamic acid was also found (0.11 mg/100 g). The 
methanolic extract of C. militaris proved to inhibit lipid peroxidation, have reducing power 
and scavenge free radicals. This extract also revealed strong antibacterial and antifungal 
properties. Finally, the C. militaris extract was able to inhibit the proliferation of MCF-7 
(breast), NCI-H460 (non-small lung), HCT-15 (colon) and HeLa (cervical) human carcinoma 
cell lines.  
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Figure 32. Graphical abstract article 6. 
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Article 7: Chemical characterization of the medicinal mushroom Phellinus 
linteus (Berkeley & Curtis) Teng and contribution of different fractions to 
its bioactivity 
 
Reference: Filipa S. Reis, João C.M. Barreira, Ricardo C. Calhelha, Leo J.L.D. van 
Griensven, Ana Ćirić, Jasmina Glamočlija, Marina Soković, Isabel C.F.R. Ferreira. (2014). 
LWT – Food Science and Technology, 58, 478-485.  
DOI: 10.1016/j.lwt.2014.04.013 
 
 
Resumen 
Las setas son ampliamente apreciadas por sus propiedades organolépticas, siendo también 
reconocidas como una buena fuente de compuestos bioactivos que proporcionan actividad 
antioxidante, antimicrobiana y citotóxica. Sus polisacáridos (incluyendo glucanos) se señalan 
con frecuencia como los compuestos más bioactivos aislados de setas, pero otros compuestos 
tales como triterpenoides, también podrían destacarse por su bioactividad. La bioactividad de 
Phellinus linteus se evaluó en las fracciones seleccionadas (polisacáridos, glucanos y 
triterpenoides), así como en el extracto metanólico y etanólico, dado que en muchas 
ocasiones, cuando se analizan compuestos aislados, los posibles efectos sinérgicos se pueden 
perder. Los mejores resultados obtenidos frente a la actividades antioxidante y antibacteriana 
se observaron en el extracto metanolico, mientras que las fracciones de glucano y 
triterpenoides mostrarón la mayor actividad antifúngica. Por el contrario, lo extracto etanólico 
reveló los mejores resultados frente a la actividad citotóxica. Los resultados obtenidos en este 
estudio ponen de manifiesto que de los extractos de P. linteus y sus fracciones podrían ser 
útiles para encontrar compuestos antimicrobianos, antioxidantes y agentes citotóxicos, como 
alternativas a las sustancias sintéticas empleadas en la agricultura, la industria alimentaria y/o 
la industria farmacéutica. 
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Abstract 
Mushrooms are widely appreciated for their organoleptic qualities, being also recognized as 
good sources of bioactive compounds that provide antioxidant, antimicrobial and cytotoxic 
activities. Polysaccharides (including glucans) are often pointed out as the most bioactive 
compounds isolated from mushrooms, but other molecules such as triterpenoids, might also 
be highlighted for their bioactivity. In scientific research, when isolated compounds are used, 
potential synergistic effects might be lost. Accordingly, the bioactivity of Phellinus linteus 
was evaluated in selected fractions (polysaccharides, glucans and triterpenoids), as well as in 
the methanolic and ethanolic extracts. The best antioxidant and antibacterial activities were 
obtained with methanolic extract, while glucan and triterpenoid fractions gave the strongest 
antifungal activity. In contrast, ethanolic extract gave the best results in cytotoxic activity, 
indicating that the bioactive compounds present might act synergistically. The differentiated 
activity of P. linteus fractions and extracts could be useful to find antimicrobial, antioxidant 
and cytotoxic agents as alternatives to synthetic chemicals with application in agriculture, 
food industry and/or pharmacy.  
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Figure 33. Graphical abstract article 7. 
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Article 8: Leccinum molle (Bon) Bon and Leccinum vulpinum Watling: The 
first study of their nutritional and antioxidant potential 
 
Reference: Filipa S. Reis, Lillian Barros, Anabela Martins, M. Helena Vasconcelos, Patricia 
Morales, Isabel C.F.R. Ferreira. (2016). Molecules, 21, 246. 
DOI: 10.3390/molecules21020246 
 
 
Resumen 
En este trabajo se presenta el perfil químico de dos especies comestibles de setas del género 
Leccinum: Leccinum molle (Bon) Bon y Leccinum vulpinum Watling, recolectados en las 
cercanías de Bragança (Noreste de Portugal). Ambas especies se caracterizaron con respecto a 
su contenido en nutrientes (azúcares solubles, ácidos grasos y vitaminas), no-nutrientes 
(ácidos fenólicos y otros ácidos orgánicos) y actividad antioxidante. Hasta donde sabemos, no 
se han realizado estudios previos sobre la caracterización química y la bioactividad de estas 
especies. En consecuencia, este estudio pretende aumentar la información disponible sobre las 
especies de hongos comestibles, así como resaltar otro factor importante en la conservación 
de los recursos micológicos: su potencial como fuentes de compuestos bioactivos. En general, 
ambas especies revelaron perfiles de nutrientes similares, con bajos niveles de grasa; fructosa, 
manitol y trehalosa como los principales azúcares solubles; así como elevados porcentajes de 
ácidos grasos monoinsaturados y poliinsaturados. Las especies estudiadas destacaron por la 
presencia de compuestos bioactivos, como ácidos fenólicos (ácido gálico, ácido 
protocatechúico y ácido p-hidroxibenzoico), ácidos orgánicos (ácidos cítrico y fumárico) y 
presentaron buenos resultados frente a los diferentes ensayos de actividad antioxidante. 
 
 
Abstract 
This work presents the chemical profile of two edible species of mushrooms from the genus 
Leccinum: Leccinum molle (Bon) Bon and Leccinum vulpinum Watling, both harvested on the 
outskirts of Bragança (Northeastern Portugal). Both species were prepared and characterized 
regarding their content in nutrients (i.e., free sugars, fatty acids and vitamins), non-nutrients 
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(i.e., phenolic and other organic acids) and antioxidant activity. To the best of our knowledge, 
no previous studies on the chemical characterization and bioactivity of these species have 
been undertaken. Accordingly, this study intends to increase the available information 
concerning edible mushroom species, as well as to highlight another important factor 
regarding the conservation of the mycological resources – their potential as sources of 
nutraceutical/pharmaceutical compounds. Overall, both species revealed similar nutrient 
profiles, with low fat levels, fructose, mannitol and trehalose as the foremost free sugars, and 
high percentages of mono- and polyunsaturated fatty acids. They also revealed the presence of 
bioactive compounds, namely phenolic (e.g., gallic acid, protocatechuic acid and p-
hydroxybenzoic acid) and organic acids (e.g., citric and fumaric acids) and presented 
antioxidant properties.  
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Figure 34. Graphical abstract article 8. 
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Article 9: Leccinum vulpinum Watling induces DNA damage, decreases cell 
proliferation and induces apoptosis on the human MCF-7 breast cancer cell 
line 
  
Reference: Filipa S. Reis, Diana Sousa, Lillian Barros, Anabela Martins, Patricia Morales, 
Isabel C.F.R. Ferreira, M. Helena Vasconcelos. (2016). Food and Chemical Toxicology, 90, 
45-54. 
DOI: 10.1016/j.fct.2016.02.005 
 
 
Resumen 
El objetivo del presente trabajo fue estudiar la actividad antitumoral de un extracto fenólico 
(rico en ácidos hidroxibenzoicos) de la seta comestible Leccinum vulpinum Watling. En una 
primera aproximación, se ensayó el extracto frente a una serie de cuatro lineas celulares 
tumorales humanas. Posteriormente, debido a los buenos resultados obtenidos y a la evidencia 
científica existente en relación al consumo de esta seta y los datos de prevalencia del cancer 
de mama, se realizó un estudio detallado de la bioactividad del extracto seleccionado en 
células MCF-7, empleandose una línea celular de adenocarcinoma de mama y otra linea 
celular no maligna de mama MCF-10A (como control). En general, se observó una 
disminución de la proliferación celular y de la inducción de la apoptosis, además, los 
resultados obtenidos sugieren que el extracto fenólico podría causar daño en el ADN celular 
de las células MCF-7. De modo que, los resultados obtenidos ponen de manifiesto el potencial 
de esta seta como fuente de compuestos biológicamente activos, particularmente con 
actividad antitumoral. 
 
 
Abstract  
The current work aimed to study the antitumour activity of a phenolic extract of the edible 
mushroom Leccinum vulpinum Watling, rich essentially in hydroxybenzoic acids. In a first 
approach, the mushroom extract was tested against cancer cell growth by using four human 
tumour cell lines. Given the positive results obtained in these initial screening experiments 
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and the evidence of some studies for an inverse relationship between mushroom consumption 
and breast cancer risk, a detailed study of the bioactivity of the extract was carried out on 
MCF-7 cells. Once the selected cell line to precede the work was the breast adenocarcinoma 
cell line, the human breast non-malignant cell line MCF-10A was used as control. Overall, the 
extract decreased cellular proliferation and induced apoptosis. Furthermore, the results also 
suggest that the extract causes cellular DNA damage. Data obtained highlight the potential of 
mushrooms as a source of biologically active compounds, particularly with antitumour 
activity. 
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Figure 35. Graphical abstract article 9. 
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Article 10: Methanolic extract of Ganoderma lucidum induces autophagy of 
AGS human gastric tumor cells  
 
Reference: Filipa S. Reis, Raquel T. Lima, Patricia Morales, Isabel C.F.R. Ferreira, M. Helena 
Vasconcelos. (2015). Molecules, 20, 17872-17882. 
DOI: 10.3390/molecules201017872 
 
 
Resumen 
Ganoderma lucidum es una de las especies de setas más estudiadas hasta la fecha, 
particularmente en cuanto a sus propiedades medicinales. Estudios previos (incluyendo los 
llevados a cabo por los autores) han demostrado evidencias científicas de que el extracto 
metanólico de G. lucidum afecta a la autofagia celular. Sin embargo, no se sabe si induce 
autofagia o disminuye el flujo autofágico. Tras el tratamiento de una línea celular de 
adenocarcinoma gástrico (AGS) con el extracto metabólico obtenido a partir de esta seta, se 
observó un aumento de la formación de autofagosomas (vacuolas típicas de la autofagia), un 
aumento de los niveles celulares de LC3-II y una disminución de los niveles celulares de p62, 
lo que confirma que el extracto metabólico estudiado afecta a la autofagia celular. Así como, 
el tratamento de las células AGS con el extracto junto con inhibidores de proteasas 
lisosómicos, aumentaron los niveles celulares de LC3-II y p62. Los resultados obtenidos 
demostraron que, en las células AGS, el extracto metanólico de G. lucidum causa una 
inducción de autofagia, en lugar de una reducción en el flujo autofágico, elucidandose así uno 
de los posibles mecanismos de acción de dicho extracto frente a esta linea celular tumoral. 
 
 
Abstract 
Ganoderma lucidum is one of the most widely studied mushroom species, particularly in what 
concerns its medicinal properties. Previous studies (including those from some of us) have 
shown some evidence that the methanolic extract of G. lucidum affects cellular autophagy. 
However, it was not known if it induces autophagy or decreases the autophagic flux. The 
treatment of a gastric adenocarcinoma cell line (AGS) with the mushroom extract increased 
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the formation of autophagosomes (vacuoles typical from autophagy). Moreover, the cellular 
levels of LC3-II were also increased, and the cellular levels of p62 decreased, confirming that 
the extract affects cellular autophagy. Treating the cells with the extract together with 
lysossomal protease inhibitors, the cellular levels of LC3-II and p62 increased.  
The results obtained proved that, in AGS cells, the methanolic extract of G. lucidum causes an 
induction of autophagy, rather than a reduction in the autophagic flux. To our knowledge, this 
is the first study proving that statement.  
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Figure 36. Graphical abstract article 10. 
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As previously referred, the present work started with the analysis of some commercially 
available mushroom species. The mushrooms selected were the most widely appreciated 
mushrooms (Agaricus bisporus (white and brown mushrooms), Flammulina velutipes, 
Lentinula edodes, Pleurotus eryngii and Pleurotus ostreatus). In addition, an inter-species 
comparative study was performed. Furthermore, some of these species were cultured by in 
vitro techniques to try to obtain greater concentrations of bioactive compounds (e.g., phenolic 
and related compounds). 
The remaining studied species comprised wild edible mushrooms from the Northeastern 
region of Bragança (Portugal). Moreover, three wild species from other countries were also 
considered, with the purpose of making some comparative studies (Suillus granulatus) which 
allowed the opportunity to study some medicinal species usually not consumed or used in the 
Portuguese culture (Cordyceps militaris and Phellinus linteus). 
 
 
6.1. Mushrooms nutritional value 
 
Regarding the nutritional value of the studied cultivated and wild mushrooms, in general, 
similar results were obtained (Table 4).  
Carbohydrates were the main macronutrient present in all the species, and the highest levels 
were found in the cultivated F. velutipes, L. edodes and P. ostreatus (85.9 and 87.84 g/100 g 
dw) and mostly in P. linteus (95.3 g/100 g dw), which agrees with literature that states that 
carbohydrates constitute about one-half of mushroom dry matter (Kalač, 2013). 
Carbohydrates content includes also dietary fibre, such as the structural polysaccharides β-
glucans, chitin, hemicelluloses and pectin substances (Kalač, 2009 and 2013). Since P. linteus 
is a thick, hard and woody mushroom, this could explain the particularly high carbohydrates 
content. 
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Table 4. Nutritional values of the studied edible mushroom species (mean ± SD). 
 
Species 
Total carbohydrates 
(g/100g dw) 
Crude protein 
(g/100g dw) 
Fat 
(g/100g dw) 
Ash 
(g/100g dw) 
Energy 
(kcal/100g dw) 
Cultivated  
Agaricus bisporus (J.E. Lange) Imbach  
(white mushroom) 
74.0 ± 0.9g 14.1 ± 0.2d 2.2 ± 0.2e 10 ± 1f 372 ± 3d 
Agaricus bisporus (J.E. Lange) Imbach 
(brown mushroom) 
71.1 ± 0.3fg 15.7 ± 0.1b 1.7 ± 0.1f 11.4 ± 0.3e 362.92 ± 0.06e 
Pleurotus ostreatus (Jacq. Ex Fr.) P. Kumm. 85.9 ± 0.3e 7.0 ± 0.3g 1.42 ± 0.08g 5.7 ± 0.4i 384 ± 2bc 
Pleurotus eryngii (DC.) Quél.  74 ± 5fgh 11.0 ± 0.3f 1.5 ± 0.1g 6.2 ± 0.5hi 420 ± 24ab 
Lentinula edodes (Berk.) Pegler 87.1 ± 0.3d 4.4 ± 0.4j 1.75 ± 0.08f 6.7 ± 0.5h 381.9 ± 0.2cd 
Flammulina velutipes (Curtis) Singer 87.84 ± 0.08c 3.89 ± 0.08j 1.8 ± 0.1f 7.2 ± 0.8gh 376 ± 5d 
Phellinus linteus (Berkeley & Curtis) Teng 95.3 ± 0.2a 2.8 ± 0.3k 0.49 ± 0.03h 1.33 ± 0.05j 397.14 ± 0.05a 
Wild  
Agaricus albertii (Bon.)  56.7 ± 0.3i 19.83 ± 0.02a 1.38 ± 0.03g 22.1 ± 0.3b 318 ± 1g 
Agaricus urinascens var. excellens (F.H. 
Møller) Nauta  
55 ± 1i 14.5 ± 0.4cd 1.4 ± 0.1g 29.6 ± 0.8a 288 ± 3h 
Pleurotus eryngii (DC.) Quél. 78.6 ± 0.5fg 2.090 ± 0.006j 4.36 ± 0.06a 15.0 ± 0.4c 362 ± 1e 
Suillus granulatus (L.) Roussel (Portugal)  73.5 ± 0.3h 14.8 ± 0.3c 3.74 ± 0.09b 8.0 ± 0.4g 387 ± 2abc 
Suillus granulatus (L.) Roussel (Serbia) 89.353 ± 0.005b  7.929 ± 0.001l 0.27 ± 0.04i 10.38 ± 0.04f 359.8 ± 0.4f 
Leccinum molle Bon (Bon) 78.4 ± 0.6fh 13.1 ± 0.6e 2.80 ± 0.07d 5.7 ± 0.3i 391.2 ± 0.6a 
Leccinum vulpinum Watling  72.9 ± 0.3h 10.5 ± 0.3f 2.97 ± 0.06c 13.6 ± 0.4d 360 ± 2e 
 
The different accuracy in the expression of the results is explained by the maintenance of the decimal places allowed by the magnitude of standard deviation. 
In each column, different letters mean statistical significant differences among the samples. Significance level was set as p<0.05. 
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Mushrooms are reported to be a good source of protein, being the amino acid composition 
comparable with protein of animal origin. Indeed, it has been reported that leucine, valine, 
glutamine, glutamic and aspartic acids are the most abundant amino acids in mushrooms 
(Asgar et al., 2010; Léon-Guzmán et al., 1997; Longvah & Deosthale, 1998; Mattila et al., 
2002; Mdachi et al., 2004; Ouzouni et al., 2009; Ribeiro et al., 2008a). The crude protein 
content calculated for the studied species varies between 2.090 and 19.83 g/100 g dw. 
Although some lower values were obtained especially for the cultivated mushrooms F. 
velutipes, L. edodes and P. ostreatus, and for the wild species P. eryngii, the values obtained 
for the remaining samples are close to the range of values reported in the literature (22.8 and 
24.9 g/100g dw; Kalač, 2013). The estimated medium values of the content of crude protein 
of mushrooms is approximately 20 % of total dry matter (Kalač, 2013).  
Therefore, in terms of crude protein, mushrooms are below the contribution made by the 
animal meats, but is above other products such as milk, some vegetable (e.g., onion and 
cabbage), fruits (e.g., oranges and apples) or cereals (e.g., rice and corn) (Cheung, 2008). 
Diferent studies indicate that the content of free amino acids is low (about 1% of dry matter), 
which means that their nutritional contribution is limited, but still higher than that of most 
plant proteins and with all the nine essential amino acids required by human body (Cheung, 
2008; Ghorai et al., 2009; Kalač, 2009 and 2013).  
 
In addition to their good protein and carbohydrates content, mushrooms present low contents 
of total fat.  Usually these levels vary between 2 and 6 % of dry matter (Kalač, 2009 and 
2013). Given the low total fat content, the nutritional contribution of mushroom lipids is 
limited, what makes them an excellent food choice. In fact, in the present work, the studied 
species also revealead a low fat content with values that ranged between 0.49 and 4.36 g/100 
g dw. Within fatty acids composition mono- and polyunsaturated fatty acids, outweigh 
saturated fatty acids, as will be describe bellow (Kalač, 2009 and 2013).   
 
The reported values of ash were also fairly low especially in the cultivated samples (1.33 and 
11.4 g/100 g dw). In the wild mushrooms the contents were reasonably higher (≈ 5.7 and 29.6 
g/100 g dw). Indeed, wild mushrooms are reported as having higher ash contents. This may be 
due to the greater diversity of the substrate (environment) in mushrooms growing wild, 
comparing with cultivated species grown in controlled environments and with less variety at 
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the substrate level (Kalač, 2013). According to literature, the mineral composition (ash) of 
mushrooms varies between 5 – 12 % of dry matter. The major elements present in mushrooms 
ash are potassium and phosphorous, being their contents higher or comparable to those found 
in most vegetables. However, magnesium, calcium and sodium are normally found in lower 
amounts (Kalač, 2009 and 2013).  
 
Given the low fat content, together with the presence of partially digestible or indigestible 
carbohydrates, result in low energetic values, an average value of about 370 kcal/100 g dw, 
making mushrooms low calorie and healthy foods excellent to be inserted in low calorie diets 
(Kalač, 2009 and 2013). Overall, the studied edible mushrooms revealed low fat contents and 
quite low energetic values, the present results corroborate the idea that mushrooms seem to be 
an excellent choice to include in healthy and low calorie diets. 
 
Soluble sugars 
Soluble sugars profile was assessed for all the studied mushrooms (except for Ganoderma 
lucidum, which chemical composition have been previously studied). The results are 
presented in Table 5. 
Mannitol and trehalose were the main sugars detected in all the studied mushrooms. In fact, 
these were the only soluble sugars detected in some of the analysed species, such as the 
mycorrhizal mushrooms, P. eryngii (wild species) and C. militaris. Actually, regarding 
Codyceps species, some works report the presence of mannitol pointing this polyol as 
responsible for their bioactive properties, such as diuretic, anti-tussive and anti-free radical 
activities (Das et al., 2010; Paterson & Russel, 2008). For the other species, the obtained data 
were variable, cultivated A. bisporus (white and brown mushrooms), F. velutipes, L. edodes, 
P. ostreatus and P. eryngii species have, besides mannitol and trehalose, fructose in their 
chemical constitution. In P. ostreatus and F. velutipes sucrose was also present. Some authors 
also have identified other soluble sugars (ribose, xylose, mannose or glucose) in these 
cultivated species (Kim et al., 2009; Tsai et al., 2009). These differences may be justified by 
the different substrates used for mushrooms cultivation. 
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Table 5. Soluble sugars content of the studied edible mushroom species (g/100 g dw; mean ± 
SD). 
The different accuracy in the expression of the results is explained by the maintenance of the decimal 
places allowed by the magnitude of standard deviation. nd- not detected. In each column, different 
letters mean statistical significant differences among the samples. Significance level was set as p<0.05. 
 
 
 
 
Species Fructose Mannitol Sucrose Trehalose 
Cultivated  
Agaricus bisporus (J.E. Lange) 
Imbach (white mushroom) 
0.360 ± 0.001i 64 ± 1a nd 1.8 ± 0.1l 
Agaricus bisporus (J.E. Lange) 
Imbach (brown mushroom) 
0.44 ± 0.02h 49.1 ± 0.9b nd 2.7 ± 0.2k 
Pleurotus ostreatus (Jacq. Ex 
Fr.) P. Kumm. 
0.10 ± 0.02k 5.0 ± 0.2h 0.25 ± 0.02b 40.8 ± 0.2b 
Pleurotus eryngii (DC.) Quél. 0.250 ± 0.001j 5.48 ± 0.01g nd 73 ± 1a 
Lentinula edodes (Berk.) Pegler 3.4 ± 0.3d 50 ± 4b nd 17 ± 1e 
Flammulina velutipes (Curtis) 
Singer 
38 ± 2a 8.0 ± 0.6e 0.73 ± 0.02a 22 ± 1d 
Cordyceps militaris (L.) Link nd 2.01 ± 0.08l nd 24.7 ± 0.8c 
Wild 
Amanita caesarea (Scop.) Pers nd 2.10 ± 0.06l nd 3.147 ± 0.008j 
Cortinarius violaceus (L.: Fr.) 
Gray 
nd 6.35 ± 0.02f nd 7.9 ± 0.1h 
Lactarius volemus (Fr.) Fr. nd 27 ± 1c nd 0.931 ± 0.003n 
Suillus luteus (L.: Fries) Gray nd 1.29 ± 0.02n nd 1.35 ± 0.03m 
Agaricus albertii (Bon.)  0.48 ± 0.02g 4.78 ± 0.01h nd 0.70 ± 0.02o 
Agaricus urinascens var. 
excellens (F.H. Møller) Nauta 
0.597 ± 0.004f 0.767 ± 0.004o nd 0.14 ± 0.01p 
Pleurotus eryngii (DC.) Quél. nd 1.40 ± 0.06m nd 14.2 ± 0.1f 
Suillus granulatus (L.) Roussel 
(Portugal) 
4.49 ± 0.01c 3.33 ± 0.05i nd 4.86 ± 0.03i 
Suillus granulatus (L.) Roussel 
(Serbia) 
7.02 ± 0.16b 3.18 ± 0.14j nd 2.57 ± 0.13k 
Leccinum molle Bon (Bon) 3.06 ± 0.01de 11.3 ± 0.1d nd 2.71 ± 0.04k 
Leccinum vulpinum Watling 4.52 ± 0.06c 2.680 ± 0.001k nd 8.310 ± 0.001g 
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Mannitol and trehalose were also present in all the studied wild species. However, in A. 
albertii, A. urinascens var. excellens, both S. granulatus species and both Leccinum species, 
fructose was also detected. Fructose is mostly associated with plants and fruits. In 
mushrooms, this naturally occurring sugar has important functions, namely as an intermediate 
for the synthesis of mannitol (Sassoon et al., 2001).  
 
Fatty acids 
The results for the fatty acids composition of the studied edible mushrooms are presented in 
Table 6. 
As previously referred the main fatty acids found in mushrooms are the saturated palmitic 
acid (C16:0), the unsaturated oleic acid (C18:1n9), and predominantly the polyunsaturated 
linoleic acid (C18:2n6). Even with low lipid contents, mushrooms are quite rich in 
unsaturated fatty acids, being mushrooms a source of essential fatty acids. The unsaturated 
fatty acids usually prevailed over saturated fat (Kalač, 2009 and 2013), these were the 
majority fatty acids found in the studied species, with the exception of P. linteus, since the 
percentage of SFA (58.3%) was the highest fraction comparing with MUFA (14.6%) and 
PUFA (27.1%), similar results was also reported in on P. linteus from China (Deng et al., 
2011). Even though, this profile is not so relevant in terms of dietary intake, considering the 
particularly low fat amounts (0.49 g/100 g dw). Excluding P. linteus, in all the other 
cultivated species PUFA percentages were up to 69.4%, being the great contributor the 
essential fatty acid linoleic acid. In the wild species both MUFA and/or PUFA are the 
prevailing fatty acids. One interesting data is regarding cultivated Pleurotus species, these 
mushrooms, obtained under similar conditions, have a fatty very similar acid profile, without 
significant differences between the percentages of MUFA (13.1 – 13.6%) and PUFA (69.4%). 
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Table 6. Main fatty acids present in the studied edible mushrooms (relative percentage, mean ± SD). 
 
 
The different accuracy in the expression of the results is explained by the maintenance of the decimal places allowed by the magnitude of standard deviation. Palmitic acid (C16:0); stearic acid 
(C18:0); oleic acid (C18:1n9); linoleic acid (C18:2n6). SFA- saturated fatty acids; MUFA- monounsaturated fatty acids; PUFA- polyunsaturated fatty acids. In each column, different letters 
mean statistical significant differences among the samples. Significance level was set as p<0.05. 
Species C16:0 C18:0 C18:1n9 C18:2n6 SFA MUFA PUFA 
Cultivated 
Agaricus bisporus (J.E. Lange) Imbach 
(white mushroom) 
11.9 ± 0.1f 3.082 ± 0.001h 1.1 ± 0.3o 77.7 ± 0.3c 20.31 ± 0.03f 1.4 ± 0.3q 78.3 ± 0.3c 
Agaricus bisporus (J.E. Lange) Imbach 
(brown mushroom) 
11.07 ± 0.04h 2.96 ± 0.08h 1.3 ± 0.2o 79.41 ± 0.07b 18.4 ± 0.3h 1.8 ± 0.2q 79.82 ± 0.07b 
Pleurotus ostreatus Jacq. Ex Fr.) P. Kumm. 11.15 ± 0.09gh 1.60 ± 0.09m 12.7 ± 0.1k 68.9 ± 0.3efg 17.0 ± 0.2j 13.6 ± 0.1l 69.4 ± 0.3f 
Pleurotus eryngii (DC.) Quél. 12.8 ± 0.4e 1.7 ± 0.1lm 12.3 ± 0.3k 69 ± 1fg 17.4 ± 0.5ij 13.1 ± 0.5l 69.4 ± 0.9f 
Lentinula edodes (Berk.) Pegler 10.28 ± 0.07j 1.58 ± 0.06m 2.3 ± 0.1n 81.1 ± 0.2a 15.09 ± 0.05l 2.9 ± 0.2o 82.0 ± 0.2a 
Flammulina velutipes (Curtis) Singer 11.02 ± 0.08h 2.04 ± 0.05k 5.70 ± 0.03m 45.38 ± 0.03n 18.46 ± 0.09h 7.24 ± 0.03n 74.31 ± 0.07e 
Cordyceps militaris (L.) Link 12.76 ± 0.03e 5.710 ± 0.001c 7.29 ± 0.03l 68.00 ± 0.06fg 23.40 ± 0.02e 7.73 ± 0.03m 68.87 ± 0.05f 
Phellinus linteus (Berkeley & Curtis) Teng 26.8 ± 0.2a 12.3 ± 0.1a 13.5 ± 0.1j 25.3 ± 0.1qr 58.3 ± 0.1a 14.6 ± 0.1k 27.1 ± 0.2n 
Wild 
Amanita caesarea (Scop.) Pers 12.4 ± 0.2e 4.9 ± 0.1d 53.8 ± 0.6a 25.7 ± 0.8qrs 19.2 ± 0.2g 54.8 ± 0.6a 26.0 ± 0.8n 
Cortinarius violaceus (L.: Fr.) Gray 14.02 ± 0.02d 1.668 ± 0.006m 14.6 ± 0.6i 66.2 ± 0.5h 17.46 ± 0.07ij 16.0 ± 0.6j 66.6 ± 0.5g 
Lactarius volemus (Fr.) Fr. 12.2 ± 0.2ef 6.4 ± 0.3b 39.27 ± 0.07c 34.38 ± 0.06p 23.92 ± 0.08d 40.80 ± 0.06c 35.28 ± 0.03m 
Suillus luteus (L.: Fries) Gray 10.57 ± 0.02i 2.06 ± 0.03k 31.2 ± 0.1e 52.3 ± 0.3l 14.32 ± 0.09n 33.0 ± 0.2e 52.8 ± 0.3k 
Agaricus albertii (Bon.)   11.14 ± 0.03gh 3.12 ± 0.02f 2.0 ± 0.3n 75.7 ± 0.2d 21.14 ± 0.03m 2.4 ± 0.3p 76.5 ± 0.3d 
Agaricus urinascens var. excellens (F.H. 
Møller) Nauta 
14.9 ± 0.1c 3.572 ± 0.007e 5.5 ± 0.3m 51.2 ± 0.5m 28.79 ± 0.06b 19.2 ± 0.4i 52.0 ± 0.5k 
Pleurotus eryngii (DC.) Quél. 17.4 ± 0.1b 4.76 ± 0.03d 47.52 ± 0.03b 24.7 ± 0.1qs 25.79 ± 0.08c 49.05 ± 0.03b 25.2 ± 0.1n 
Suillus granulatus (L.) Roussel  (Portugal)  9.64 ± 0.02k 3.191 ± 0.002g 24.64 ± 0.06g 57.14 ± 0.09j 15.44 ± 0.05k 26.55 ± 0.02g 58.01 ± 00.07i 
Suillus granulatus (L.) Roussel (Serbia) 9.62 ± 0.06k 2.65 ± 0.07j 20.08 ± 0.07h 64.0 ± 0.2i 14.3 ± 0.1n 21.30 ± 0.08h 64.4 ± 0.2h 
Leccinum molle Bon (Bon) 11.20 ± 0.08gh 1.791 ± 0.006l 38.6 ± 0.1d 43.49 ± 0.04o 16.9 ± 0.2j 39.3 ± 0.1d 43.79 ± 0.02l 
Leccinum vulpinum Watling 12.2 ± 0.1ef 2.78 ± 0.02i 27.06 ± 0.04f 53.5 ± 0.1k 17.1 ± 0.1j 28.61 ± 0.03f 54.3 ± 0.1j 
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6.2. Mushrooms as a source of bioactive compounds  
 
Given the theme of the present thesis, the edible mushroom species were studied as a source 
of interesting compounds, as well as matrices with antioxidant, antimicrobial and antitumour 
potential. Accordingly, in the next sections, the contents in nutrients (i.e., soluble sugars, 
ascorbic acid, fatty acids and tocopherols) and non-nutrients (i.e., phenolic and other organic 
acids), as well as the bioactivities are detailed for the studied samples. 
 
6.2.1. Bioactive compounds 
Regarding vitamin and pro-vitamin contents, mushrooms are particularly rich in riboflavin 
(vitamin B2), niacin (vitamin B3) and ergocalciferol (vitamin D2). Thiamine is another vitamin 
from B complex that is also present in some mushroom species, as well as folic acid and 
folates (Kalač, 2009 and 2013). Also carotenoids and particularly β-carotene (pro-vitamin A) 
are also present in mushrooms, even in small quantities (Kalač, 2009 and 2013). Ascorbic 
acid and tocopherols have been extensively detected in several mushroom species (Heleno et 
al., 2010; Pereira et al., 2012; Reis et al., 2011b). 
 
Ascorbic acid (Vitamin C) 
Although best known for its presence in fruits (mainly citric fruits) and vegetables, vitamin C, 
namely ascorbic acid, has also been found in fungi (Barros et al., 2007a; Ferreira et al., 2009; 
Kalač, 2013; Pereira et al., 2012; Reis et al., 2011b). Literature reports that this vitamin is 
present in small quantities that may vary between 15-30 mg/100g fw (Kalač, 2013).  
Ascorbic acid was survey in some of the wild mycorrhizal species under study with values 
that range 70 and 175 mg/100 g dw, in C. violaceus and A. caesarea, respectively (Table 7).  
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Table 7. Ascorbic acid content of the studied edible mushroom species (mg/100 g dw; mean 
± SD). 
 
Species Ascorbic acid  
Amanita caesarea (Scop.) Pers 175 ± 12a 
Cortinarius violaceus (L.: Fr.) Gray 70 ± 8c 
Lactarius volemus (Fr.) Fr. 84 ± 3b 
Suillus luteus (L.: Fries) Gray 87 ± 10b 
The different accuracy in the expression of the results is explained by the maintenance of the decimal 
places allowed by the magnitude of standard deviation. In each column, different letters mean 
statistical significant differences among the samples. Significance level was set as p<0.05. 
 
As far as we know, there are no reports on ascorbic acid presence in some of these studied 
species, namely on C. violaceus and S. luteus. Some authors reported ascorbic acid contents 
of 0.1 mg/100 g dw in L. volemus (Ozen et al., 2011) and 207 mg/100 g dw in A. caesarea 
(Valentão et al., 2005a).  
 
Pereira et al. (2012) studied some Portuguese wild edible mushrooms, reporting lower 
ascorbic acid levels. Different species have bben studied, namely Clitocybe gibba (Pers.) 
Kumm, Hygrophorus chrysodon (Batsch) Fr., Suillus variegatus (Sw.) Kuntze, Boletus 
impolitus Fr., Clavariadelphus pistillaris (L.) Donk, Ramaria aurea (Schaeff.) Quél., 
Agaricus campestris L. ex Fr., Agaricus lutosus (F.H. Møller) F.H. Møller, Leucoagaricus 
leucothites (Vittad.) Wasser, Amanita umbrinolutea (Secr. ex Gillet), Clavariadelphus 
truncatus (Quél.) Donk, Cortinarius praestans (Cordier) Gillet, Flammulina velutipes (Curtis) 
Singer, Amanita rubescens (Pers. ex Fr.) Gray, and Cantharellus cibarius Fr. The ascorbic 
acid levels ranging from 0.66 – 33.2 mg/100 g dw (Table S1). However, other authors 
reported higher values for Calvatia utriformis (Bull.) Jaap., Clitopilus prunulus (Scop. ex Fr.) 
P. Kumm, Lycoperdon echinatum Pers., Lyophyllum decastes (Fries: Fries) Singer, 
Macrolepiota excoriata (Schaeff.) M.M. Moser, Boletus erythropus (Pers.), Boletus fragrans 
(Vittadini), Hygrophorus pustulatus (Persoon : Fries) Fries, Russula cyanoxantha (Schaeff.) 
Fr., and Russula olivacea (Schaeff.) Fr., Armillaria mellea (Vahl. Ex Fr.) Kummer, Calocybe 
gambosa (Fr.) Donk, and Clitocybe odora (Fr.) P. Kumm. (81 – 400 mg/100 g dw) (Grangeia 
et al., 2011; Ribeiro et al., 2006; Vaz et al., 2011a; Table S1). Another study, reported the 
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ascorbic acid content in some Portuguese Boletus species, from 270 – 532 mg/100 g dw 
(Heleno et al., 2011; Table S1). This variance may be justified by the involvement of ascorbic 
acid in difference mechanisms related to the ageing process, so the mature stage of the 
mushroom will have influence on the ascorbic acid levels (Barros et al., 2007b). 
Temperature is one of the most reported post-harvest parameters to cause the decrease in the 
levels of ascorbic acid, as well as the heating time. Though temperature influences the 
amounts of this vitamin in food, low temperatures do not appear to greatly affect the natural 
decrease of ascorbic acid resulting from processing. However, the losses during freeze-drying 
(used in our samples) seem to be much lower comparing to air-drying treatments (Veras et al., 
2012). Actually, many studies have been carried out on several matrices, concluding that the 
low temperatures and residual moisture contents of the lyophilisation process can inhibit a 
degradation of ascorbic acid (Veras et al., 2012). Some studies show that the ascorbic acid 
content in lyophilized wild mushrooms may be quite low (0.66 – 33.16 mg/100 g dw; Pereira 
et al., 2012), while other species have a range between 81.32 – 400.36 mg/100 g dw 
(Grangeia et al., 2011). 
 
Other Organic acids  
In addition to their functions in primary metabolism, some of the organic acids mainly found 
in mushrooms have also biological activity. Citric and quinic acids are known for their 
antioxidant potential (Choe & Min, 2009; Hung et al., 2006). Fumaric acid has been referred 
as effective against psoriasis and inflammation and as potentially neuro- and chemoprotector 
(Altmeyer et al., 1994; Baati et al., 2011). Malic acid has bactericidal effects (Raybaudi-
Massilia et al., 2009), being employed in food additives as well as excipient in pharmaceutical 
and polymer industries (Nagarajkumar et al., 2005). While oxalic acid is also uses as excipient 
in pharmaceutical (Lian et al., 1999), it’s widely distributed in plant foods, mainly greens and 
vegetables. A high oxalic acid consumption in the diet could be associated with toxic effects, 
this compound is associated with calcium oxalate monohydrate crystals formation that are 
accumulated in the urinary system, which are associated with renal failure (Guo & McMartin, 
2005) and kidney stones (Taylor & Curhan, 2007). In addition, oxalic acid is assumed to have 
a negative impact on mineral absorption due to the ability to bind free minerals in the small 
intestine, forming insoluble oxalates that remain non-absorbed in the gut. Generally, oxalic 
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acid may reduce calcium absorption in about 1/6, so foods with a ratio of oxalic acid/Ca lower 
than 2.5 are preferably for human diet (Mahan et al., 2012). Although oxalate is present in 
numerous mushroom species, their levels are much lower than the others found in several 
vegetables, such as chard, spinach, among others. Moreover, oxalate is poorly absorbed. It has 
been estimated that 2 – 12% of the oxalate ingested is absorbed, the higher percentage when 
consumed during fasting (Noonan & Savage, 1999) and the minimal poison dose for humans 
is proximately 5 g per day for an adult (Guil et al., 1997). 
 
The amounts of organic acids present in the studied edible mushrooms are presented in Table 
8. There was not a main organic acid for all studied mushrooms. In general terms, malic acid 
was found in higher amounts in A. albertii (1.39 g/100g dw) and P. eryngii (6.1 g/100g dw), 
and citric acid in C. militaris (8 g/100g dw), L. molle (2.62 g/100g dw) and S. granulatus 
(from Serbia; 1.77 g/100g dw). C. militaris, the studied cultivated species, revealed the 
presence of oxalic acid (0.334 g/100 g dw), citric acid (8.0 g/100 g dw) and fumaric acid (0.13 
g/100 g dw). In some of the wild species, besides these three acids, it was possible to quantify 
also quinic and malic acids. It should be noted that the chemistry of an organism may also 
vary according to the conditions under which it develops (Hanson, 2008). This difference 
between cultivated and wild samples may be due to the environmental conditions. Moreover, 
once the organic acids are constituents of the Krebs cycle, and being wild mushrooms more 
prone to adverse conditions, these may have higher energy requirements comparing to 
mushrooms growing under controlled conditions. Interestingly, in S. granulatus, some acids 
were only obtained in the Portuguese species (quinic acid), and others in the Serbian one 
(malic and citric acids). These results support the idea that the chemical content among 
species from different sources can be similar, as a characteristic of the species, but the 
chemical profile may vary between them. Other authors dentified in S. granulatus oxalic, 
aconitic, citric, malic, quinic, succinic, shikimic and fumaric acids, with succinic and shikimic 
acids appearing in lower quantities (Ribeiro et al., 2006 and 2008b; Table S1). Although 
morphologically similar, fungi metabolites may be very different. Some metabolites may be 
produced by all the varieties of a particular species, while others may be specific metabolites 
of an organism. 
Although similar quantities of organic acids have been found in several species of edible 
mushrooms (Table S1), some of them produce considerably higher quantities of total organic 
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acids than those found in the present work. This is the case of Agaricus comtulus Fr. (13 
g/100 g dw), Boletus aereus Bull. (11 g/100 g dw) Boletus armeniacus Quél. (18 g/100 g dw), 
Clitocybe odora (Fr.) P.Kumm. (22 g/100 g dw), Lentinula edodes (Berk.) Pegler (21 g/100 g 
dw), Lepista nuda (Bull.) Cooke (18 g/100 g dw), Marasmius oreades (Bolton) Fr (14 g/100 g 
dw), and Sarcodon imbricatus (L.) P.Karst. (25 g/100 g dw) (Barros et al., 2013; Table S1). 
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Table 8. Organic acids content of the studied edible mushroom species (g/100 g dw; mean ± SD) 
 
Species Oxalic acid Quinic acid Malic acid Citric acid Fumaric acid 
Cultivated 
Cordyceps militaris (L.) Link 0.334 ± 0.001e nd nd 8.0 ± 0.1a 0.13 ± 0.03fg 
Wild 
Agaricus albertii (Bon.) 0.623 ± 0.003c 0.65 ± 0.02a 1.39 ± 0.02b 0.71 ± 0.02d 0.1551 ± 0.0003fg 
Agaricus urinascens var. excellens (F.H. Møller) Nauta 0.865 ± 0.001b nd 0.76 ± 0.02d 0.4956 ± 0.0004e 0.0978 ± 0.0004g 
Pleurotus eryngii DC.) Quél. 0.246 ± 0.005g nd 6.1 ± 0.1a 0.426 ± 0.001f 0.5469 ± 0.0001d 
Suillus granulatus (L.) Roussel (Portugal) 3.35 ± 0.08a 0.36 ± 0.01b nd nd 0.923 ± 0.001c 
Suillus granulatus (L.) Roussel (Serbia) 0.42 ± 0.02d nd 0.94 ± 0.16c 1.77 ± 0.25c 1.31 ± 0.03a 
Leccinum molle Bon (Bon) 0.29 ± 0.01f nd nd 2.62 ± 0.07b 1.0387 ± 0.0007b 
Leccinum vulpinum Watling 0.115 ± 0.001h 0.133 ± 0.002c nd nd 0.2501 ± 0.0001e 
The different accuracy in the expression of the results is explained by the maintenance of the decimal places allowed by the magnitude of standard deviation. 
nd- not detected. In each column, different letters mean statistical significant differences among the samples. Significance level was set as p<0.05. 
 
 
 
 
 
                                                                                Integrative Discussion 
148 
 
 
Phenolic acids and related compounds  
Phenolic compounds, namely phenolic acids, are reported in literature as one of the main 
antioxidants found in mushrooms all over the world (Ferreira et al., 2009; Kim et al., 2008; 
Nowacka et al., 2015; Yahia et al., 2017).  
Phenolic compounds are secondary metabolites produced in response to the environmental 
conditions, such as light or pollution, protecting mushrooms from the different biotic and 
abiotic stresses. So, the obtained results both for in vitro and in vivo species may be related 
with different responses of the species to the surroundings. Hereupon, in vitro culture may be 
a method for obtaining bioactive compounds. This methodology can be optimized, for 
instance by increasing the stress conditions (e.g., placing the cultures in light). 
 
In general the profile of phenolic compounds varied greatly depending on the species; 
however, p-hydroxybenzoic acid and cinnamic acids were detected in almost all samples, 
highlighting A. albertii, A. urinascens and P. eryngii by presenting the highest contents of 
these two bioactive compounds (Table 9). Regarding the most widely appreciated cultivated 
mushrooms, the phenolic contents were variable, being A. bisporus the species with the 
highest contents of total phenolic acids (≈ 6.6 mg/100 g dw). As previous referred, the 
mycelium of these species (A. bisporus, L. edodes, P. ostreatus and P. eryngii) was produced 
through in vitro techniques (data not shown in this section), and the profiles differed slightly 
between species and even within species.  
About the wild samples, it was possible to quantify one or more phenolic acids in the studied 
mushrooms. Generally, wild mushroom presented higher content of phenolic acids comparing 
to cultivated species. This is because these species, into the wild, may be subject to greater 
stress conditions.  Thus, it is normal that some compounds are found in certain species and 
not in others, just as the same species may have different profiles depending on the nature of 
its growth.  
Some of the studied Portuguese wild edible species studied in the present work, have been 
also studies for phenolic compounds composition by other authors. Barros et al. (2009) 
identified only p-hydroxybenzoic acid (2.6 mg/100 g dw) in A. bisporus, phenolic acid not 
identified by us in both A. bisporus species studied. Fernandes et al. (2015), reported the 
presence of only p-hydroxybenzoic acid (3.9 mg/100 g dw) and the related compound 
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cinnamic acid (2.48 mg/100 g dw) in A. caesarea (Table S1). There are also some reports 
with the studied Suillus species. S. granulatus and S. luteus have been studied by Ribeiro et al. 
(2006), and both phenolic profiles have been reported as constituted only by quercetin (0.2 – 
1.59 mg/100 g dw for S. granulatus and 0.46 mg/100 g dw for S. luteus; Table S1).   
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Table 9. Phenolic acids (and related compounds) content of the studied edible mushroom species (mg/100 g dw; mean ± SD). 
The different accuracy in the expression of the results is explained by the maintenance of the decimal places allowed by the magnitude of standard deviation. nd- not detected. 
In each column, different letters mean statistical significant differences among the samples. Significance level was set as p<0.05. 
Species Gallic acid Protocatechuic acid p-Hydroxybenzoic acid p-Coumaric acid Cinnamic acid 
Cultivated 
Agaricus bisporus (J.E. Lange) Imbach 
(white mushroom) 
6.3 ± 0.6a nd nd 0.231 ± 0.003c 0.038 ± 0.001k 
Agaricus bisporus (J.E. Lange) Imbach 
(brown mushroom) 
nd nd nd  nd 0.0094 ± 0.0001o 
Pleurotus ostreatus (Jacq. Ex Fr.) P. Kumm. nd 0.077 ± 0.001d  0.156 ± 0.003h 0.081 ± 0.002e 0.023 ± 0.001m 
Pleurotus eryngii (DC.) Quél. nd 0.006 ± 0.001f 0.010 ± 0.002m 0.104 ± 0.002d 0.0195 ± 0.0006n 
Lentinula edodes (Berk.) Pegler   nd 0.0364 ± 0.0004e 0.157 ± 0.007h nd 0.00194 ± 0.00006p 
Cordyceps militaris (L.) Link nd nd 0.021 ± 0.001l nd 0.1060 ± 0.0006j 
Wild 
Amanita caesarea  Scop.) Pers nd 0.67 ± 0.03a 0.72 ± 0.01e nd 0.0310 ± 0.0005l 
Cortinarius violaceus (L.: Fr.) Gray nd nd 1.30 ± 0.05d nd 0.565 ± 0.009d 
Lactarius volemus (Fr.) Fr. nd nd 0.46 ± 0.04g nd 0.321 ± 0.001f 
Suillus luteus (L.: Fries) Gray nd 0.468 ± 0.006b nd nd 0.41 ± 0.01e 
Agaricus albertii (Bon.) nd  nd 8.2 ± 0.3a 3.5 ± 0.3a 2.51 ± 0.04a 
Agaricus urinascens var. excellens (F.H. Møller) 
Nauta 
nd nd 3.3 ± 0.2c 1.3 ± 0.1b 1.8 ± 0.1b 
Pleurotus eryngii (DC.) Quél. nd nd 3.8 ± 0.2b nd 0.854 ± 0.004c 
Suillus granulatus (L.) Roussel 
(Portugal) 
0.105 ± 0.006b nd 0.4828 ± 0.0005f nd 0.1271 ± 0.0003i 
Suillus granulatus (L.) Roussel 
(Serbia) 
nd nd 0.13 ± 0.01i nd 0.03 ± 0.001n 
Leccinum molle  Bon (Bon) nd nd 0.060 ± 0.002k nd 0.1313 ± 0.0004h 
Leccinum vulpinum Watling 0.0831 ± 0.0006c 0.35 ± 0.02c 0.090 ± 0.001j nd 0.1720 ± 0.0004g 
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Vitamin E – Tocopherols  
Regarding tocopherols, as shown in Table 10, we could not detect an isoform prevalent in all 
the species.  
Generally, cultivated species revealed lower values of total tocopherols (≈ 2 – 56 µg/100 g 
dw) comparing with wild species (≈ 25 – 528 µg/100 g dw). Since tocopherols have 
antioxidant properties, their production could be higher when mushrooms are under stress 
conditions. Therefore, the controlled production of mushrooms (cultivated species) may not 
allowed the production of high quantites of tocopherols. Not all the analyzed isoforms were 
characterized in the selected mushroos, the wild Agaricus species did not revealed any 
isoform of vitamin E and the cultivated C. militaris only presented α-tocopherol. This may 
have been due effectively to its absence, or due to being degraded, once vitamin E is very 
sensitive to heat and light. Furthermore, there is not a major isoform for all analyzed 
mushrooms, β-tocopherol was the main isoform found in S. granulatus (from both origins), γ-
tocopherol in L. vulpinum and S. luteus (297 and 337 µg/100 g dw, respectively), while δ-
tocopherol was the main isoform found in A. caesarea (74.3 µg/100 g dw). 
 
In mushrooms, according with literature, the content in tocopherols is usually between 0.05 – 
0.3 mg/100 g dw, levels quite lower than those found in vegetables (Kalač, 2013).  
It is possible to find in literature other similar works including different species of Portuguese 
wild edible mushrooms. In those studies, which include species belonging to different genus, 
such as Amanita, Boletus, Laccaria, Lactarius, Lepista, Russula or Suillus species, β-
tocopherol (Heleno et al., 2010; Reis et al., 2014a and 2014b) and γ-tocopherol (Leal et al., 
2013; Reis et al., 2011b and 2012a, Vaz et al., 2011a), seems to be the prevailing isoforms, 
which is according with our results. 
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Table 10. Tocopherols composition of the studied edible mushroom species (µg/100 g dw; mean ± SD). 
 
The different accuracy in the expression of the results is explained by the maintenance of the decimal places allowed by the magnitude of standard deviation. 
nd- not detected. In each column, different letters mean statistical significant differences among the samples. Significance level was set as p<0.05. 
Species α-Tocopherol β-Tocopherol γ-Tocopherol δ-Tocopherol Total tocopherols 
Cultivated 
Agaricus bisporus (J.E. Lange) Imbach (white mushroom) 0.23 ± 0.01kj 0.85 ± 0.01i 1.51 ± 0.09i 2.6 ± 0.1g 5.18 ± 0.02m 
Agaricus bisporus (J.E. Lange) Imbach (brown mushroom) 0.28 ± 0.05j 0.71 ± 0.07j 1.1 ± 0.2j 2.54 ± 0.07g 4.6 ± 0.3n 
Pleurotus ostreatus (Jacq. Ex Fr.) P. Kumm. 0.59 ± 0.05i nd 1.4 ± 0.2ijh 1.6 ± 0.1h 3.6 ± 0.3o 
Pleurotus eryngii (DC.) Quél. 0.251 ± 0.007j 2.16 ± 0.01h 1.8 ± 0.1h 0.62 ± 0.02i 4.9 ± 0.2n 
Lentinula edodes (Berk.) Pegler 0.92 ± 0.03h nd 5.5 ± 0.4g 4.4 ± 0.4f 10.83 ± 0.07l 
Flammulina velutipes (Curtis) Singer 0.19 ± 0.02l nd 1.62 ± 0.02hi nd 1.81 ± 0.01p 
Cordyceps militaris (L.) Link 56 ± 2a nd nd nd 56 ± 2i 
Phellinus linteus Berkeley & Curtis) Teng 27.2 ± 0.5b nd 20 ± 2e nd 48 ± 3j 
Wild 
Amanita caesarea (Scop.) Pers 7.0 ± 0.2g nd 46 ± 1c 74.3 ± 0.3b 127.3 ± 0.9f 
Cortinarius violaceus L.: Fr.) Gray 8.3 ± 0.6fg 26 ± 2e 258 ± 14b 55 ± 2d 348 ± 19c 
Lactarius volemus (Fr.) Fr. 7.5 ± 0.6fg nd 31 ± 1d 69 ± 2c 108 ± 3g 
Suillus luteus (L.: Fries) Gray 19 ± 2c 15 ± 1f 337 ± 29a 79 ± 3b 450 ± 35b 
Agaricus albertii (Bon.) nd nd nd nd nd 
Agaricus urinascens var. excellens (F.H. Møller) Nauta nd nd nd nd nd 
Pleurotus eryngii (DC.) Quél. 7 ± 1fg 48 ± 6d 32 ± 5d nd 87 ± 2h 
Suillus granulatus (L.) Roussel (Portugal)  17.9 ± 0.5c 175 ± 2c nd 102 ± 3a 295 ± 5d 
Suillus granulatus (L.) Roussel (Serbia) 6.8 ± 0.3g 179.7 ± 0.6b 13.6 ± 0.9f 19.8 ± 0.3e 219.9 ± 0.8e 
Leccinum molle Bon (Bon) 12.5 ± 0.3e 12.9 ± 0.5g nd nd 25.4 ± 0.1k 
Leccinum vulpinum Watling 14.8 ± 0.5d 216 ± 10a 297 ± 26ab nd 528 ± 34a 
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6.3. Evaluation of the antioxidant potential of mushrooms  
 
The results for the antioxidant potential of the studied mushrooms are presented in Table 11. 
All the studied samples revealed antioxidant potential. Regarding cultivated samples, C. 
militaris revealed antioxidant potential mainly through lipid peroxidation inhibition (lowest 
EC50 values for β-carotene/linoleate and TBARS assays, between 0.77 – 1.05 mg/mL). The 
remaining cultivated species seems to have antioxidant potential maily through their reducing 
power capacity and lipid peroxidation inhibition, since the higher EC50 values were obtained 
for the DPPH radical-scavengung activity assay (2.28 – 12.2 mg/mL). Although, P. linteus 
have been also studied for this activity, different fractions (polysaccharides, glucans and 
triterpenoids) were analysed from this mushroom, and then compared with the methanolic and 
ethanolic extract. Therefore, for this integrative discussion, this species will not be taking into 
account (see article number 7, in Results section). However, it has been concluded that P. 
linteus proved to have high potential for antioxidant purposes. Among the assayed fractions, 
glucans showed the lowest antioxidant activity. The highest activity among assays was 
obtained for TBARS formation inhibition, while the worst values resulted from β-carotene 
bleaching inhibition. Neverthless, the methanolic extract of P. linteus revealed the lowest 
EC50 values for DPPH radical-scavenging activity (70 µg/mL), reducing power (50.5 µg/mL) 
and lipid peroxidation inhibition, either for β-carotene bleaching inhibition (114 µg/mL) as 
well as for TBARS inhibition (8 µg/mL).  
 
Concerning the wild species, it seems that they have better antioxidant properties (generally, 
lower EC50 values). However, these results are not so linear and unbending. In general terms, 
S. granulatus (from both origins) and L. vulpinum presented the better results in all 
antioxidant assays, comparing with the other wild species, while S. luteus also revealed good 
results for the reducing power and β-carotene bleaching inhibition assays. When we compare 
samples from the same genus (A. albertii and A. urinascens var. excellens) or from the same 
species from different origins (S. granulatus), we can see statistically significant differences 
in almost all the assays. This result would be expected, since the chemical profiles previous 
analysed also varied.  
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Since species with higher content of antioxidant compounds, such as tocopherols (L. 
vulpinum, S. luteus or S. granulatus from Portugal) or phenolic compounds (A. albertii), did 
not reveal a differentiating antioxidant activity, a synergistic action between the explored 
compounds and others may be inherent to this property. 
Barros et al. (2008a) described the antioxidant potential of A. bisporus, reporting EC50 values 
higher than those found by us. The authors obtained EC50 values of 3.63 mg/mL for reducing 
power, 9.61 mg/mL for the DPPH radical-scavenging activity, 21.39 mg/mL for β-carotene 
bleaching inhibition and 46.82 mg/mL for TBARS inhibition. Fernandes et al. (2015) reported 
for A. caesarea similar EC50 values specially concerning the reducing power (1.36 mg/mL) 
and for the DPPH radical-scavenging activity (8.0 mg/mL). The aqueous extract of S. 
granulatus has been studied by Ribeiro et al. (2008) for its antioxidant potential. However, as 
the authors reported the DPPH radical-scavenging activity as IC25 values (0.184 – 196 
mg/mL), we cannot compare directly with ours (Table S1). A methanol / water extract 
obtained from S. luteus has been studied for its antioxidant potential, revealing EC50 values 
similar to ours (0.97 mg/mL for reducing power, 2.86 mg/mL for DPPH radical-scavenging 
activity and 1.64 mg/mL for β-carotene bleaching inhibition) (Ribeiro et al., 2015; Table S1).     
Therefore, although the present study discloses that mushrooms are indeed natural matrices 
with antioxidant properties, further studied need to be performed in order to identify the 
compounds effectively responsible for this activity. For instance, it is possible to fractionate 
the studied extracts, and to charcaterize the most bioactive fractions, in order to verify the 
compounds present in these. 
 
 
                                                                                Integrative Discussion 
155 
 
 
 
Table 11. Antioxidant potential of the studied edible mushroom species (mean ± SD).  
 
Species 
Assay 
Reducing Power Radical scavenging activity Lipid peroxidation inhibition 
Folin-Ciocalteu  
assay  
Ferricyanide/Prussian blue 
assay  
DPPH radical-scavenging activity 
assay 
β-carotene/linoleate  
assay  
TBARS 
assay  
Cultivated 
Agaricus bisporus (J.E. Lange) Imbach 
(white mushroom) 
23.3 ± 0.3e 0.81 ± 0.02g 3.13 ± 0.09j 3 ± 1gh 2.9 ± 0.5c 
Agaricus bisporus (J.E. Lange) Imbach 
(brown mushroom) 
37.3 ± 0.2c 1.46 ± 0.04h 2.28 ± 0.06k 4.8 ± 0.2de 1.45 ± 0.08d 
Pleurotus ostreatus (Jacq. Ex Fr.) P. 
Kumm. 
12.5 ± 0.2f 3.31 ± 0.02c 6.5 ± 0.2i 2.7 ± 0.2hi 2.6 ± 0.9c 
Pleurotus  eryngii (DC.) Quél. 7 ± 2g 3.72 ± 0.07b 8.7 ± 0.1g 4.7 ± 0.6ef 3.9 ± 0.6b 
Lentinula edodes (Berk.) Pegler 8.8 ± 0.9g 2.62 ± 0.04e 6.4 ± 0.7hi 3.9 ± 0.3fg 1.6 ± 0.4d 
Cordyceps militaris (L.) Link 15.8 ± 0.5f 5.55 ± 0.03a 12.2 ± 0.7d 1.05 ± 0.07j 0.77 ± 0.03ef 
Wild 
Amanita caesarea (Scop.) Pers - 1.8 ± 0.1g 7.4 ± 0.2hi 8.1 ± 0.3c - 
Cortinarius violaceus (L.: Fr.) Gray - 2.35 ± 0.07e 15.7 ± 0.4b 5.7 ± 0.2d - 
Lactarius volemus (Fr.) Fr. - 2.4 ± 0.2e 21.7 ± 0.2a 9.1 ± 0.03b - 
Suillus luteus (L.: Fries) Gray - 0.74 ± 0.02i 1.93 ± 0.04l 0.61 ± 0.01k - 
Agaricus albertii (Bon.) 18.36 ± 0.09f 3.04 ± 0.02d 10.2 ± 0.2e 3.8 ± 0.4g 0.6 ± 0.3fg 
Agaricus urinascens var. excellens (F.H. 
Møller) Nauta 
15.4 ± 0.3f 3.71 ± 0.03b 13.8 ± 0.2c 4.3 ± 0.3efg 6.6 ± 0.9a 
Pleurotus eryngii (DC.) Quél. 18 ± 5ef 2.18 ± 0.04ef 9.21 ± 0.05f 15 ± 1a 1.59 ± 0.02d 
Suillus granulatus (L.) Roussel  (Portugal) 40.8 ± 0.8b 0.569 ± 0.009j 0.98 ± 0.02n 0.45 ± 0.08m 0.033 ± 0.001g 
Suillus granulatus (L.) Roussel  (Serbia) 44.4 ± 0.3a 0.412 ± 0.006l 0.89 ± 0.02o 0.48 ± 0.05l 0.167 ± 0.007g 
Leccinum molle  Bon (Bon) 23.1 ± 0.2ef 2.127 ± 0.002f 10.7 ± 0.5e 2.4 ± 0.2i 1.3 ± 0.2de 
Leccinum vulpinum Watling 35.4 ± 0.7d 0.541 ± 0.0065k 1.19 ± 0.01m 0.15 ± 0.07n 0.279 ± 0.004g 
The different accuracy in the expression of the results is explained by the maintenance of the decimal places allowed by the magnitude of standard deviation. (-) not performed. Concerning the 
Folin-Ciocalteu assay, higher values mean higher reducing power; for the other assays, the results are presented in EC50 values, which means that higher values correspond to lower reducing 
power or antioxidant potential. EC50: extract concentration corresponding to 50% antioxidant activity or 0.5 absorbance for the ferricyanide/Prussian blue assay. In each column, different letters 
mean statistical significant differences among the samples. Significance level was set as p<0.05. 
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6.4. Evaluation of the antimicrobial potential of mushrooms 
 
The antimicrobial potential was assessed for the cultivated C. militaris, as well as for the wild 
S. granulatus species (from Portugal and Serbia). As for the antioxidant potential, P. linteus 
have been also studied for this activity (different fractions, compared with different extracts; 
see article number 7 from Results section). Once again, the methanolic extract was the one 
that showed the best results, comparing with the ethanolic extract and with the different 
fractions. Regarding these latter, the glucans fraction was the less effective against bacterial 
growth, except in the case of Salmonella typhimurium. Furthermore, the fractions with highest 
antifungal activity were glucans and triterpenoids (which were actually the least effective 
against bacteria), presenting lower MIC and MFC values than bifonazole and ketoconazole on 
Aspergillus versicolor, Aspergillus ochraceus, Trichoderma viride and Penicillium 
funiculosum. A. versicolor, A. ochraceus and T. viride (MIC < 0.27 mg/mL; MFC < 0.77 
mg/mL, for all samples) were the fungal species with highest susceptibility to P. linteus.  
However, as previously referred, for this integrative discussion, only C. militaris and S. 
granulatus will be taking into account.  
Figure 37 to Figure 40 represent the minimum inhibition concentration (MIC) for bacteria and 
fungi, minimum bactericidal concentration (MBC) and minimum fungicidal concentration 
(MFC) for the studied mushroom species. Regarding bacteria, the mushroom methanolic 
extracts were tested against Staphylococcus aureus, Bacillus cereus, Micrococcus flavus, 
Listeria monocytogenes, Pseudomonas aeruginosa, Salmonella typhimurium, Escherichia coli 
and Enterobacter cloacae. While, the selected fungi for the antifungal assays were 
Aspergillus fumigatus, Aspergillus versicolor, Aspergillus ochraceus, Aspergillus niger, 
Trichoderma víride, Penicillium funiculosum, Penicillium ochrochloron and Penicillium 
verrucosum var. cyclopium.    
According the literature, mushrooms generally exhibit higher antibacterial effects against 
Gram-positive bacteria (Alves et al., 2012). In the present work, all the species revealed 
antimicrobial properties against both Gram-positive (Staphylococcus aureus, Bacillus cereus, 
Micrococcus flavus and Listeria monocytogenes) and Gram-negative (Pseudomonas 
aeruginosa, Salmonella typhimurium, Escherichia coli and Enterobacter cloacae) bacteria, 
with no apparent trend.  
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Regarding antibacterial MIC’s (Figure 37), samples revealed very interesting results even 
with lower MIC values (0.05 – 0.2 mg/mL) than the antibiotics streptomycin and ampicillin 
(0.04 – 0.74). Except in the case of C. militaris, which revealed values much higher than the 
previous ones (0.015 – 3.0 mg/mL).    
 
 
Figure 37. Antibacterial MIC’s (mg/mL of extract). 
 
Regarding the antibacterial MBC’s (Figure 38), the trend remained; both S. granulatus 
species presented lower values (0.05 – 0.4 mg/mL) than C. militaris (0.03 – 3.0 mg/mL) and 
even than commercial antibiotics (0.09 – 0.74 mg/mL). 
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Figure 38. Antibacterial MBC’s (mg/mL of extract). 
 
As previously referred, the extracts were also tested against different fungi strains. Regarding 
antifungal MIC’s, C. militaris revealed the better results against Aspergillus fumigatus (0.04 
mg/mL), Aspergillus versicolor (0.04 mg/mL) and Aspergillus ochraceus (0.04 mg/mL) even 
when compared with the antifungal drugs bifonazole (0.15 mg/mL) and ketoconazole (0.2 
mg/mL). However, it presented the highest MIC’s against Aspergillus niger (0.75 mg/mL) 
and Penicillium verrucosum var. cyclopium (6.25 mg/mL) (Figure 39).  
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Figure 39. Antifungal MIC’s (mg/mL of extract). 
 
Regarding the antifungal MFC’s, the better results were presented by S. granulatus, mainly 
the Serbian species (0.05 – 0.2 mg/mL). As in the antibacterial activity, C. militaris presented 
the highest MFC values, specially against Aspergillus fumigatus (6.25 mg/mL), Aspergillus 
versicolor (1.5 mg/mL), Aspergillus ochraceus (6.25 mg/mL), Aspergillus niger (6.25 
mg/mL), and Penicillium verrucosum var. cyclopium (12.5 mg/mL) (Figure 40).   
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Figure 40. Antifungal MFC’s (mg/mL of extract). 
 
Although C. militaris revealed the highest MIC’s, MBC’s and MFC’s against almost all 
bacteria and fungi strains, its antimicrobial potential (or the antimicrobial potential of its 
constituints) has been proved along the years. For example, Park et al. (2009) studied the 
antifungal potential of a protein extracted from this mushroom species against Fusarium 
oxysporum and Botrytis cinerea, using the disc plate diffusion assay. The authors obtained 
good results especially for Fusarium oxysporum. Wong et al. (2011), also studied the 
antifungal activity of cordymin (an antifungal peptide obtained from C. militaris), reporting 
IC50 values of 50 μM, 10 μM, 80 μM, and 0.75 mM for the inhibition of mycelial growth of 
Bipolaris maydis, Mycosphaerella arachidicola, Rhizoctonia solani and Candida albicans, 
respectively. Tuli et al. (2014) studied the antimicrobial activity of C. militaris fractions 
(hexane; chloroform; n-butanol; aqueous) and cordycepin, a nucleoside derivative, testing 
them against pathogenic bacteria (Staphylococcus aureus and Klebsiella pneumoniae) and 
fungi (Aspergillus niger and Trichophyton rubrum). Using also the disc plate diffusion assay, 
the authors concluded that both extracts of C. militaris and cordycepin, revealed a broad-
spectrum of activity against both gram-positive and gram-negative bacteria and fungi as well. 
The authors stated also that the antimicrobial activity is directly correlated with the content of 
cordycepin.  
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Overall, the studied species revealed antibacterial and antifungal antivities. Since S. 
granulatus and C. militaris shown higher values of some of the organic acids (i.e., oxalic acid, 
citric acid and fumaric acid), these may be contributing for the antimicrobial potential of these 
mushrooms, as reported in literature (Mani-Lopez et al., 2012; Theron & Lues, 2011). 
However, as for other bioactivities, and as for many natural matrices, other compounds, such 
as phenolic compounds, may contribute for this behaviour in a synergistic way.  
The antimicrobial potential of the studied mushrooms against different bacteria and fungi 
strains could be useful to discover new alternative to the existing antimicrobial agents, as well 
as constitute alternatives to synthetic chemicals with application in agriculture, food or 
pharmaceutical industry.   
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6.5. Evaluation of the antitumor potential of mushrooms 
 
6.5.1. Antiproliferative effects 
Some of the mushroom species were also studied for their antitumour potential (C. militaris, 
L. vulpinum and G. lucidum). For those samples, the extracts were tested against a panel of 
human tumour cell lines, in order to verify their growth inhibitory capacity.  All the tested 
species exhibited cytotoxicity effects in the studied human tumour cell lines ( 
Table 12). Moreover, the cytotoxicity was also tested against non-tumour cell cultures 
obtained from porcine liver (data not shown in this section), and all the studied mushrooms 
showed no significant effect on those cells, at least up to the maximum concentrations tested 
(400 µg/mL). These results were expected, since the studied mushroom species were carefully 
identified and used based on their classification as being edible. However, it is important to 
confirm the lack of effect in hepatocytes of the mushroom’s concentrations tested. 
 
Table 12. Antiproliferative effects of the studied edible mushroom species (mean ± SD). 
 
 
Species 
GI50 (µg/mL extract) 
HCT-15 MCF-7 NCI-H460 AGS HeLa HepG2 
Cultivated 
Cordyceps militaris 
(L.) Link 
73 ± 3ª 90.1 ± 0.4b 48 ± 7c - 66 ± 4 >400 
Wild 
Leccinum vulpinum 
Watling 
53 ± 6b 98 ± 10a 114 ± 8a 135 ± 2a - - 
Ganoderma lucidum 
(Curtis) P. Karst. 
69 ± 2a 67 ± 3c 78 ± 3b 66 ± 6b - - 
 
The different accuracy in the expression of the results is explained by the maintenance of the decimal places 
allowed by the magnitude of standard deviation. (-) not performed. Values correspond to the mean ± SD of three 
independent experiments, carried out with duplicates. GI50 values correspond to the extract concentration causing 
50% of growth inhibition in human tumor cell lines. 
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Different extracts/compounds from several species of mushrooms were tested in human 
tumour cell lines in order to study their growth inhibitory activity (Heleno et al., 2014; Patel 
& Goyal, 2012; Vaz et al., 2012a). From the studied species,  one of them, the G. lucidum, has 
been reported as a medicinal mushroom with antitumour potential (Calviño et al., 2010; 
Ferreira et al., 2015; Harhaji Trajković et al., 2009; Liang et al., 2012; Oliveira et al., 2014). 
Some of these authors have reported GI50 values for this species between 93 – 387 mg/mL in 
the same cell lines as the ones used in this study (Oliveira et al., 2014). However, to the best 
of our knowledge, this is the first report for L. vulpinum bioactivity. Overall, the data obtained 
highlights the antitumour potential of these mushrooms. Other scientists proved that an 
aqueous extract from C. militaris induced programmed cell death on a human promyelocytic 
leukemia cell line (Lee et al., 2006) and on human glioblastoma cell lines (GBM8401 and U-
87MG), which consisted on apoptosis and autophagy (Yang et al., 2012b). Similar studies 
have been carried out with several extracts of G. lucidum, proving that this species induces 
programmed cell death, mainly apoptosis, on different human tumour cell lines (Hernandez-
Marquez et al., 2014; Hong et al., 2004; Hsieh & Wu, 2013; Hu et al., 2002; Jang et al., 2010; 
Ji et al., 2011; Jiang et al., 2004; Müller et al., 2006).  
Therefore, other studies should be performed based on the published literature, for the 
evaluation of mushrooms antitumour potential, pharmacological investigation and clinical 
trials.  
In the present work, given the promising results obtained in the screening, the potential 
mechanism of action of some species (G. lucidum and L. vulpinum) was elucidated (articles 9 
and 10). As reported, the antitumour potential of these species, in different cell lines, was 
found to be mediated by the induction of programmed cell death, namely apoptosis and 
autophagy. 
As previously referred, the methanolic extract of L. vulpinum inhibited the cell growth of 
different cell lines (HCT-15, NCI-H460, MCF-7 and AGS), with the lowest GI50 
concentrations having been obtained in the HCT-15 and MCF-7 cell lines. It was decided to 
continue the studies in the MCF-7 cells since there is evidence for an inverse relationship 
between mushroom consumption and breast cancer risk (Hong et al., 2008; Roupas et al., 
2012; Shin et al., 2010; Zhang et al., 2009). Overall, the extract inhibited the growth of the 
human MCF-7 breast cancer cell line, by inducing DNA damage, inhibiting cellular 
proliferation and leading to cell death by apoptosis. This extract also revealed cytotoxic 
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effects in the human breast non-malignant cell line MCF-10A (used as control), but only 
when tested at much higher concentrations.  
Regarding the G. lucidum, previous studies have shown evidence that its methanolic extract 
affects cellular autophagy. Therefore, AGS cells were treated with this extract, in order to see 
if it induced autophagy or decreased the autophagic flux.  It was found that the extract 
increased the formation of autophagosomes (vacuoles typical of autophagy). Moreover, the 
cellular levels of LC3-II were also increased, and the cellular levels of p62 decreased, 
confirming that the extract affects cellular autophagy. When treating the cells with the extract 
together with lysossomal protease inhibitors, the cellular levels of LC3-II and p62 increased. 
These results proved that, in AGS cells, the methanolic extract of G. lucidum causes an 
induction of autophagy, rather than a reduction in the autophagic flux.   
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Conclusions 
Mushrooms from the Northeastern Portugal proved to have a great nutritional value, being 
low-calorie foods, rich in polyols, polyunsaturated fatty acids and a source of bioactive 
compounds (tocopherols, phenolic and organic acids), which may confer antioxidant, 
antimicrobial and antitumour potential. Therefore, these mushrooms could be considered 
functional foods and a source of nutraceutical / pharmaceutical products. These data 
increase knowledge and promote the traditional use and consumption of these natural 
products. 
1) Nutritional value: The studied edible mushrooms revealed low fat contents and 
quite low energetic values.  
The soluble sugars found in all the mushroom species (both cultivated and wild) were 
mannitol and trehalose, A. bisporus and both Pleurotus species revealed the highest 
levels of these sugars. Moreover, the cultivated F. velutipes stands out for having the 
higher contents of fructose (not detected in all the species), and the cultivated P. 
ostreatus, revealed the presence of sucrose.  
Regarding the fatty acids profile, in almost all the species unsaturated fatty acids 
prevailed over saturated fatty acids. The exception was the cultivated P. linteus, which 
stands out as the species with the highest contents of SFA (58.3%). Generally, the 
highest contents of MUFA were detected in the wild species and the highest PUFA 
contents in the cultivated species.   
 
2) Bioactive compounds: Wild mushrooms seem to be richer in bioactive 
compounds; some of them revealed the presence of ascorbic acid, as well as the 
highest contents of oxalic, malic, quinic and fumaric acids.  
Regarding all the phenolic acids identified, as well as the related compound cinnamic 
acid, these prevailed in the wild species. Nevertheless, the cultivated A. bisporus 
revealed the highest levels of gallic acid. 
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Regarding the vitamin E isoforms, the highest quantities of α-tocopherol were found in 
both cultivated species C. militaris and P. linteus. However, all the other isoforms 
were mainly detected in the wild species (i.e., β-tocopherol prevailed in both S. 
granulatus and L. vulpinum; γ-tocopherol prevailed in S. luteus, L. vulpinum, C. 
violaceus and A. caesarea; and δ-tocopherol prevailed in S. granulatus from Portugal, 
S. luteus, A. caesarea and L. volemus). 
Regarding their ecology, some of the studied wild species (i.e., A. caesarea, C. 
violaceus, L. volemus, L. molle, L. vulpinum, S. granulatus and S. luteus) are 
mycorrhizal mushrooms. These species seem to be an exceptional source of bioactive 
compounds. This may be due to the mycorrhization process itself, since it is related to 
metabolites production. Although the profile of the investigated metabolites in these 
species was similar to the profile found in other species, this symbiosis can be further 
investigated to obtain novel compounds, which were not studied in this work.  
 
3) Bioactive properties: The studied wild species revealed the highest contents of 
bioactive compounds as also presented greater bioactive potential. This was verified 
for the antioxidant activity of the species, since both S. granulatus and L. vulpinum 
revealed the lower EC50 values for all the performed in vitro assays.  
Regarding the antimicrobial potential, only one cultivated species and one wild species 
were studied and compared (C. militaris and S. granulatus from Portugal and Serbia). 
Once again, the better results were obtained for the wild species.  
Regarding the evaluation of the antiproliferative activity, no similar trend was 
observed when comparing activity with contents in bioactive compounds. However, 
all studied species (C. militaris, L. vulpinum and G. lucidum) inhibited the growth of 
the tested human tumour cell lines.  
In addition, by investigating the possible mechanisms of action of the mushrooms 
extracts (L. vulpinum and G. lucidum), it was possible to verify that the species under 
study demonstrated antitumour potential by different mechanisms. G. lucidum induced 
autophagic cell death. Thus, G. lucidum and/or its compounds may be studied as a new 
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source for compounds that induce cancer cell death. Unlike G. lucidum, L. vulpinum 
induced apoptosis and caused cellular DNA damage. 
The results presented in this thesis indicate that Portuguese wild edible mushrooms 
may have value as inducers of different types of programmed cell death in human 
tumour cells, and thus may contain potential antitumour compounds.  It would be 
interesting to attempt the isolation of compounds with antitumour activity (from the 
extracts which presented tumour cell growth inhibitory potential) and this may be the 
basis for future work. 
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Conclusiones 
Las setas objeto de estudio, procedentes del Noreste de Portugal, presentaron un gran valor 
nutricional, siendo alimentos bajos en calorías, ricos en polioles, ácidos grasos 
poliinsaturados y fuente de compuestos compuestos potencialmente bioactivos (tocoferoles, 
ácidos fenólicos y orgánicos) que les confieren a dichas especie propiedades antioxidantes, 
antimicrobianas y antitumorales. Así, las setas pueden considerarse como alimentos 
funcionales y una fuente de productos nutracéuticos y/o farmacéuticos. Estos datos aumentan 
el conocimiento y promueven el consumo tradicional de estos produtos naturales. 
1) Valor nutricional: Las setas comestibles estudiadas presentaron bajos contenidos 
de grasa y valores energéticos bastante bajos.  
Los azúcares solubles encontrados en todas las especies de setas (tanto cultivadas 
como silvestres) fueron mannitol y trehalosa, A. bisporus y ambas especies de 
Pleurotus destacaron por presentar los niveles más altos de estos azúcares. Mientras 
que F. velutipes destacó por su contenido en fructosa (no detectado en todas las 
especies), y P. ostreatus por la presencia de sacarosa.  
Respecto al perfil de los ácidos grasos, en casi todas las especies predominaron los 
ácidos grasos insaturados frente a los ácidos grasos saturados, excepto en el caso de P. 
linteus (cultivada), que presentó un mayor porcentaje relativo de AGS (58,3%). En 
general, las especies silvestres destacan por presentar mayores porcentajes de AGMI y 
las cultivadas por los AGPI. 
 
2) Compuestos bioactivos: Las setas silvestres parecen ser más ricas en compuestos 
bioactivos que las cultivadas. En algunas especies silvestres se observaron niveles 
interesantes de ácido ascórbico, así como los contenidos más altos de otros ácidos 
orgánicos como el ácidos oxálico, málico, quínico y fumárico.  
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Las especies silvestres descaron por su contenido en todos los ácidos fenólicos 
identificados, así como por el ácido cinámico. En A. bisporus (cultivado) se observó la 
mayor concentración de ácido gálico.  
En cuanto a las isoformas de vitamina E, se encontraron las mayores cantidades de α-
tocoferol en ambas especies cultivadas C. militaris y P. linteus. El resto de isoformas 
se detectaron principalmente en las especies silvestres (es decir, β-tocoferol prevaleció 
tanto en S. granulatus y L. vulpinum, γ-tocoferol prevaleció en S. luteus, L. vulpinum, 
C. violaceus y A. caesarea y δ-tocoferol prevaleció en S. granulatus de Portugal, S. 
luteus, A. caesarea y L. volemus). 
Algunas de las especies silvestres estudiadas (A. caesarea, C. violaceus, L. volemus, L. 
molle, L. vulpinum, S. granulatus y S. luteus), son hongos micorrízicos. Estas especies 
parecen ser una fuente excepcional de compuestos bioactivos. Esto puede deberse al 
propio proceso de micorrización, ya que está relacionado con la producción de 
metabolitos. Aunque el perfil de los metabolitos evaluados en estas especies fue 
similar al de los otros, esta simbiosis podría utilizarse para obtener nuevos 
compuestos, los cuales no fueron encuesta en este trabajo. 
 
3) Actividad biológica: Las especies con los mayores contenidos de compuestos 
bioactivos también presentaron la mayor actividad biológica en terminos de capacidad 
antioxidante, antimicrobiana y antitumoral, siendo especialmente patente en las setas 
silvestres estudiadas.  
Como ocurrió para la actividad antioxidante, en el caso de S. granulatus y L. 
vulpinum, las cuales presentaron los menores valores de EC50 para todos los ensayos in 
vitro realizados y por lo tanto mayor capacidad antioxidante.  
En cuanto al potencial antimicrobiano, sólo se estudiaron y compararon una sola 
especie cultivada y una especie silvestre (C. militaris y S. granulatus de Portugal y 
Serbia). Una vez más, los mejores resultados se obtuvieron en las especies silvestres. 
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Para la evaluación de la actividad antiproliferativa, se ha demostrado que todas las 
especies estudiadas (C. militaris, L. vulpinum y G. lucidum) inhiben el crecimiento 
celular de las líneas celulares tumorales humanas ensayadas.  
Además, al investigar los posibles mecanismos de acción de los extractos de las setas, 
L. vulpinum y G. lucidum demostraron potencial antitumoral aparentemente a través 
de diferentes mecanismos. Los resultados obtenidos demuestran que G. lucidum es un 
inductor de la autofagia, de modo que G. lucidum y/o sus compuestos pueden ser 
explotados como un nuevo enfoque para terapias basadas en la inducción de la muerte 
de células cancerosas. Mientras que L. vulpinum resultó ser un inductor de la 
apoptosis, así como causar daños en el ADN celular.  
Los resultados obtenidos en esta memoria, indican que las setas comestibles silvestres 
portuguesas pueden tener valor como inductores de diferentes tipos de muerte celular 
programada en líneas celulares tumorales humanas. Sería interesante intentar el 
aislamiento de los compuestos con actividad antitumoral (de los extractos que 
presentaban potencial inhibidor del crecimiento de células tumorales) y esto puede ser 
la base para el futuros trabajos (nuevos hallazgos de potenciales agentes 
antitumorales). 
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ANNEX 1. SUPPLEMENTARY MATERIAL  
 
Table S1. Vitamin C and main organic acids found in Portuguese edible mushrooms. 
 
Mushroom species 
Ascorbic acid 
Other organic acids 
Quantity Reference 
Agaricus albertii (Bon.) 
Oxalic acid 
Quinic acid 
Malic acid 
Citric acid  
Fumaric acid 
0.62 a 
0.65 a  
1.39 a 
0.71 a 
0.16 a 
Reis et al., 2014b 
Agaricus arvensis Schaeff. Ascorbic acid 0.002 – 0.04 b 
Barros et al., 2007a and 
2008a 
Agaricus bisporus (J.E. Lange) 
Imbach 
Ascorbic acid 0.003 b 
Barros et al., 2008a and 
2008b 
Oxalic acid  
Quinic acid  
Malic acid 
Citric acid 
Fumaric acid 
1.53 – 1.96 a 
0.64 a 
2.95 – 3.01 a  
3.46 – 4.32 a 
0.11 – 0.26 a 
Barros et al., 2013 
Agaricus campestris L. ex Fr.  
Ascorbic acid 0.02 a Pereira et al., 2012 
Oxalic acid 
Malic acid  
Fumaric acid 
1.13 a 
1.78 a  
0.30 a 
Barros et al., 2013 
Agaricus comtulus Fr. 
Oxalic acid  
Quinic acid  
Malic acid  
Citric acid 
Fumaric acid 
0.96 a  
0.79 a 
1.13 a 
2.66 a  
0.20 a  
Barros et al., 2013 
Agaricus lutosus (F.H. Møller) F.H. 
Møller  
Ascorbic acid 0.03 a Pereira et al., 2012 
Oxalic acid 
Malic acid  
Citric acid  
Fumaric acid  
0.59 a  
1.16 a  
5.83 a  
0.35 a  
Barros et al., 2013 
Agaricus silvaticus Schaeff ex. Secr. 
Ascorbic acid 0.004 b 
Barros et al., 2008a and 
2008b 
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid  
0.49 a  
2.39 a  
4.30 a  
0.38 a  
Barros et al., 2013 
Agaricus silvicola (Vittad.) Peck Ascorbic acid 0.004 b 
Barros et al., 2008a and 
2008b 
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Agaricus urinascens var. excellens 
(F.H. Møller) Nauta 
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid  
0.87 a  
0.76 a  
0.50 a  
0.10 a  
Reis et al., 2014b 
Amanita caesarea (Scop.) Pers 
Ascorbic acid 0.18 – 0.21 a 
Reis et al., 2011b 
Valentão et al., 2005a 
Oxalic acid  
Citric acid + Ketoglutaric acid 
Malic acid 
Succinic acid 
Shikimic acid  
Fumaric acid 
0.17 – 0.35 a  
0.05 a 
1.10 – 1.62 a 
0.000007 a 
0.0002 a 
0.004 – 0.50 a  
Barros et al., 2013 
Fernandes et al., 2015 
Valentão et al., 2005a 
Amanita crocea (Quél. in Bourd.) 
Singer ex Singer 
Oxalic acid  
Quinic acid  
Malic acid  
Citric acid  
Fumaric acid  
0.28 a  
0.23 a  
0.94 a  
2.07 a  
0.33 a  
Leal et al., 2013 
Amanita curtipes E.-J. Gilbert 
Oxalic acid  
Malic acid  
Fumaric acid  
0.27 a  
1.50 a  
0.26 a  
Fernandes et al., 2015 
Amanita mairei (Foley) 
Oxalic acid  
Citric acid  
Fumaric acid  
0.26 a  
2.63
 a 
 
0.30 a  
Leal et al., 2013 
Amanita rubescens (Pers. ex Fr.) 
Gray 
Ascorbic acid 0.34 a Ribeiro et al., 2006 
Oxalic acid  
Quinic acid  
Malic acid 
Citric acid  
Aconitic acid  
Ketoglutaric acid  
Succinic acid  
Shikimic acid  
Fumaric acid  
0.06 – 0.19 a  
6.31 – 12.41 a 
0.77 – 1.49 a  
0.13 – 1.94 a  
0.28 a  
0.10 – 5.02 a  
0.002 – 0.03 a  
0.002 – 0.01 a  
0.17 – 2.10 a  
Ribeiro et al., 2006 and 
2008b 
Amanita spissa (Fr.) Kummer 
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid 
tr (< 0.007) a  
2.62 a  
1.89 a  
0.51 a  
Barros et al., 2013 
Armillaria mellea (Vahl. ex Fr.) 
Kummer  
Ascorbic acid 0.15 a Vaz et al., 2011a 
Oxalic acid 
Quinic acid  
Malic acid  
Fumaric acid 
0.14 a  
0.82
 a 
 
1.38 a  
0.27 a  
Barros et al., 2013 
Boletus aereus Bull. 
Oxalic acid 
Malic acid  
Fumaric acid 
2.08 a  
8.57 a  
0.03 a  
Barros et al., 2013 
Boletus armeniacus Quél.   Oxalic acid  6.22 a  Barros et al., 2013 
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Malic acid  
Fumaric acid  
11.80 a  
0.06 a  
Boletus citrinoporus Halling  
Oxalic acid  
Malic acid  
Fumaric acid  
0.56 a 
0.83 a 
0.13 a 
Barros et al., 2013 
Boletus edulis Bull. 
Oxalic acid  
Malic acid  
Citric acid  
Aconitic acid  
Succinic acid  
Fumaric acid  
0.01 – 2.26 a 
0.79 – 1.73 a 
0.05– 4.7 a 
0.21 – 0.44 a 
0.000004 – 0.02 a  
0.001 – 0.22 a  
Barros et al., 2013 
Fernandes et al., 2013a 
Ribeiro et al., 2006 and 
2008b 
Valentão et al., 2005a 
Boletus fragrans Vittad. 
Oxalic acid  
Quinic acid  
Malic acid  
Citric acid  
Fumaric acid  
0.19 a  
2.30 a 
1.71 a 
3.06 a 
0.09 a 
Barros et al., 2013 
Boletus impolitus Fr.  
Ascorbic acid 0.002 a Pereira et al., 2012 
Oxalic acid 
Malic acid  
Fumaric acid  
0.44 a 
0.76 a 
0.24 a 
Barros et al., 2013 
Boletus porosporus Imler ex Bon & 
G. Moreno 
Oxalic acid  
Quinic acid  
Citric acid  
Fumaric acid  
0.34 a 
1.93 a 
0.21 a 
0.07 a 
Leal et al., 2013 
Boletus regius Krombh. 
Oxalic acid  
Quinic acid  
Citric acid  
Fumaric acid  
0.17 a 
0.18 a 
3.32 a 
0.07 a 
Leal et al., 2013 
Boletus reticulatus Schaeff.  
Oxalic acid 
Malic acid  
Fumaric acid  
0.39 a 
0.46 a 
0.03 a 
Barros et al., 2013 
Bovista aestivalis (Bonord.) 
Demoulin  
Oxalic acid  
Malic acid  
Fumaric acid  
1.06 a 
tr (< 0.007) a  
0.01 a 
Barros et al., 2013 
Bovista nigrescens (Pers.) 
Oxalic acid  
Malic acid  
Fumaric acid  
0.08 a  
0.05 a  
tr (< 0.007) a  
Barros et al., 2013 
Calocybe gambosa (Fr.) Donk 
Ascorbic acid 
0.04 b 
0.18 a 
Barros et al., 2008b 
Vaz et al., 2011a 
Oxalic acid  
Malic acid  
Fumaric acid  
1.19
 a 
 
2.44 a  
0.05 a  
Barros et al., 2013 
Calvatia utriformis (Bull.) Jaap. Ascorbic acid 0.15 a Grangeia et al., 2011 
Cantharellus cibarius Fr. Ascorbic acid 
0.04 – 0.09 b 
0.002 – 0.02 a  
Barros et al., 2008b and 
2008c 
Valentão et al., 2005b 
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Oxalic acid  
Malic acid  
Citric acid  
Shikimic acid  
Fumaric acid  
0.13 – 0.29 a  
0.02 – 5.94 a  
0.003 – 1.20 a  
tr (≤ 0.00009) a  
0.00004 – 0.25 a  
Barros et al., 2013 
Valentão et al., 2005b 
Chlorophyllum rhacodes (Vittadini) 
Vellinga 
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid  
1.02 a  
0.56 a  
3.47 a  
0.63 a  
Barros et al., 2013 
Clavariadelphus pistillaris (L.) 
Donk  
Ascorbic acid 0.003 a Pereira et al., 2012 
Oxalic acid  
Malic acid  
Fumaric acid  
0.10 a  
2.12 a  
0.91 a  
Barros et al., 2013 
Clavariadelphus truncatus (Quél.) 
Donk  
Ascorbic acid 0.007 a Pereira et al., 2012 
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid  
0.39 a 
0.27 a 
0.78 a 
0.12 a 
Barros et al., 2013 
Clitocybe costata Kühner & 
Romagn.  
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid  
0.81 a 
2.49 a 
2.67 a 
0.33 a 
Barros et al., 2013 
Clitocybe gibba (Pers.) P. Kumm. 
Ascorbic acid 0.02 a Pereira et al., 2012 
Oxalic acid  
Malic acid  
Fumaric acid  
1.26 a 
0.33 a 
0.33 a 
Barros et al., 2013 
Clitocybe odora (Fr.) P. Kumm.  
Ascorbic acid 0.17 a Vaz et al., 2011a 
Oxalic acid  
Quinic acid  
Malic acid  
Fumaric acid  
1.41 a 
19.82 a 
0.43 a 
0.12 a  
Barros et al., 2013 
Clitocybe subconnexa Murrill 
Oxalic acid  
Fumaric acid  
2.64 a  
0.23 a  
Heleno et al., 2015a 
Clitopilus prunulus (Scop. ex Fr.) P. 
Kumm 
Ascorbic acid 0.40 a Grangeia et al., 2011 
Coprinus comatus (O.F.Müll.) Pers.  
Ascorbic acid 0.13 a Vaz et al., 2011a 
Oxalic acid  
Malic acid  
Fumaric acid  
0.49 a  
2.03 a  
0.85 a  
Barros et al., 2013 
Cortinarius praestans Cordier 
Ascorbic acid 0.009 a Pereira et al., 2012 
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid  
0.15 a  
1.93 a  
1.34 a  
1.23 a 
Barros et al., 2013 
Cortinarius violaceus (L.: Fr.) Gray 
Ascorbic acid 0.07 a Reis et al., 2011b 
Oxalic acid  0.18 a Barros et al., 2013 
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Quinic acid   
Malic acid  
Citric acid  
Fumaric acid  
0.40 a 
0.87 a 
0.53 a 
0.87 a 
Craterellus cornucopioides (L.) 
Pers. 
Ascorbic acid 0.09 b Barros et al., 2008b 
Oxalic acid  
Malic acid  
Fumaric acid  
0.33 a 
2.78 a 
0.26 a 
Barros et al., 2013 
Fistulina hepatica (Schaeff.) With.  
Ascorbic acid 0.01 – 0.28 a Ribeiro et al., 2007 
Oxalic acid  
Malic acid  
Citric acid  
Aconitic acid 
Fumaric acid  
0.0005 – 0.02 a  
0.02 – 3.34 a 
0.003 – 2.97 a 
0.0007 – 0.008 a 
0.003 – 0.38 a 
Barros et al., 2013 
Ribeiro et al., 2007 
Flammulina velutipes (Curtis) 
Singer  
Ascorbic acid 0.02 a Pereira et al., 2012 
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid  
0.51 – 1.41 a 
1.85 – 3.28 a 
6.05 a 
0.16 – 0.21 a 
Barros et al., 2013 
Gyromitra esculenta (Pers. ex Pers.) 
Fr. 
Oxalic acid  
Quinic acid  
Malic acid  
Citric acid  
Fumaric acid 
0.13 a 
1.43 a 
0.69 a 
1.46 a 
0.36 a 
Leal et al., 2013 
Gyroporus castaneus (Bull.) Quel. 
Citric acid + Ketoglutaric acid 
Malic acid + Quinic acid 
Succinic acid 
Fumaric acid 
0.12 a 
0.38 a 
0.00002 a 
0.007 a 
Valentão et al., 2005a 
Helvella lacunosa (Afzel.) 
Oxalic acid  
Quinic acid  
Malic acid    
Citric acid  
Fumaric acid  
2.98 a 
0.24 a 
1.96 a 
1.42 a 
0.33 a 
Leal et al., 2013 
Hericium erinaceus (Bull.) Persoon 
Oxalic acid  
Malic acid  
Fumaric acid  
0.06 a 
3.09 a 
0.60 a 
Heleno et al., 2015b 
Hericium coralloides (Scop.) Pers. 
Oxalic acid  
Malic acid  
Fumaric acid 
0.09 a 
0.47 a 
0.37 a 
Heleno et al., 2015b 
Hydnum repandum L. 
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid  
0.003
 a
 
3.47 a  
3.82 a  
0.61 a  
Fernandes et al., 2013a 
Hygrophoropsis aurantiaca  
(Wulfen) Maire 
Oxalic acid  
Malic acid  
Fumaric acid 
0.52 a  
1.46 a  
0.10 a  
Barros et al., 2013 
                                                                             Supplementary Material 
 
 
Hygrophorus agathosmus (Fr.) Fr. 
Oxalic acid  
Quinic acid + Malic acid 
Citric acid  
Aconitic acid 
Ketoglutaric acid 
Succinic acid  
Shikimic acid 
Fumaric acid  
0.16 – 0.22 a 
2.35 – 2.77 a 
2.05 – 2.29 a 
0.18 a  
0.24 – 0.26 a 
0.44 – 0.85 a 
0.01 a  
0.62 – 2.10 a 
Ribeiro et al., 2006 
Hygrophorus chrysodon (Fr.) Fr. 
Ascorbic acid 0.03 a Pereira et al., 2012 
Oxalic acid  
Malic acid  
Fumaric acid  
0.49 a  
0.07 a  
0.02 a  
Barros et al., 2013 
Hygrophorus pustulatus (Persoon: 
Fries) Fries 
Ascorbic acid 0.39 a  Grangeia et al., 2011 
Laccaria amethystine (Huds.) 
Cooke  
Oxalic acid 
Malic acid  
Citric acid  
Fumaric acid 
0.20 a  
0.80 a  
1.43 a  
0.66 a  
Barros et al., 2013 
Lactarius deliciosus (L. ex Fr.) 
S.F.Gray  
Ascorbic acid 0.008 – 0.10 a 
Barros et al., 2007b 
Valentão et al., 2005a 
Oxalic acid 
Malic acid  
Citric acid + ketoglutaric acid 
Succinic acid 
Fumaric acid  
0.0005 – 0.51 a  
2.33 a  
0.009 – 0.61 a 
tr (< 0.0001) a  
0.001 – 0.11 a  
Barros et al., 2013 
Valentão et al., 2005a 
Lactarius piperatus (L.) Pers. Ascorbic acid 0.003 – 0.02 b Barros et al., 2007b 
Lactarius volemus (Fr.) Fr.   
Ascorbic acid 0.08 a Reis et al., 2011b 
Oxalic acid 
Quinic acid  
Malic acid  
Fumaric acid  
0.66 a  
0.12 a  
2.98 a  
0.25 a  
Barros et al., 2013 
Lentinula edodes (Berk.) Pegler  
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid  
1.01 a  
2.89 a  
16.56 a 
0.50 a  
Barros et al., 2013 
Lepista nuda (Bull.) H.E. Bigelow 
& A.H. Sm.  
Ascorbic acid 0.023 b Barros et al., 2008c 
Oxalic acid  
Quinic acid  
Malic acid  
Fumaric acid 
4.34 a  
12.53 a 
0.87 a  
0.07
 a 
 
Barros et al., 2013 
Leucoagaricus leucothites (Vittad.) 
Wasser  
Ascorbic acid 0.02 a Pereira et al., 2012 
Oxalic acid  
Malic acid  
Fumaric acid  
0.33 a  
1.74 a  
0.59 a  
Barros et al., 2013 
Leucopaxillus giganteus (Sowerby) 
Singer 
Ascorbic acid 0.01 b   Barros et al., 2007a 
Oxalic acid  0.21 a  Barros et al., 2013 
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Malic acid  
Fumaric acid 
6.03 a  
0.23 a  
Lycoperdon echinatum Pers. Ascorbic acid 0.17 a Grangeia et al., 2011 
Lycoperdon molle Pers.  Ascorbic acid 0.03 b Barros et al., 2008c 
Lycoperdon perlatum Pers. Ascorbic acid 0.02 b Barros et al., 2008c 
Lycoperdon umbrinum Pers.  
Oxalic acid  
Malic acid  
Fumaric acid  
0.14 a  
tr (< 0.007) a 
0.02 a  
Barros et al., 2013 
Lyophyllum decastes (Fries: Fries) 
Singer 
Ascorbic acid 0.39 a Grangeia et al., 2011 
Macrolepiota excoriata (Schaeff.) 
Wasser 
Ascorbic acid 0.18 a Grangeia et al., 2011 
Oxalic acid  
Malic acid  
Fumaric acid  
0.64 a  
2.37 a  
0.24 a  
Barros et al., 2013 
Macrolepiota procera (Scop.) 
Singer 
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid 
1.33 a  
0.97 a  
2.64 a  
0.04 a 
Barros et al., 2013 
Marasmius oreades (Bolton) Fr 
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid 
1.80 a  
7.86 a  
4.36 a  
0.04 a  
Barros et al., 2013 
Phellinus linteus (Berkeley & 
Curtis) Teng 
Oxalic acid  0.30 a  Reis et al., 2014c 
Pleurotus eryngii (DC.) Quél.   
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid 
0.20 – 0.25 a 
1.85 – 6.15 a 
0.43 – 2.87 a 
0.25 – 0.55 a 
Barros et al., 2013 
Reis et al., 2014b 
Pleurotus ostreatus (Jacq. ex Fr.) P. 
Kumm.  
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid  
0.44 a  
1.51 a  
2.14 a  
0.34 a  
Barros et al., 2013 
Ramaria aurea (Schaeff.) Quél.  
Ascorbic acid 0.0007 a Pereira et al., 2012 
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid  
0.14 a  
0.46 a  
0.44 a  
0.48 a  
Barros et al., 2013 
Russula aurea Pers. 
 
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid  
1.09 a  
4.53 a  
1.20 a  
0.38 a  
Leal et al., 2013 
Russula cyanoxantha (Schaeff.) Fr. 
Ascorbic acid 0.19 a Grangeia et al., 2011 
Oxalic acid  
Quinic acid  
Malic acid  
Citric acid  
0.05 – 0.12 a 
3.52 – 6.38 a 
3.16 – 5.86 a 
0.17 – 0.85 a 
Ribeiro et al., 2006 and 
2008b 
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Aconitic acid  
Succinic acid  
Fumaric acid  
0.01 – 0.04 a  
0.09 – 0.23 a  
0.53 – 0.83 a  
Russula delica Fr. 
Oxalic acid  
Malic acid  
Fumaric acid  
1.01 a  
2.95 a  
0.23 a  
Barros et al., 2013 
Russula olivacea (Schaeff.) Fr.   
Ascorbic acid 0.25 a Grangeia et al., 2011 
Oxalic acid  
Malic acid  
Fumaric acid  
0.37 a  
1.17 a  
0.22 a  
Barros et al., 2013 
Russula virescens (Schaeff.) Fr. 
Oxalic acid  
Malic acid  
Citric acid  
Fumaric acid  
0.78 a  
2.71 a  
0.55 a  
0.23 a  
Leal et al., 2013 
Sarcodon imbricatus (L.) P. Karst.  
Ascorbic acid 0.02 b  Barros et al., 2007a 
Oxalic acid  
Malic acid  
Fumaric acid  
1.27 a  
24.07 a  
0.08 a  
Barros et al., 2013 
Suillus bellinii (Inzenga) Watling 
Oxalic acid  
Quinic acid + Malic  
Citric acid 
Succinic acid  
Shikimic acid  
Fumaric acid  
0.16 – 0.33 a 
0.91 – 3.12 a  
0.62 – 1.12 a  
0.57 – 0.69 a  
0.01 a  
0.53 – 0.75 a  
Ribeiro et al., 2006 
Suillus collinitus (Fr.) Kuntze 
Ascorbic acid 0.009 – 0.38 a Valentão et al., 2005a 
Oxalic acid 
Citric acid + Ketoglutaric acid 
Malic acid + Quinic acid 
Succinic acid 
Fumaric acid 
0.003 – 0.01 a 
0.04 – 0.29 a 
0.05 – 0.27 a 
tr (< 0.0009) a 
0.005 – 0.04 a 
Valentão et al., 2005a 
Suillus granulatus (L.) Roussel 
Oxalic acid  
Quinic acid  
Malic acid  
Citric acid  
Aconitic acid  
Succinic acid  
Shikimic acid  
Fumaric acid  
0.02 – 3.35 a  
0.29 – 8.64 a  
0.09 – 1.37 a  
0.14 – 4.79 a  
0.15 – 5.27 a  
0.007 – 0.22 a  
0.01 – 0.03 a  
0.14 – 2.82 a  
Reis et al., 2014a 
Ribeiro et al., 2006 and 
2008b 
Suillus luteus (L.: Fries) Gray 
Ascorbic acid 0.09 a Reis et al., 2011 
Oxalic acid  
Quinic acid + Malic acid 
Citric acid  
Aconitic acid  
Succinic acid  
Shikimic acid  
Fumaric acid  
0.20 – 0.69 a  
1.66 – 4.50 a  
0.38 – 1.03 a  
0.97 a  
0.13 – 0.23 a 
0.01 a  
0.87 – 1.38 a  
Ribeiro et al., 2006 
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Suillus variegatus (Sw.) Kuntze  
 
Ascorbic acid 0.006 a Pereira et al., 2012 
Oxalic acid  
Malic acid  
Fumaric acid  
2.46 a  
0.38 a 
0.02 a  
Barros et al., 2013 
Tricholoma acerbum (Bull.) Quél. Ascorbic acid 0.02 b Barros et al., 2008c 
Tricholoma imbricatum (Fr.) 
P.Kumm. 
 
Oxalic acid  
Malic acid  
Fumaric acid  
0.33 a  
4.43 a  
0.63 a  
Barros et al., 2013 
Tricholoma portentosum (Fr.) Quél. 
Oxalic acid 
Malic acid  
Citric acid  
Fumaric acid 
0.43 a  
6.49 a  
1.90 a  
0.50 a  
Barros et al., 2013 
Tricholomopsis rutilans (Schaeff.: 
Fr.) Sing. 
Oxalic acid  
Quinic acid + Malic acid 
Citric acid  
Aconitic acid  
Succinic acid  
Shikimic acid  
Fumaric acid  
0.08 – 0.29 a 
1.69 – 2.41 a 
0.69 – 0.78 a 
0.24 a  
0.84 a  
0.01 a  
0.37 – 0.49 a 
Ribeiro et al., 2006 
Volvopluteus gloiocephalus (DC.) 
Vizzini, Contu & Justo 
Oxalic acid  
Fumaric acid  
0.37 a  
0.13 a  
Heleno et al., 2015a 
Xerocomus chrysenteron (Bull.) 
Šutara 
Citric acid + Ketoglutaric acid 
Malic acid + Quinic acid 
Succinic acid 
Fumaric acid 
0.04 a 
0.30 a 
0.002 a 
0.001 a 
Valentão et al., 2005a 
 tr- trace; values are presented in: ag/100 g of dry weight and bg/100 g of extract. 
 
 
 
 
 
Table S2.  Main phenolic acids and related compounds found in Portuguese edible 
mushrooms. 
 
Mushroom species 
Phenolic acid / related 
compound 
Quantity Reference 
Agaricus albertii (Bon.)  
p-Hydroxybenzoic acid  8.23 
Reis et al., 2014b p-Coumaric acid  3.53 
Cinnamic acid  2.51 
Agaricus arvensis Schaeff. 
p-Hydroxybenzoic acid  7.01 
Barros et al., 2009 
p-Coumaric acid  4.87 
Agaricus bisporus (J.E. Lange) Gallic acid  6.28 Barros et al., 2009 
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Imbach p-Hydroxybenzoic acid  2.56 Reis et al., 2012b 
p-Coumaric acid  0.23 
Cinnamic acid  0.01 – 0.04 
Agaricus silvicola (Vittad.) Peck 
p-Hydroxybenzoic acid  23.87 
Barros et al., 2009 
p-Coumaric acid 4.57 
Agaricus urinascens var. excellens 
(F.H. Møller) Nauta 
p-Hydroxybenzoic acid 3.27 
Reis et al., 2014b p-Coumaric acid  1.33 
Cinnamic acid  1.75 
Amanita caesarea (Scop.) Pers 
Protocatechuic acid  0.67 
Reis et al., 2011b 
Fernandes et al., 2015 
p-Hydroxybenzoic acid  0.72 – 4.7 
Cinnamic acid  0.03 – 2.48 
Amanita crocea (Quél. in Bourd.) 
Singer ex Singer 
Protocatechuic acid  21.33 
Leal et al., 2013 p-Hydroxybenzoic acid  0.74 
Cinnamic acid  tr (< 0.13) 
Amanita curtipes E.-J. Gilbert p-Hydroxybenzoic acid  0.10 – 0.32 Fernandes et al., 2015 
Amanita mairei (Foley) 
p-Hydroxybenzoic acid 5.94 
Leal et al., 2013 
Cinnamic acid 6.87 
Amanita rubescens (Pers. ex Fr.) 
Gray 
p-Hydroxybenzoic acid  49.09 Ribeiro et al., 2006 
Armillaria mellea (Vahl. ex Fr.) 
Kummer  
p-Hydroxybenzoic acid  0.40 
Vaz et al., 2011a 
Cinnamic acid  0.87 
Boletus aereus Bull. 
p-Hydroxybenzoic acid 1.34 
Heleno et al., 2011 p-Coumaric aci 0.45 
Cinnamic acid 3.16 
Boletus edulis Bull. 
Protocatechuic acid  0.20 
Fernandes et al., 2014 
Heleno et al., 2011 
p-Hydroxybenzoic acid  0.66 
p-Coumaric acid  0.12 – 0.56 
Cinnamic acid  0.37 – 1.11 
Boletus porosporus Imler ex Bon & 
G. Moreno 
p-Hydroxybenzoic acid  0.31 
Leal et al., 2013 
Cinnamic acid  tr (< 0.13) 
Boletus regius Krombh. 
Protocatechuic acid  1.15 
Leal et al., 2013 
p-Hydroxybenzoic acid  1.77 
p-Coumaric acid  2.08 
Chrysin derivatives  7.33 – 11.16 
Cinnamic acid  6.05 
Boletus reticulatus Schaeff. 
p-Hydroxybenzoic acid  1.21 
Heleno et al., 2011 
Cinnamic acid  0.28 
Calocybe gambosa (Fr.) Donk 
Protocatechuic acid  0.26 
Vaz et al., 2011a 
p-Hydroxybenzoic acid 3.84 
p-Coumaric acid  0.40 
Cinnamic acid  1.77 
Cantharellus cibarius Fr. 
Hydroxytyrosol  21.09 – 43.74 
Valentão et al., 2005b 
3-O-Caffeoylquinic acid 0.23 – 2.00 
Tyrosol  3.54 – 45.01 
4-O-Caffeoylquinic acid  0.04 – 0.26 
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5-O-Caffeoylquinic acid  0.07 – 0.27 
Caffeic acid  0.03 – 0.42 
p-Coumaric acid  0.03 – 0.32 
Rutin  0.04 – 1.23 
Luteolin  7.58 – 8.84 
Apigenin  1.44 – 1.54 
Clitocybe odora (Fr.) P. Kumm. 
p-Hydroxybenzoic acid  2.79 
Vaz et al., 2011a p-Coumaric acid  0.18 
Cinnamic acid  1.38 
Clitocybe subconnexa Murrill 
Gallic acid  0.01 – 0.06 
Heleno et al., 2015a 
Protocatechuic acid  0.03 – 0.18 
p-Coumaric acid  0.02 – 016 
Cinnamic acid  0.01 – 0.07 
Coprinopsis atramentaria (Bull.) 
Redhead, Vilgalys & Moncalvo 
p-Hydroxybenzoic acid  4.71 
Heleno et al., 2012a p-Coumaric acid  0.82 
Cinnamic acid  1.70 
Coprinus comatus (O.F.Müll.) Pers. 
p-Hydroxybenzoic acid  6.15 
Vaz et al., 2011a p-Coumaric acid 1.88 
Cinnamic acid  1.26 
Cortinarius violaceus (L.: Fr.) Gray 
p-Hydroxybenzoic acid 1.30 
Reis et al., 2011b 
Cinnamic acid 0.56 
Fistulina hepatica (Schaeff.) With. 
Protocatechuic acid 6.76 
Vaz et al., 2011b 
Ribeiro et al., 2007 
p-Hydroxybenzoic acid  4.19 
p-Coumaric acid  9.48 – 16.23 
Cinnamic acid  0.22 
Caffeic acid  9.90 – 13.97 
Ellagic acid  17.11 – 28.46 
Ganoderma lucidum (Curtis) P. 
Karst. 
p-Hydroxybenzoic acid  0.58 
Heleno et al., 2012b p-Coumaric acid  0.38 
Cinnamic acid  0.28 
Gyromitra esculenta (Pers. ex Pers.) 
Fr. 
Protocatechuic acid 3.74 
Leal et al., 2013 
Cinnamic acid tr (< 0.13) 
Helvella lacunosa (Afzel.) 
Protocatechuic acid  0.77 
Leal et al., 2013 p-Hydroxybenzoic acid 0.13 
p-Coumaric acid  0.17 
Hericium erinaceus (Bull.) Persoon 
Gallic acid  0.008 – 0.08 
Heleno et al., 2015b p-Hydroxybenzoic acid  0.001 – 0.07 
p-Coumaric acid  0.02 – 0.14 
Hericium coralloides (Scop.) Pers. 
Gallic acid  0.01 – 0.13 
Heleno et al., 2015b p-Hydroxybenzoic acid 0.002 – 0.10 
p-Coumaric acid  0.02 – 0.15 
Hydnum repandum L. Cinnamic acid  0.45 Vaz et al., 2011b 
Hygrophoropsis aurantiaca 
(Wulfen) Maire 
Cinnamic acid  0.35 Vaz et al., 2011b 
Hygrophorus agathosmus (Fr.) Fr. Protocatechuic acid  1.79 Vaz et al., 2011b 
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p-Coumaric acid  0.87 
Cinnamic acid  4.60 
Hygrophorus olivaceoalbus Fr. (Fr.) 
p-Hydroxybenzoic acid  0.74 
Vaz et al., 2011b 
Cinnamic acid  0.09 
Lactarius deliciosus (L. ex Fr.) 
S.F.Gray 
p-Hydroxybenzoic acid  2.27 Barros et al., 2009 
Lactarius salmonicolor R.Heim & 
Leclair 
p-Hydroxybenzoic acid 0.34 
Vaz et al., 2011b 
Cinnamic acid  0.26 
Lactarius volemus (Fr.) Fr.   
p-Hydroxybenzoic acid  0.46 
Reis et al., 2011b 
Cinnamic acid  0.32 
Lentinula edodes (Berk.) Pegler 
Protocatechuic acid  0.04 
Reis et al., 2012b p-Hydroxybenzoic acid 0.16 
Cinnamic acid  0.002 
Lepista nuda (Bull.) H.E. Bigelow 
& A.H. Sm. 
Protocatechuic acid  3.35 
Barros et al., 2009 p-Hydroxybenzoic acid 2.93 
p-Coumaric acid  0.38 
Lycoperdon molle Pers. 
p-Hydroxybenzoic acid  4.17 
Barros et al., 2009 
Vanillic acid isomers  0.40 – 3.60 
Pleurotus eryngii (DC.) Quél.   
Protocatechuic acid  0.01 
Reis et al., 2012b and 
2014b 
p-Hydroxybenzoic acid  0.01 – 3.81 
p-Coumaric acid  0.10 
Cinnamic acid  0.02 – 0.85 
Pleurotus ostreatus (Jacq. ex Fr.) P. 
Kumm. 
Protocatechuic acid  0.08 
Reis et al., 2012b 
p-Hydroxybenzoic acid  0.16 
p-Coumaric acid  0.08 
Cinnamic acid 0.02 
Russula aurea Pers. 
p-Hydroxybenzoic acid  1.02 
Leal et al., 2013 
Cinnamic acid 17.15 
Russula caerulea (Pers.) Fr. Cinnamic acid  0.26 Vaz et al., 2011b 
Russula delica Fr. 
Gallic acid  0.03 – 0.10 
Fernandes et al., 2014 
Cinnamic acid  0.0008 – 0.0009 
Russula virescens (Schaeff.) Fr. 
p-Hydroxybenzoic acid  22.59 
Leal et al., 2013 
Cinnamic acid 15.75 
Sarcodon imbricatus (L.) P. Karst. p-Hydroxybenzoic acid  3.32 Barros et al., 2009 
Suillus collinitus (Fr.) Kuntze 
Protocatechuic acid 0.52 
Vaz et al., 2011b p-Hydroxybenzoic acid  1.41 
Cinnamic acid  0.13 
Suillus granulatus (L.) Roussel 
Gallic acid 0.11 
Reis et al., 2014a 
Ribeiro et al., 2006 
p-Hydroxybenzoic acid  0.48 
Cinnamic acid 0.13 
Quercetin  0.2 – 1.59 
Suillus luteus (L.: Fries) Gray 
Protocatechuic acid  0.47 
Reis et al., 2011b 
Ribeiro et al., 2006 
Cinnamic acid  0.41 
Quercetin  0.46 
Suillus mediterraneensis (Jacquet. & Protocatechuic acid  0.14 Vaz et al., 2011b 
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J.Blum) Redeuilh p-Hydroxybenzoic acid  0.20 
Cinnamic acid 0.10 
Tricholoma acerbum (Bull.) Quél. 
p-Hydroxybenzoic acid  2.97 
Barros et al., 2009 
Vanillic acid  0.49 – 0.78 
Tricholoma atrosquamosum 
(Chevall.) Sacc. 
p-Coumaric acid  7.93 
Vaz et al., 2011b 
Cinnamic acid 0.74 
Volvopluteus gloiocephalus (DC.) 
Vizzini, Contu & Justo 
Gallic acid  0.02 – 0.07 
Heleno et al., 2015a 
p-Hydroxybenzoic acid  0.003 – 0.09 
p-Coumaric acid  0.02 – 0.17 
Cinnamic acid  0.05 – 0.07 
Xerocomus chrysenteron (Bull.) 
Šutara 
Protocatechuic acid  0.54 
Heleno et al., 2012a 
p-Hydroxybenzoic acid 0.98 
p-Coumaric acid  0.55 
Cinnamic acid  0.55 
Values are presented in mg/100 g of dry weight. 
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Table S3.  Antioxidant properties of Portuguese edible mushroom species. 
Mushroom species  Extract Antioxidant activity mechanism 
Concentration of reducing 
substances / EC50 values 
Reference 
Agaricus albertii (Bon.) Methanolic 
Reducing power 
18.36 (mg GAE/g extract) 
3.04 (EC50; mg/mL) 
Reis et al., 2014b 
DPPH radical scavenging activity 10.17 (EC50; mg/mL) 
β-carotene bleaching inhibition 3.78 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
0.61 (EC50; mg/mL) 
Agaricus arvensis Schaeff. Methanolic 
Reducing power 
2.75 (mg GAE/g extract) 
2.86 - 4.20 (EC50; mg/mL) 
Barros et al., 2007a, 
2008a and 2009 
DPPH radical scavenging activity 3.50 - 48.30 (EC50; mg/mL) 
Inhibition of erythrocyte hemolysis > 5 - >50 (EC50; mg/mL) 
β-carotene bleaching inhibition > 5 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
>50 (EC50; mg/mL)  
Agaricus bisporus (J.E. Lange) 
Imbach 
Methanolic 
Reducing power 
4.49 - 37.33 (mg GAE/g extract) 
1.47 - 3.63 (EC50; mg/mL) 
Barros et al., 2008a 
and 2009 
Reis et al., 2012b DPPH radical scavenging activity 2.29 - 9.61 (EC50; mg/mL)  
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Inhibition of erythrocyte hemolysis > 50 (EC50; mg/mL) 
β-carotene bleaching inhibition 4.85 - 21.39 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
1.45 - 46.82 (EC50; mg/mL) 
Agaricus campestres L. ex Fr. Methanolic 
Reducing power 
20.94 (mg GAE/g extract) 
2.70 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 5.48 (EC50; mg/mL) 
β-carotene bleaching inhibition 4.59 (EC50; mg/mL) 
Agaricus comtulus Fr. Methanolic 
Reducing power 
24.13 (mg GAE/g extract) 
1.29 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 2.22 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.08 (EC50; mg/mL) 
Agaricus lutosus (F.H. Møller) 
F.H. Møller 
Methanolic 
Reducing power 
46.56 (mg GAE/g extract) 
0.91 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 2.54 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.90 (EC50; mg/mL) 
Agaricus silvaticus Schaeff ex. 
Secr. 
Methanolic 
Reducing power 2.08 (EC50; mg/mL) 
Barros et al., 2008a 
DPPH radical scavenging activity 5.37 (EC50; mg/mL) 
Inhibition of erythrocyte hemolysis 22.15 (EC50; mg/mL) 
β-carotene bleaching inhibition 3.72 (EC50; mg/mL) 
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Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
17.79 (EC50; mg/mL) 
Agaricus silvicola (Vittad.) 
Peck 
Methanolic 
Reducing power 
6.40 (mg GAE/g extract) 
3.24 (EC50; mg/mL) 
Barros et al., 2008a 
and 2009 
DPPH radical scavenging activity 6.39 (EC50; mg/mL) 
Inhibition of erythrocyte hemolysis 43.75 (EC50; mg/mL) 
β-carotene bleaching inhibition 14.75 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
31.97 (EC50; mg/mL) 
Agaricus urinascens var. 
excellens (F.H. Møller) Nauta 
Methanolic 
Reducing power 
15.44 (mg GAE/g extract) 
3.71 (EC50; mg/mL) 
Reis et al., 2014b 
DPPH radical scavenging activity 13.80 (EC50; mg/mL) 
β-carotene bleaching inhibition 4.30 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
6.60 (EC50; mg/mL) 
Amanita caesarea (Scop.) Pers Methanolic 
Reducing power 
29.8 (mg GAE/g extract) 
1.36 - 1.85 (EC50; mg/mL) 
Fernandes et al., 
2015 
Reis et al., 2011b DPPH radical scavenging activity 7.41 - 8 (EC50; mg/mL) 
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β-carotene bleaching inhibition 3.7 - 7.47 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
1.5 (EC50; mg/mL)  
Amanita crocea (Quél. in 
Bourd.) Singer ex Singer 
Methanolic 
Reducing power 
22.27 (mg GAE/g extract) 
1.08 (EC50; mg/mL) 
Leal et al., 2013 
DPPH radical scavenging activity 7.94 (EC50; mg/mL) 
β-carotene bleaching inhibition 50.44 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
1.44 (EC50; mg/mL) 
Amanita curtipes E.-J. Gilbert Methanolic 
Reducing power 
30.6 (mg GAE/g extract) 
1.53 (EC50; mg/mL) 
Fernandes et al., 
2015 
DPPH radical scavenging activity 19.0 (EC50; mg/mL)   
β-carotene bleaching inhibition 9.8 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
0.7 (EC50; mg/mL) 
Amanita mairei (Foley) Methanolic 
Reducing power 
8.94 (mg GAE/ g extract) 
2.00 (EC50; mg/mL) Leal et al., 2013 
DPPH radical scavenging activity 13.81 (EC50; mg/mL) 
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β-carotene bleaching inhibition 14.10 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
0.66 (EC50; mg/mL) 
Amanita rubescens (Pers. ex 
Fr.) Gray 
Aqueous DPPH radical scavenging activity 0.304 - 0.990 (IC25; mg/mL) Ribeiro et al., 2008b 
Amanita umbrinolutea (Secr. ex 
Gillet) Bataille 
 
Methanolic 
Reducing power 
9.22 (mg GAE/ g extract) 
2.71 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 10.02 (EC50; mg/mL) 
β-carotene bleaching inhibition 3.69 (EC50; mg/mL) 
Armillaria mellea (Vahl. ex Fr.) 
Kummer 
Ethanolic 
Polysaccharidic 
Reducing power 0.98 – 7.53 (EC50; mg/mL) 
Vaz et al., 2011a DPPH radical scavenging activity 3.95 - 17.13 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.87  - 8.94 (EC50; mg/mL) 
Boletus aereus Bull. Methanolic 
Reducing power 
46.05 (mg GAE/ g extract)  
0.47 (EC50; mg/mL) 
Heleno et al., 2011 
DPPH radical scavenging activity 0.25 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.60 (EC50; mg/mL) 
Boletus armeniacus Quél. 
 
Methanolic 
Reducing power 
44.66 (mg GAE/ g extract)   
0.63 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 1.74 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.77 (EC50; mg/mL) 
Boletus edulis Bull. Aqueous DPPH radical scavenging activity 0.0774 - 0.184 (IC25; mg/mL) Ribeiro et al., 2008b 
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Methanolic 
Reducing power 
28.56 – 57 (mg GAE/ g extract) 
0.62 - 1.16 (EC50; mg/mL) 
Fernandes et al., 
2013a and 2014 
Heleno et al., 2011 
DPPH radical scavenging activity 0.43 – 2.00 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.60 - 2.46 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
1.60 – 3.3 (EC50; mg/mL) 
Boletus impolitus Fr. Methanolic 
Reducing power 
15.50 (mg GAE/g extract) 
2.04 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 5.81 (EC50; mg/mL) 
β-carotene bleaching inhibition 2.04 (EC50; mg/mL) 
Boletus porosporus Imler ex 
Bon & G. Moreno 
Methanolic 
Reducing power 
20.15 (mg GAE/g extract) 
1.58 (EC50; mg/mL) 
Leal et al., 2013 
DPPH radical scavenging activity 6.97 (EC50; mg/mL) 
β-carotene bleaching inhibition 17.08 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
5.49 (EC50; mg/mL) 
Boletus regius (Krombh.) Methanolic 
Reducing power 
30.21 (mg GAE/g extract) 
0.49 (EC50; mg/mL) Leal et al., 2013 
DPPH radical scavenging activity 2.06 (EC50; mg/mL) 
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β-carotene bleaching inhibition 3.81 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
0.51 (EC50; mg/mL) 
Boletus reticulatus Schaeff. Methanolic 
Reducing power 
42.62 (mg GAE/g extract) 
0.96 (EC50; mg/mL) 
Heleno et al., 2011 
DPPH radical scavenging activity 0.38 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.62 (EC50; mg/mL) 
Bovista aestivalis (Bonord.) 
Demoulin 
Methanolic 
Reducing power 
50.91 (mg GAE/g extract) 
0.51 (EC50; mg/mL)  
Pereira et al., 2012 
DPPH radical scavenging activity 2.05 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.61 (EC50; mg/mL) 
Bovista nigrescens (Pers.) Methanolic 
Reducing power 
26.50 (mg GAE/g extract) 
1.21 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 4.62 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.91 (EC50; mg/mL) 
Calocybe gambosa (Fr.) Donk 
Ethanolic 
Polysaccharidic 
Reducing power 2.38 – 11.46 (EC50; mg/mL) 
Vaz et al., 2011a DPPH radical scavenging activity 7.08 – 34.60 (EC50; mg/mL) 
β-carotene bleaching inhibition 7.57 – 8.17 (EC50; mg/mL) 
Calvatia utriformis (Bull. ex 
Pers.) Jaap 
Methanolic 
Reducing power 1.16 (EC50; mg/mL) 
Grangeia et al., 2011 
DPPH radical scavenging activity 0.68 (EC50; mg/mL) 
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 β-carotene bleaching inhibition 8.40 (EC50; mg/mL) 
Cantharellus cibarius Fr. Methanolic 
Reducing power 
1.75 (mg GAE/g extract) 
8.72 (EC50; mg/mL) 
Barros et al., 2008b 
and 2009 
DPPH radical scavenging activity 19.65 (EC50; mg/mL) 
β-carotene bleaching inhibition 8.40 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
8.59 (EC50; mg/mL) 
Chlorophyllum rhacodes 
(Vittadini) Vellinga 
Methanolic 
Reducing power 
22.77 (mg GAE/g extract) 
2.22 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 5.32 (EC50; mg/mL) 
β-carotene bleaching inhibition 2.33 (EC50; mg/mL) 
Clavariadelphus pistillaris (L.) 
Donk 
Methanolic 
Reducing power 
48.10 (mg GAE/g extract) 
0.70 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 1.30 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.94 (EC50; mg/mL) 
Clavariadelphus truncates 
(Quél.) Donk 
Methanolic 
Reducing power 
7.66 (mg GAE/g extract) 
1.33 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 2.74 (EC50; mg/mL) 
β-carotene bleaching inhibition 2.35 (EC50; mg/mL) 
Clitocybe alexandri (Gillet) Ethanolic Reducing power 1.5 – 6.3 (mg GAE/g extract) Heleno et al., 2010 
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Gillet Methanolic 
Polysaccharidic 
0.9 - 7.0 (EC50; mg/mL) Vaz et al., 2010 
DPPH radical scavenging activity 2.5 - 28.7 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.2 - 4.5 (EC50; mg/mL) 
Clitocybe costata Kummer & 
Romagnesi 
Methanolic 
Reducing power 
13.71 (mg GAE/g extract) 
1.66 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 10.56 (EC50; mg/mL) 
β-carotene bleaching inhibition 3.22 (EC50; mg/mL) 
Clitocybe gibba (Pers.) Kumm Methanolic 
Reducing power 
25.26 (mg GAE/g extract) 
1.46 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 10.61 (EC50; mg/mL) 
β-carotene bleaching inhibition 4.00 (EC50; mg/mL) 
Clitocybe odora (Fr.) P. Kumm. 
Ethanolic 
Polysaccharidic 
Reducing power 0.94 – 3.63  (EC50; mg/mL) 
Vaz et al., 2011a DPPH radical scavenging activity 3.56 – 6.77  (EC50; mg/mL) 
β-carotene bleaching inhibition 0.27 – 1.36  (EC50; mg/mL) 
Clitopilus prunulus (Scop. ex 
Fr.) P. Kumm. 
Methanolic 
Reducing power 3.36  (EC50; mg/mL) 
Grangeia et al., 2011 DPPH radical scavenging activity 1.75  (EC50; mg/mL)  
β-carotene bleaching inhibition 12.06  (EC50; mg/mL) 
Coprinopsis atramentaria 
(Bull.) Redhead, Vilgalys & 
Moncalvo 
Phenolic 
Polysaccharidic 
Reducing power 
33.58 (mg GAE/g extract) 
0.88 – 1.29 (EC50; mg/mL) 
Heleno et al., 2012a 
DPPH radical scavenging activity 2.48 – 3.87 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.81 – 1.03 (EC50; mg/mL) 
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Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
1.01 – 1.09 (EC50; mg/mL) 
Methanol/water 
(80:20, v/v) 
Reducing power 1.11 (EC50; mg/mL)   
Ribeiro et al., 2015 DPPH radical scavenging activity 4.62 (EC50; mg/mL) 
β-carotene bleaching inhibition 5.28 (EC50; mg/mL) 
Coprinus comatus (O.F.Müll.) 
Pers. 
Ethanolic 
Polysaccharidic 
Reducing power 1.47 – 4.67 (EC50; mg/mL) 
Vaz et al., 2011a DPPH radical scavenging activity 2.56 – 7.31 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.26 – 7.43 (EC50; mg/mL) 
Cortinarius glaucopus 
(Schaeff.) Fr. 
Methanolic 
Reducing power 2.80 (mg GAE/g extract)  
Heleno et al., 2010 DPPH radical scavenging activity 16.59 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.73 (EC50; mg/mL) 
Cortinarius praestans (Cordier) 
Gillet 
Methanolic 
Reducing power 
17.81 (mg GAE/g extract) 
1.70 (EC50; mg/mL)   
Pereira et al., 2012 
DPPH radical scavenging activity 3.04 (EC50; mg/mL) 
β-carotene bleaching inhibition 2.04 (EC50; mg/mL) 
Cortinarius violaceus (L.: Fr.) 
Gray 
Methanolic 
Reducing power 2.36 (EC50; mg/mL) 
Reis et al., 2011b DPPH radical scavenging activity 15.70 (EC50; mg/mL) 
β-carotene bleaching inhibition 5.73 (EC50; mg/mL)   
Flammulina velutipes (Curtis) 
Singer 
Methanolic Reducing power 
12.98 (mg GAE/g extract) 
1.94 (EC50; mg/mL)   
Pereira et al., 2012 
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DPPH radical scavenging activity 6.19 (EC50; mg/mL)   
β-carotene bleaching inhibition 1.12 (EC50; mg/mL)   
Fistulina hepatica (Schaeff.) 
With. 
Methanolic 
Reducing power 4.44 (mg GAE/g extract) 
Heleno et al., 2010 DPPH radical scavenging activity 5.32 (EC50; mg/mL)   
β-carotene bleaching inhibition 0.94 (EC50; mg/mL)   
Ganoderma lucidum (Curtis) P. 
Karst. 
Phenolic 
Polysaccharidic 
Reducing power 
28.64 – 55.53 (mg GAE/g 
extract) 
0.62 – 0.81 (EC50; mg/mL)  
Heleno et al., 2012b 
DPPH radical scavenging activity 0.14 – 0.22 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.26 – 9.03 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
0.10 – 1.21 (EC50; mg/mL) 
Gyromitra esculenta (Pers. ex 
Pers.) Fr. 
Methanolic 
Reducing power 
27.16 (mg GAE/g extract) 
6.82 (EC50; mg/mL) 
Leal et al., 2013 
DPPH radical scavenging activity 12.66 (EC50; mg/mL) 
β-carotene bleaching inhibition 9.15 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
3.95 (EC50; mg/mL) 
Helvella lacunose (Afzel.) Methanolic Reducing power 13.66 (mg GAE/g extract) Leal et al., 2013 
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17.60 (EC50; mg/mL) 
DPPH radical scavenging activity 26.92 (EC50; mg/mL) 
β-carotene bleaching inhibition 6.53 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
1.13 (EC50; mg/mL) 
Hericium erinaceus (Bull.) 
Persoon 
Methanolic 
Reducing power 
13.41 (mg GAE/g extract) 
3.47 (EC50; mg/mL) 
Heleno et al.,  2015b 
DPPH radical scavenging activity 24.53 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.27 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
1.37 (EC50; mg/mL) 
Hericium coralloides (Scop.) 
Pers. 
Methanolic 
Reducing power 
16.29 (mg GAE/g extract) 
1.63 (EC50; mg/mL) 
Heleno et al.,  2015b 
DPPH radical scavenging activity 22.53 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.28 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
0.74 (EC50; mg/mL) 
Hydnum repandum L. Methanolic Reducing power 0.51 – 6.80 (mg GAE/g extract)  Heleno et al., 2010 
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2.47 (EC50; mg/mL) Fernandes et al., 
2013a DPPH radical scavenging activity 30.00 – 31.00 (EC50; mg/mL) 
β-carotene bleaching inhibition 3.80 - 28.72 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
0.9 (EC50; mg/mL) 
Hygrophoropsis aurantiaca 
(Wulfen) Maire 
Methanolic 
Reducing power 7.90 (mg GAE/g extract)  
Heleno et al., 2010 DPPH radical scavenging activity 1.20 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.71 (EC50; mg/mL) 
Hygrophorus chrysodon (Fr.) 
Fr. 
Methanolic 
Reducing power 
4.58 (mg GAE/g extract) 
7.82 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 20.02 (EC50; mg/mL) 
β-carotene bleaching inhibition 5.95 (EC50; mg/mL) 
Hygrophorus pustulatus (Pers. : 
Fr.) Fries 
Methanolic 
Reducing power 2.61 (EC50; mg/mL) 
Grangeia et al., 2011 DPPH radical scavenging activity 0.74 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.28  (EC50; mg/mL) 
Hypholoma capnoides (Fr.) P. 
Kumm. 
Methanolic 
Reducing power 1.71 (mg GAE/g extract) 
Heleno et al., 2010 DPPH radical scavenging activity 20.85 (EC50; mg/mL)  
β-carotene bleaching inhibition 2.90 (EC50; mg/mL) 
Laccaria amethystina (Huds.) 
Cooke 
Methanolic 
Reducing power 2.85 (mg GAE/g extract) 
Heleno et al., 2010 
DPPH radical scavenging activity 15.72 (EC50; mg/mL) 
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β-carotene bleaching inhibition 1.23 (EC50; mg/mL) 
Laccaria laccata (Scop.) Cooke Methanolic 
Reducing power 1.59 (mg GAE/g extract) 
Heleno et al., 2010 DPPH radical scavenging activity 21.95 (EC50; mg/mL) 
β-carotene bleaching inhibition 3.69 (EC50; mg/mL) 
Lactarius aurantiacus (Pers.) 
Gray 
Methanolic 
Reducing power 0.58 (mg GAE/g extract) 
Heleno et al., 2010 DPPH radical scavenging activity 30.00 (EC50; mg/mL) 
β-carotene bleaching inhibition 7.48 (EC50; mg/mL) 
Lactarius deliciosus (L. ex Fr.) 
S.F.Gray 
Methanolic 
Reducing power 
2.95 – 10.66 (mg GAE/g extract) 
3.42 – 6.69 (EC50; mg/mL)   
Barros et al., 2007c 
and 2009 
Ferreira et al., 2007 
DPPH radical scavenging activity 8.52 – 20.54 (EC50; mg/mL) 
β-carotene bleaching inhibition 3.74 – 3.76 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
26.40 – 29.63 (EC50; mg/mL) 
Lactarius piperatus (L.) Pers. Methanolic 
Reducing power 
2.03 – 5.76 (mg GAE/g extract) 
2.29 – 5.50 (EC50; mg/mL) 
Barros et al., 2007d 
and 2009 
DPPH radical scavenging activity 5.19 - 23.44 (EC50; mg/mL) 
Inhibition of erythrocyte hemolysis 12.14 - > 50 (EC50; mg/mL) 
β-carotene bleaching inhibition 12.08 – 45.06 (EC50; mg/mL) 
Lactarius salmonicolor R.Heim 
& Leclair 
Methanolic 
Reducing power 4.14 (mg GAE/g extract) 
Heleno et al., 2010 
DPPH radical scavenging activity 7.80 (EC50; mg/mL) 
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β-carotene bleaching inhibition 1.01 (EC50; mg/mL) 
Lactarius volemus (Fr.) Fr.   Methanolic 
Reducing power 2.42 (EC50; mg/mL) 
Reis et al., 2011b DPPH radical scavenging activity 21.68 (EC50; mg/mL) 
β-carotene bleaching inhibition 9.08 (EC50; mg/mL) 
Lentinula edodes (Berk.) Pegler Methanolic 
Reducing power 
8.84 (mg GAE/g extract) 
2.62 (EC50; mg/mL) 
Reis et al., 2012b 
DPPH radical scavenging activity 6.43 (EC50; mg/mL) 
β-carotene bleaching inhibition 3.92 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
1.64 (EC50; mg/mL) 
Lepista inversa (Scop. Fr.) Pat. 
Ethanolic 
Methanolic 
Polysaccharidic 
Reducing power 
3.6 – 10.8 (mg GAE/g extract) 
0.7 - 2.9 (EC50; mg/mL) Heleno et al., 2010 
Vaz et al., 2010 DPPH radical scavenging activity 1.8 - 10.6 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.9 - 1.1 (EC50; mg/mL) 
Lepista nuda (Bull.) H.E. 
Bigelow & A.H. Sm. 
Methanolic 
Reducing power 
6.31 – 20.54 (mg GAE/g extract) 
1.50 – 3.53 (EC50; mg/mL) 
Barros et al., 2008c 
and 2009 
Pinto et al., 2013 
DPPH radical scavenging activity 4.41 – 8.73 (EC50; mg/mL) 
β-carotene bleaching inhibition 4.21 – 9.48 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
1.75 – 5.80 (EC50; mg/mL) 
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(TBARS) 
Lepista sordida (Fr.) Sing. Methanolic 
Reducing power 4.10 (mg GAE/g extract)   
Heleno et al., 2010 DPPH radical scavenging activity 9.82 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.03 (EC50; mg/mL) 
Leucoagaricus leucothites 
(Vittad.) Wasser 
Methanolic 
Reducing power 
15.75 (mg GAE/g extract)   
3.28 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 11.33 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.00 (EC50; mg/mL) 
Leucopaxillus giganteus 
(Sowerby) Singer 
Methanolic 
Reducing power 
6.29 (mg GAE/g extract)   
1.71 (EC50; mg/mL) 
Barros et al., 2007a 
and 2009 
DPPH radical scavenging activity 1.44 (EC50; mg/mL) 
Inhibition of erythrocyte hemolysis 1.80 (EC50; mg/mL) 
β-carotene bleaching inhibition 2.00 (EC50; mg/mL) 
Lycoperdon echinatum Pers. Methanolic 
Reducing power 1.61 (EC50; mg/mL) 
Grangeia et al., 2011 DPPH radical scavenging activity 1.04 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.24 (EC50; mg/mL) 
Lycoperdon molle Pers. Methanolic 
Reducing power 
11.48 (mg GAE/g extract) 
2.27 (EC50; mg/mL)    
Barros et al., 2008c 
and 2009 
DPPH radical scavenging activity 3.23 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.92 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 3.31 (EC50; mg/mL) 
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thiobarbituric acid reactive substances 
(TBARS) 
Lycoperdon perlatum Pers. Methanolic 
Reducing power 
10.57 (mg GAE/g extract) 
2.96 (EC50; mg/mL)   
Barros et al., 2008c 
and 2009 
DPPH radical scavenging activity 3.95 (EC50; mg/mL) 
β-carotene bleaching inhibition 2.49 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
4.64 (EC50; mg/mL) 
Lycoperdon umbrinum Pers. Methanolic 
Reducing power 
27.02 (mg GAE/g extract) 
1.27 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 3.45 (EC50; mg/mL) 
β-carotene bleaching inhibition 2.24 (EC50; mg/mL) 
Lyophyllum decastes (Fr. ex Fr.) 
Sing. 
Methanolic 
Reducing power 0.97 (EC50; mg/mL) 
Grangeia et al., 2011 DPPH radical scavenging activity 0.29 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.98 (EC50; mg/mL) 
Macrolepiota excoriate 
(Schaeff.) Wasser 
Methanolic 
Reducing power 1.84 (EC50; mg/mL) 
Grangeia et al., 2011 DPPH radical scavenging activity 1.32 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.23 (EC50; mg/mL) 
Macrolepiota mastoidea (Fr.) 
Singer 
Methanolic Reducing power 
2.69 – 3.08 (mg GAE/g extract) 
4.35 – 4.44 (EC50; mg/mL) 
Barros et al., 2007c 
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DPPH radical scavenging activity 8.18 – 8.49 (EC50; mg/mL) 
β-carotene bleaching inhibition 6.48 – 8.92 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
24.20 – 34.42 (EC50; mg/mL) 
Macrolepiota procera (Scop.) 
Singer 
Methanolic 
Reducing power 
3.17 (mg GAE/g extract) 
4.18 – 4.49 (EC50; mg/mL)   
Barros et al., 2007c 
and 2009 
Fernandes et al., 
2013b 
DPPH radical scavenging activity 5.38 – 6.95 (EC50; mg/mL) 
β-carotene bleaching inhibition 5.19 – 6.23 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
> 50 (EC50; mg/mL) 
Morchella esculenta Fr. Methanolic 
Reducing power 
34.64 (mg GAE/g extract) 
6.34 (EC50; mg/mL) 
Heleno et al., 2013a 
DPPH radical scavenging activity 6.06 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.81 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
1.01 (EC50; mg/mL) 
Pleurotus eryngii (D.C.:Fr.) 
Quél. 
Methanolic Reducing power 
7.14 - 18.43 (mg GAE/g extract) 
2.17 - 3.72 (EC50; mg/mL) 
Reis et al., 2012b 
and 2014b  
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DPPH radical scavenging activity 8.67 - 9.21 (EC50; mg/mL) 
β-carotene bleaching inhibition 4.68 - 14.90 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
1.59 - 3.95 (EC50; mg/mL) 
Pleurotus ostreatus (Jacq. ex 
Fr.) P. Kumm. 
Methanolic 
Reducing power 
12.54 (mg GAE/g extract) 
3.31 (EC50; mg/mL) 
Reis et al., 2012b 
DPPH radical scavenging activity 6.54 (EC50; mg/mL) 
β-carotene bleaching inhibition 2.74 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
2.58 (EC50; mg/mL) 
Ramaria aurea (Schaeff.) Quél. Methanolic 
Reducing power 
8.46 (mg GAE/g extract) 
0.99 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 3.70 (EC50; mg/mL) 
β-carotene bleaching inhibition 2.46 (EC50; mg/mL) 
Russula aurea Pers. Methanolic 
Reducing power 
12.23 (mg GAE/g extract) 
2.91 (EC50; mg/mL) 
Leal et al., 2013 DPPH radical scavenging activity 11.34 (EC50; mg/mL) 
β-carotene bleaching inhibition 9.70 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 2.98 (EC50; mg/mL) 
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thiobarbituric acid reactive substances 
(TBARS) 
Russula cyanoxantha (Schaeff.) 
Fr. 
Aqueous DPPH radical scavenging activity 0.760 - 0.936 (IC25; mg/mL) Ribeiro et al., 2008b 
Methanolic 
Reducing power 2.26 (EC50; mg/mL) 
Grangeia et al., 2011 DPPH radical scavenging activity 0.69 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.98 (EC50; mg/mL) 
Russula delica Fr. Methanolic 
Reducing power 
2.28 - 47 (mg GAE/g extract) 
0.26 (EC50; mg/mL) 
Heleno et al., 2010 
Fernandes et al., 
2014 
DPPH radical scavenging activity 4.3 - 20.53 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.53 - 2.28 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
1.23 (EC50; mg/mL) 
Russula olivacea (Schaeff.) Fr. Methanolic 
Reducing power 7.85 (EC50; mg/mL) 
Grangeia et al., 2011 DPPH radical scavenging activity 1.47 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.95 (EC50; mg/mL) 
Russula vesca Fr. Methanolic 
Reducing power 6.61 (mg GAE/g extract) 
Heleno et al., 2010 DPPH radical scavenging activity 3.91 (EC50; mg/mL)  
β-carotene bleaching inhibition 0.91 (EC50; mg/mL) 
Russula virescens (Schaeff.) Fr. Methanolic Reducing power 
14.05 (mg GAE/g extract) 
8.24 (EC50; mg/mL)  
Leal et al., 2013 
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DPPH radical scavenging activity 30.21 (EC50; mg/mL) 
β-carotene bleaching inhibition 4.28 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
0.23 (EC50; mg/mL) 
Sarcodon imbricatus (L.) P. 
Karst. 
Methanolic 
Reducing power 
2.22 – 3.06 (mg GAE/g extract) 
2.79 – 5.94 (EC50; mg/mL) 
Barros et al., 2007a, 
2007c and 2009 
DPPH radical scavenging activity 1.67 – 10.98 (EC50; mg/mL) 
Inhibition of erythrocyte hemolysis > 5 (EC50; mg/mL) 
β-carotene bleaching inhibition 3.53 – 4.45 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
38.17 – 41.14 (EC50; mg/mL) 
Suillus collinitus (Fr.) Kuntze Methanolic 
Reducing power 3.16 (mg GAE/g extract) 
Heleno et al., 2010 DPPH radical scavenging activity 14.05 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.20 (EC50; mg/mL) 
Suillus granulatus (L.) Roussel 
Aqueous DPPH radical scavenging activity 0.184 - 196 (IC25; mg/mL) Ribeiro et al., 2008b 
Methanolic 
Reducing power 
40.78 (mg GAE/g extract) 
0.57 (EC50; mg/mL) 
Reis et al., 2014a 
DPPH radical scavenging activity 0.98 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.45 (EC50; mg/mL) 
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Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
0.03 (EC50; mg/mL) 
Suillus luteus (L.: Fries) Gray 
Methanolic 
Reducing power 0.75 (EC50; mg/mL) 
Reis et al., 2011b DPPH radical scavenging activity 1.92 (EC50; mg/mL)  
β-carotene bleaching inhibition 0.61 (EC50; mg/mL) 
Methanol/water 
(80:20, v/v) 
Reducing power 0.97 (EC50; mg/mL) 
Ribeiro et al., 2015 DPPH radical scavenging activity 2.86 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.64 (EC50; mg/mL) 
Suillus mediterraneensis 
(Jacquet. & J.Blum) Redeuilh 
Methanolic 
Reducing power 0.81 (mg GAE/g extract) 
Heleno et al., 2010 DPPH radical scavenging activity 2.90 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.81 (EC50; mg/mL) 
Suillus variegatus (Sw.) Kuntze Methanolic 
Reducing power 
58.14 (mg GAE/g extract) 
0.52 (EC50; mg/mL) 
Pereira et al., 2012 
DPPH radical scavenging activity 0.86 (EC50; mg/mL) 
β-carotene bleaching inhibition 1.00 (EC50; mg/mL) 
Tricholoma acerbum (Bull.) 
Quél. 
Methanolic 
Reducing power 
5.53 (mg GAE/g extract) 
3.27 (EC50; mg/mL) 
Barros et al., 2008c 
and 2009 
DPPH radical scavenging activity 3.60 (EC50; mg/mL) 
β-carotene bleaching inhibition 5.89 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 6.20 (EC50; mg/mL) 
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thiobarbituric acid reactive substances 
(TBARS) 
Tricholoma portentosum (Fr.) 
Quél. 
Methanolic 
Reducing power 
3.91 – 10.80 (mg GAE/g extract)  
3.12 – 4.82 (EC50; mg/mL) Ferreira et al., 2007 
DPPH radical scavenging activity 22.9 – >50 (EC50; mg/mL) 
Xerocomus chrysenteron (Bull.) 
Šutara 
Phenolic 
Polysaccharidic 
Reducing power 
36.28 (mg GAE/g extract) 
1.28 – 2.90 (EC50; mg/mL) 
Heleno et al., 2012b 
DPPH radical scavenging activity 2.06 – 11.31 (EC50; mg/mL) 
β-carotene bleaching inhibition 0.95 – 4.43 (EC50; mg/mL) 
Inhibition of lipid peroxidation using 
thiobarbituric acid reactive substances 
(TBARS) 
0.44 – 4.94 (EC50; mg/mL) 
GAE - Gallic acid equivalents; EC50: extract concentration corresponding to 50% antioxidant activity or 0.5 absorbance for the reducing power assay. 
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Table S4. Antibacterial properties of Portuguese edible mushroom species. 
 
Mushroom species Extract 
Pathogens against which the 
antimicrobial activity is exerted 
MIC (mg/mL) 
MBC (mg/mL) 
Reference 
Agaricus bisporus (J.E. Lange) Imbach Methanolic Bacillus subtilis MIC: 0.005 Barros et al., 2008b 
Agaricus silvicola (Vittad.) Peck Methanolic 
Bacillus cereus MIC: 0.005 
Barros et al., 2008b Bacillus subtilis MIC: 0.050 
Staphylococus aureus MIC: 0.005 
Boletus edulis Bull. Methanolic Staphylococus aureus MIC: 0.005 Barros et al., 2008b 
Cantharellus cibarius Fr. Methanolic 
Bacillus cereus MIC: 0.005 
Barros et al., 2008b and 
2008c 
Bacillus subtilis MIC: 0.005 
Staphylococus aureus MIC: 0.005 - 0.050 
Ganoderma lucidum (Curtis) P. Karst. Methanolic 
Bacillus cereus 
MIC: 0.013 
MBC: 0.035 
Heleno et al., 2013b 
Enterobacter cloacae 
MIC: 0.350  
MBC: 0.750 
Escherichia coli 
MIC: 0.350 
MBC: 0.750 
Listeria monocytogenes 
MIC: 0.300 
MBC: 0.750 
Micrococcus flavus 
MIC: 0.500 
MBC: 0.750 
Pseudomonas aeruginosa 
MIC: 0.750 
MBC: 1.500 
Salmonella typhimurium 
MIC: 0.350 
MBC: 0.750 
Staphylococus aureus MIC: 0.025 
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MBC: 0.035 
Lactarius deliciosus (L. ex Fr.) S.F.Gray Methanolic 
Bacillus cereus MIC: 0.5 – 50 
Barros et al., 2007e 
Bacillus subtilis MIC: 0.5 – 300 
Candida albicans MIC: 50 – 100 
Cryptococcus neoformans MIC: 10 – 50 
Pseudomonas aeruginosa MIC: 5 – 300 
Staphylococus aureus MIC: 5 – 50 
Lactarius piperatus (L.) Pers. Methanolic 
Bacillus cereus MIC: 0.5 
Barros et al., 2007b 
Bacillus subtilis MIC: 0.5 
Escherichia coli MIC: 5 
Klebsiella pneumoniae MIC: 0.5 – 5 
Pseudomonas aeruginosa MIC: 0.5 – 5 
Staphylococus aureus MIC: 0.5 
Lepista nuda (Bull.) H.E. Bigelow & 
A.H. Sm. 
Methanolic 
Bacillus cereus MIC: 0.005 
Barros et al., 2008c Bacillus subtilis MIC: 0.005 
Staphylococus aureus MIC: 0.005 
Phellinus linteus (Berkeley & Curtis) 
Teng 
Methanolic 
Bacillus cereus 
MIC: 0.032 
MBC: 0.043  
Reis et al., 2014c 
Enterobacter cloacae 
MIC: 0.048 
MBC: 0.104 
Escherichia coli 
MIC: 0.072 
MBC: 0.12 
Listeria monocytogenes 
MIC: 0.048 
MBC: 0.18 
Micrococcus flavus 
MIC: 0.048 
MBC: 0.13 
Pseudomonas aeruginosa MIC: 0.13 
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MBC: 0.17 
Salmonella typhimurium 
MIC: 0.095 
MBC: 0.19 
Staphylococus aureus 
MIC: 0.12 
MBC: 019 
Ethanolic 
Bacillus cereus 
MIC: 0.077 
MBC: 0.10 
Enterobacter cloacae 
MIC: 0.12 
MBC: 0.22 
Escherichia coli 
MIC: 0.17 
MBC: 0.23 
Listeria monocytogenes 
MIC: 0.022 
MBC: 0.40 
Micrococcus flavus 
MIC: 0.15 
MBC: 0.18 
Pseudomonas aeruginosa 
MIC: 0.047 
MBC: 0.12 
Salmonella typhimurium 
MIC: 0.12 
MBC: 0.37 
Staphylococus aureus 
MIC: 0.10 
MBC: 0.22 
Sarcodon imbricatus (L.) P. Karst. Methanolic 
Bacillus cereus MIC: 10 – 300 
Barros et al., 2007e 
Cryptococcus neoformans MIC: 300 
Suillus granulatus (L.) Roussel Methanolic 
Bacillus cereus 
MIC: 0.10 
MBC: 0.20 
Reis et al., 2014a 
Enterobacter cloacae 
MIC: 0.15  
MBC: 0.2 
Escherichia coli MIC: 0.15 
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MBC: 0.2 
Listeria monocytogenes 
MIC: 0.2 
MBC: 0.4 
Micrococcus flavus 
MIC: 0.2 
MBC: 0.4 
Pseudomonas aeruginosa 
MIC: 0.15 
MBC: 0.2 
Salmonella typhimurium 
MIC: 0.15 
MBC: 0.2 
Staphylococus aureus 
MIC: 0.15 
MBC: 0.2 
Tricholoma acerbum (Bull.) Quél. Methanolic Bacillus subtilis MIC: 0.5 Barros et al., 2008b 
Tricholoma portentosum (Fr.) Quél. Methanolic 
Bacillus cereus MIC: 100 – 300 
Barros et al., 2007e Bacillus subtilis MIC: 300 
Cryptococcus neoformans MIC: 300 
MIC – minimum inhibitory concentration; MBC – minimum bactericidal concentration. 
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Table S5. Antifungal properties of Portuguese edible mushroom species. 
 
Mushroom species Extract 
Pathogens against which the 
antifungal activity is exerted 
MIC (mg/mL) 
MFC (mg/mL) 
Reference 
Ganoderma lucidum (Curtis) P. Karst. Methanolic 
Aspergillus fumigatus 
MIC: 1.5 
MFC: 3.0 
Heleno et al., 2013b 
Aspergillus niger 
MIC: 1.5 
MFC: 3.0 
Aspergillus ochraceus 
MIC: 0.75 
MFC: 1.5 
Aspergillus versicolor 
MIC: 0.1 
MFC: 4.5 
Penicillium funiculosum 
MIC: 0.09 
MFC: 1.5 
Penicillium ochrochloron 
MIC: 0.35 
MFC: 0.7 
Penicillium verrucosum 
MIC: 1.5 
MFC: 3.0 
Trichoderma viride 
MIC: 0.005 
MFC: 0.1 
Suillus granulatus (L.) Roussel Methanolic 
Aspergillus fumigatus 
MIC: 0.45 
MFC: 0.8 
Reis et al., 2014a 
Aspergillus niger 
MIC: 0.05 
MFC: 0.1 
Aspergillus ochraceus 
MIC: 0.1 
MFC: 0.2 
Aspergillus versicolor MIC: 0.1 
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MFC: 0.2 
Penicillium funiculosum 
MIC: 0.05 
MFC: 0.1 
Penicillium ochrochloron 
MIC: 0.075 
MFC: 0.1 
Penicillium verrucosum var. 
cyclopium 
MIC: 0.1 
MFC: 0.4 
Trichoderma viride 
MIC: 0.075 
MFC: 0.1 
MIC – minimum inhibitory concentration; MFC – minimum fungicidal concentration. 
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